UConn Health Center HomeResearch and Sponsored Programs
HOME MEET OUR TEAM FUNDING OPPORTUNITIES QUICK FACTS FAQs
 

Grant Opportunities

Grant Announcement
Deadline
NIH Academic-Community Partnership Conference Series Last date to apply 10/17/2014
American Heart Assn. Research Funding  Deadline 12/16/13 for Letter of Intent
Amer. Diabetes Assn. & Lilly Clin. Res. Awd.:  Diabetes Care in Older Adults Deadline 09/16/13
US-Israel Binational Science Foundation Deadline 08/01/13
Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Intent to Submit Deadline 7/26/13; Internal Screening Deadline 08/07/13
Children's Cardiomyopathy Foundation Mid-July 2013
Damon Runyon Cancer Research Foundation Innovation Award Deadline 07/01/13
Prostate Cancer Foundation 2013 PCF Challenge Award Deadline May 24, 2013
Donaghue Foundation Grant Opportunity - Better Health for Elders in Care Facilities Letter of Intent due May 10, 2013
US-Israel Binational Science Foundation Transformative Science Funding Opportunity Pre-proposal due May 7, 2013
OMeGA Medical Grants Assn. Orthopaedic Residency Funding Opportunity Applications accepted through Friday, May 3, 2013
US-Israel Binational Science Found. Prof. Rahamimoff Travel Grants Deadline May 2, 2013
Crohn's and Colitis Foundation Funding Opportunity LOI due May 1, 2013; Full application due 07/01/13
The Paul Marks Prize for Cancer Research Deadline 04/30/13
Brain Research Foundation Funding Opportunity Intent to Submit due 04/19/13, Letter of Intent due 07/01/13
Donaghue Foundation Grant Opportunity-Behavioral Economics.......Health & Healthcare Deadline April 17, 2013
Cancer Research Institute Irvington Fellowship Program Deadline April 1, 2013
American Stroke Assn.-Bugher Foundation Research Funding Opportunities Letter of Intent due 04/01/13; Application due 06/01/13
Charles H. Hood Foundation Child Health Research Awards Program Deadline 03/27/13, 12 noon
Macy Faculty Scholars Program Deadline 03/06/2013
FY13 DoD Psychological Health & Traumatic Brain Injury Research Program Pre-Application due 02/27/13, Application due 05/21/13
Connecting Kids to Coverage Outreach and Enrollment Grants (Cycle III) Deadline 02/21/13
The Klarman Family Found. Grants Program in Eating Disorders Research Deadline 02/13/2013, 12 noon
NIH Obesity Policy Research:  Evaluation and Measures Funding Opportunity FY2013 Deadline 02/07/2013
 2014-15 Core Fulbright Scholar Program Competition Deadline 02/01/13
2013 Blavatnik Awards for Young Scientists Deadline 01/31/13
American Heart Assn. Medical Student Fellowship Program Deadline 01/31/13
Parkinson's Disease Foundation Summer Student Fellowships Deadline 01/28/13
American Heart Assn. Winter 2013 Research Funding Opportunities Various deadlines beginning 01/22/13
Jefferson Science Fellowships Deadline January 14, 2013
HHMI New Research Opportunity for Medical Students Deadline 01/11/13
Hilda & Preston Davis Found. Postdoctoral Fellowship Pgm. in Eating Disorders Research 01/10/13, 12 noon.
The Mary Kay Ash Charitable Foundation Deadline 1/08/13
DoD Clinical and Rehabilitative Medicine Research Program Pre-application due 01/08/13
HHS-Critical Care Societies Collaborative Awards Deadline 8 p.m. 12/19/12
AFAR Julie Martin Mid-Career Award in Aging Research Deadline December 17, 2012
U.S.-Israel Binational Science Foundation Funding Opportunity Deadline December 6, 2012
Restorative Transplantation Research (RTR) Funding Opportunity Due Date December 5, 2012
DoD Breast Cancer Research Program Postdoctoral Fellowship Award Pre-application (Letter of Intent) due 12/04/12
California Table Grape Commission Health Research Grant Program Letter of Intent due 12/03/12
Simons Foundation Autism Research Initiative Letter of Intent due 11/30/12
Gates Foundation TB Vaccine Accelerator Program Letter of Inquiry due 11/26/12
Gates Foundation Grand Challenges Explorations Initiative Deadline 11/8/12 & 11/26/12
Gates Foundation Reinvent The Toilet Challenge Funding Opportunity Letter of Inquiry due 11/08/12
Gates Foundation Grant Opportunities - New Grand Challenges Explorations Topics Proposals accepted online until 11/07/12
DoD Psychological Health and Traumatic Brain Injury Res. Pgm. Funding Opps. 2012 Pre-proposal due before due date of 10/25/12
Patient-centered Outcomes Research Institute (PCORI) Funding Announcement Ltr. of Intent due 10/15/12, Deadline 12/17/12
Conn. Dept. of Public Health Biomedical Research Funding Opportunities Ltr. of Intent due 09/11/12, Deadline 10/23/12
The Cancer Research Inst.-Irvington Inst. Fellowship Program Deadline 10/01/12
Charles H. Hood Foundation Child Health Research Awards Program Deadline 09/24/2012, 12 noon
DoD Psychological Health & Traumatic Brain Injury Research Pgm. Funding Opportunities Deadline 09/21/12
Susan G. Komen Breast Cancer Research Funding Opportunities Pre-Applications due 09/10/12
U.S.-Israel Binational Science Foundation Call for Proposals for BSF Workshop Program Deadline 09/06/2012
Fondation LeDucq Research Programs 2012-2013 Deadlines 09/11/12 and 09/14/12
Gates Vaccine Innovation Award Deadline August 31, 2012
FY2012 DoD Orthopaedic Program Announcements Pre-applications due June 27, 2012
FY2012 DoD Peer Reviewed Orthopaedic Research Program Pre-applications due June 27, 2012
Gates Foundation:  Innovators in Vaccine Delivery Wanted Deadline 08/31/2012
Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Funding Opp. Intent to Submit Deadline 08/24/12, Internal Screening Deadline 09/04/12, Sponsor Deadline 11/01/12
Pew Scholars Program in the Biomedical Sciences Intent to Submit Deadline 8/24/2012, Internal Screening Deadline 9/4/12, Sponsor Deadline 11/01/12
DoD Lung Cancer Research Program Pre-applications due 08/09/12
DHHS, APIC and SHEA Partnership in Prevention Award Deadline 08/01/12
Fulbright-Management Center Innsbruck Visiting Professorship Deadline 8/01/12
The Fulbright Scholar Program for 2013-2014 is Open Deadline 08/01/12
DoD Duchenne Muscular Dystrophy Research Program Funding Opportunities Pre-applications due 07/25/12
AHA Myocarditis Joint Postdoctoral Fellowship Award & Pediatric Cardiomyopathy Award Various deadlines beginning 07/17/12
AHA Research Programs Offered for July Deadlines Various deadlines beginning 07/17/12
AHA Summer 2012 Research Programs - now available Various deadlines beginning 07/17/12
FY12 DoD CDMRP SCIRP Funding Opportunities Pre-Application deadlines 07/03/12
FY2013 DoD Armed Forces Inst. of Regenerative Medicine II (AFIRM II) Funding Opportunity Pre-Application deadline 07/02/12, 5 p.m.
AHA/ASA/Amer. Brain Found. L. M. Brass, M.D. Stroke Research Post-Doc. Fellowship Awd. Various July Deadlines
American Heart Assn. Program Offerings for July 2012 Deadlines Deadlines beginning 07/01/12
DoD Autism Research Program Funding Opportunities FY2012 Deadlines beginning 06/20/12
DoD Peer Reviewed Cancer Research Program Funding Opportunities FY2012 Deadlines 06/19/2012
PCORI Funding Announcements FY2013 Ltrs. of Intent due 06/15/12; Proposals 07/31/12
Thome Foundation Alzheimer's Disease Drug Discovery Research Funding 2012 Deadline 06/15/12
Howard Hughes Biomedical Research Competition Deadline 06/13/12
Juvenile Offender Reentry Program Evaluation Solicitation Deadline 05/31/2012
DoD Lung Cancer Research Program Funding Opportunities FY2012 Pre-Application deadline 05/30/2012
U.S. Dept. of Justice OJP Releases 2012 Program Plan Various Deadlines beginning 05/24/12
PAR-12-155: Integrative Omics Data Analysis for Discovery in Lung Diseases (R01) Letter of Intent due 05/19/12; Appl. due 06/19/12
DoD Peer Reviewed Orthopaedic Research Program Funding Opportunities FY2012 Deadlines posted on Grants.gov mid-May 2012
Gates Foundation Grant Opportunities Deadlines 05/15/2012 & 05/18/2012
Gates Foundation Reinvent the Toilet Challenge Letter of Inquiry due 5/10/12 at 10 a.m. PST
U. S. Dept. of Labor Research Funding Opportunity FY 2012 Deadline 05/10/2012
DoD Prostate Cancer Research Program Funding Opportunities Deadline 05/10/2012
DoD FY12 OCRP Outcomes Consortium Development Pre-applications Deadline 05/09/2012
U.S. Dept. of Labor Research Funding Opportunities FY 2012 Deadline 05/04/2012
Herbert W. Nickens Awards Nomination Cycle  Deadline 05/04/2012
Prof. R. Rahamimoff Travel Grants for Young Scientists Deadline 05/02/2012
2012 DoD Peer Reviewed Cancer Research Program Funding Opportunities FY2012 Deadlines begin 05/01/2012
DoD Autism Research Program Pre-Announcement of Funding Opportunities FY2012 Deadlines begin 05/01/2012
March of Dimes Prevention of Birth Defects Research Grants LOI Deadline 4/30/2012
DoD Breast Cancer Research Program Funding Opportunities FY 2012 Deadlines range from 04/26/2012 to May 3, 2012
DoD Prostate Cancer Research Program Funding Opportunities Pre-App. deadlines from 04/24/12 to 07/26/12
DoD Multiple Sclerosis Research Program Funding Opportunities FY 2012 Pre-Application Deadline 04/24/2012
DoD Ovarian Cancer Research Program Funding Opportunities Pre-application Deadlines 04/24/2012 & 05/09/2012
DoD Bone Marrow Failure Funding Opportunities FY 2012 Pre-Application Deadline 04/18/2012
March of Dimes Grant Support for Projects Related to Causes of Prematurity LOI deadline 4/15/2012
DoD Peer Reviewed Medical Research Program Funding Opportunities FY 2012 Various deadlines beginning 04/10/2012
DoD Gulf War Illness Research Funding Opportunities FY2012 Deadline for Pre-Applications 04/09/2012
DoD Amyotrophic Lateral Sclerosis Research Funding Opportunities FY 2012 Deadline for Pre-Applications 04/09/2012
BSF Transformative Science Competition Deadline 04/02/12
DoD Peer Reviewed Research Funding Opportunities Various deadlines beginning 04/01/2012
DoD Lung Cancer Research Program Funding Opportunities FY 2012 Various deadlines beginning 04/01/2012
DoD Ovarian Cancer Research Program Funding Opportunities FY 2012 Various deadlines beginning 04/01/2012
Gates Foundation Funding Opportunities Various deadlines beginning 03/23/2012
Charles H. Hood Foundation Child Health Research Awards Program deadline 3/22/2012
Prostate Cancer Found. - A. David Mazzone Awards Program Deadline 03/16/2012
2012 PCF-Mazzone Challenge Award deadline 3/16/2012
Macy Faculty Scholars Program Accepting Applications deadline 3/7/2012
Joint Program Committee for Clinical and Rehabilitative Med. Research Program FY2012 Various deadlines after 03/01/12
DoD Multiple Sclerosis Research Program Funding Opportunities FY2012 Various deadlines after 03/01/12
DoD Bone Marrow Failure Research Program Funding Opportunities FY2012 Various deadlines after 03/01/12
DoD Prostate Cancer Research Funding Opportunities FY 2012 Various deadlines beginning 03/01/12
FY12 DoD CDMRP Pre-Announcements Various deadlines beginning 03/01/12
LRF Additional Support for NIH-funded F32 Postdoctoral Fellows deadline 2/3/2012
DoD Ovarian Cancer Research Program Funding Opportunities FY2012 Various Deadlines beginning 2/01/12
DoD Peer Reviewed Med. Research Program Funding Opportunities FY2012 Various Deadlines beginning 2/01/12
DoD Gulf War Illness Research Programs Anticipated Funding for FY12 Various Deadlines beginning 2/01/12
DoD Neurofibromatosis and Tuberous Sclerosis Complex Research Programs for FY2012 Various Deadlines beginning 2/01/12
2012 Klarman Program in Eating Disorders Research deadline 2/1/2012
2012 AHA Founders Affiliate Medical Student Fellowship Program deadline 1/31/2012
Lasker Clinical Research Scholar Program deadline 1/24/12
New Request for Proposals (RFP) on Centers of Excellence in Pain Education LOI deadline 1/24/12
Kauffman Foundation Now Accepting Nominations for Junior Faculty Fellowship Grants nomination deadline 1/23/2012
Mary Kay Ash Charitable Foundation – Limited Competition deadline 1/17/2012
Postdoctoral Fellowship Program in Eating Disorders Research deadline 1/12/2012
Gates Foundation Grant Opportunities various deadlines beginning 1/11/2012
Lymphatic Research Foundation Postdoctoral Fellowship Awards Program deadline 1/10/2012
NIH Accepting Applications for Director’s Early Independence Awards LOI deadline 12/30/2011
New Scholars Program in Aging - Limited Submission Opportunity Announced LOI deadline 12/9/2011

Announcement
NIH Academic-Community Partnership Conference Series

Description: The purpose of this grant opportunity is to bring together academic institutions/organizations and community organizations to identify opportunities for addressing health disparities through the use of Community-Based Participatory Research (CBPR). The objectives of meetings conducted as part of this award will be to: (1) establish and/or enhance academic-community partnerships; (2) identify community-driven research priorities, and (3) develop long-term collaborative CBPR research agendas.

Eligibility: Non-profit organizations with or without 501(c)(3) status are encouraged to apply. The opportunity is also available to various governmental entities, local organizations, for-profit groups and small businesses.

Link to Full Announcement: Link to Full Announcement

Last Day to Apply: October 17, 2014

Grant is administered by the: National Institutes of Health

American Heart Assn. Research Funding

AHA is accepting applications for research funding for awards that will begin on July 1, 2014. Deadlines vary for affiliate and national programs and for certain award programs. Please see our funding opportunities page for program details and deadlines.

Strategically Focused Research Network -
NEW PROGRAM
The Strategically Focused Research Network for this deadline will focus on PREVENTION.


The AHA is interested in the science community exploring all aspects of prevention, which can assist the AHA in reaching its 2020 Goals and overall mission of building healthier lives free of cardiovascular disease and stroke. To that end, the AHA pursues research from the basic, clinical and population sciences. This RFA will require that each submission have an overall application from the Center Director, as well as three proposals from project Principal Investigators:

  • One proposal addressing basic science discovery in prevention
  • One proposal addressing clinical science discovery in prevention
  • One proposal addressing population science discovery in prevention

A Center application can comprise projects from more than one institution, as long as there is a named sponsoring institution, where the Center Director is located and will manage the oversight and financial responsibilities. Thus, applications should convey how these different areas of science will collaborate, both in their science discoveries and through joint team communication and integration. This program is offered by the AHA National Research Program.

To read the full Request for Applications please visit our Strategically Focused Prevention Research Network page.

Letter of Intent Deadline: Monday, December 16, 2013 5:00 PM Central Time

Mentor/AHA Mentee Award -
NEW PROGRAM
This unique program funds mentors to work with AHA early career grantees who are:

  • working in new/difficult areas of inquiry or potential for new discovery,
  • underrepresented racial and ethnic groups in science, or
  • conducting research at NIH AREA-designated institutions.

This program is being offered by the AHA National Research Program. It is for
independent investigators who hold a faculty/staff appointment equivalent to associate professor or full professor.

Focused Research Funding Opportunities
The American Heart/Stroke Association is committed to identifying and supporting specific science areas deemed vital to achieving our mission and strategic objectives. The Association has established partnerships with various organizations to fund critical need/high impact and focused research programs

AHA/ASA/American Brain Foundation Lawrence M. Brass, M.D.
Stroke Research Postdoctoral Fellowship Award
Special funding is available from the American Brain Foundation to support a training award for an individual interested in embarking on a career in stroke research related to vascular neurology, stroke and neurocritical care. Individuals should not have more than 5 years of postdoctoral research training. Interested parties should submit a postdoctoral fellowship application to their local affiliate.

AHA/CCF Pediatric Cardiomyopathy Joint Research Award
The Children’s Cardiomyopathy Foundation (CCF) has partnered with the American Heart Association (AHA) to establish a research award for investigators conducting research specific to pediatric cardiomyopathy. CCF will provide $35,000 per year for two years to fund one project related to pediatric cardiomyopathy research. The AHA will provide the balance of the funds needed to fully fund the selected award. Interested parties should submit a Beginning Grant-in-Aid or Grant-in-Aid to their local affiliate.

AHA/ Gerontological Society of America National Hartford Centers of Gerontological Nursing Excellence Postdoctoral Fellowship Award
Special funding is made available from the Gerontological Society of America-National Hartford CGNE to support an investigator proposing innovative basic, clinical or translational research projects relevant to gerontological nursing, aging, cardiovascular disease and /or stroke. In addition to an RN degree, applicants must hold a PhD, DN.Sc. or equivalent degree at the time of award activation. DNP applicants are not eligible. The chosen awardee will be expected to attend the GSA Leadership Conference both years of the fellowship. Interested parties should submit a postdoctoral fellowship application to their local affiliate.

AHA/Myocarditis Foundation Postdoctoral Fellowship Award
Supports an investigator proposing innovative basic, clinical or translational research projects relevant to the etiology, pathophysiology, diagnosis, treatment epidemiology and/or prevention of myocarditis. Interested parties should submit a postdoctoral fellowship application to their local affiliate.

 

 

Amer. Diabetes Assn. & Lilly Clinical Research Award:  Diabetes Care in Older Adults

It is currently estimated that at least 25 percent of people aged 65 and older have diabetes, and that percentage is expected to grow as the U.S. population ages. Diabetes in older adults leads to increases in morbidity, decreased functional and mental status, and reduced life expectancy.

Although significant evidence exist that lowering blood glucose, blood pressure and cholesterol reduces the risk of diabetes complications, older adults have typically been excluded from the studies that led to this evidence.

The American Diabetes Association and Eli Lilly and Company are pleased to announce a call for applications for original and innovative research proposals to further identify the safest and most effective means of diabetes treatment for the older adult population.

Application Guidelines: Clinical and translational studies focused on improving the evidence base and understanding of the goals, barriers, and effects of treatments and interventions in older adults with type 1 and type 2 diabetes will be considered.

Support: $550,000 maximum over a three-year term.

Deadline: September 16, 2013, for anticipated funding beginning January 1, 2014. To learn more about this research funding opportunity on diabetes care in older adults, or to apply, please visit professional.diabetes.org/grants-targeted
US-Israel Binational Science Foundation

The United States-Israel Educational Foundation (USIEF), the Fulbright commission for Israel, offers 8 fellowships to American post-doctoral researchers in support of work to be carried out at Israeli universities during the course of the 2014/2015-2015/2016 academic years.

 The US Post-Doctoral Fellowship Program is open to candidates in all academic disciplines.

 Program grants total $40,000, $20,000 per academic year.

 Program fellows must be accepted as post-doctoral researchers by Israeli host institutions, which agree to provide them with a standard post-doctoral grant, which they will receive in addition to their Fulbright Fellowship.  Thus, the total financial support received by Program Fellows is likely to be in the range of at least $35,000-$40,000 per year. 

 Applications for 2014/2015-2015/2016 Fulbright Post-Doctoral Fellowships must be submitted to the Council for International Exchange of Scholars by August 1, 2013.

 Further details on the program and on application procedures may be found at:

 http://fulbright.org.il/en/?page_id=1024;  

http://catalog.cies.org/viewAward.aspx?n=4397&dc=IS;

http://www.cies.org/us_scholars/us_awards/Application.htm.

 Potential candidates should contact Ms. Judy Stavsky, Deputy Director, USIEF (jstavsky@fulbright.org.il; +972-3-517-2392) for advice and assistance.

 

Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Funding Opportunity

The goal of the program is to provide opportunities for accomplished investigators still early in their careers to study the pathogenesis of infectious disease at its most fundamental level – the points where human and microbial systems connect.  The program supports research that sheds light on the fundamentals that affect the outcomes of this encounter: how colonization, infection, commensalism and other relationships play out at levels ranging from molecular interactions to systemic ones. 

 

Limit: Up to two candidates; three candidates if one nominee holds a D.V.M.; and a single additional nomination for working in a pathogenic helminthes, mycology, or reproductive science. 

Intent to Submit Deadline:  7/26/2013

Internal Screening Deadline:  8/7/2013

Sponsor Deadline:  11/1/2013

Submit e-proposals to: Larisa.Zagorski@uconn.edu

 

Because a limited number of applications can be submitted for the following program, an internal screening process may be required.  If you are considering submitting an application for the program listed below, an on-line Notification of Intent to Submit  must be completed by the requested Intent to Submit Deadline.

 

Those submitting Intents to Submit will be notified if a full competition is determined to be necessary.  Please refer to the Guidelines for the internal screening process and any updates.   Pre-proposals not adhering to these guidelines will be returned. 

 

Children's Cardiomyopathy Foundation

The Children’s Cardiomyopathy Foundation (CCF) has partnered with the American Heart Association (AHA) to establish a research award for investigators conducting research specific to pediatric cardiomyopathy. CCF will provide $35,000 per year for two years to fund one project related to pediatric cardiomyopathy research.  The AHA will provide the balance of the funds needed to fully fund the selected award. Interested parties should submit a Beginning Grant-in-Aid or Grant-in-Aid.

Damon Runyon Cancer Research Foundation Innovation Award

REMINDER: INNOVATION AWARD APPLICATION DEADLINE
July 1, 2013

Advances in cancer research often originate from innovative thinking and ingenious approaches. Securing funding for these truly out-of-the box ideas remains a challenge, especially to early career scientists.

T
he Damon Runyon-Rachleff Innovation Award provides support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis and treatment of cancer. This award is specifically designed to provide funding for extraordinary early career researchers who have an innovative, new idea but lack sufficient preliminary data to obtain traditional funding. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.

Eligible applicants (including non-U.S. citizens) must be conducting independent research at a U.S. institution. Institutional nominations are not required and there is no limit to the number of applications that can be received from a particular institution. Basic and translational/clinical projects will be considered and individuals with a background in multiple disciplines are especially encouraged to apply. The awards will provide $450,000 in direct costs during a three year award term. A complete award program description and application guidelines are available on our website (www.damonrunyon.org). Applications are due July 1, 2013.

Please feel free to contact the Foundation at 212.455.0520 or awards@damonrunyon.org with any questions.

The Damon Runyon Cancer Research Foundation wants to emphasize that applications for the Innovation Award will be accepted from all scientific disciplines (e.g., Chemistry, Computer Sciences, Mathematics, Engineering, Physics--not just biomedical) provided that the proposed research meets the selection criteria. Please distribute this notice to all appropriate departments in your Institution and encourage eligible candidates to apply.

Prostate Cancer Foundation 2013 PCF Challenge Award

The Prostate Cancer Foundation (PCF) is pleased to announce the 2013 PCF Challenge Award Request For Applications related to metastatic prostate cancer.

PCF Challenge Awards will support large-scale research projects concerning metastatic prostate cancer over a duration of two years, providing up to a total of $1 million per team. The award will cover direct research costs only. The 2013 PCF Challenge Awards focus on funding Treatment Sciences: Investigations of new ideas in man or laboratory support of a high-impact clinical investigation with a high probability of near-term patient benefit.

Proposals must be from teams of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. The team may be assembled from one institution, or several institutions from across the globe, and must embed a young investigator as an integral contributor to the team.

One of our Challenge awards will be funded in conjunction with Dana-Farber/Harvard Cancer Center (DF/HCC) and designated as an A. David Mazzone-PCF Challenge Award.

Please refer to the complete RFA link for details on eligibility requirements and application submission guidelines. Complete RFA (PDF)

You may submit your online application at www.pcfscience.org after March 22, 2013. The deadline for application submission is May 24, 2013. Funding decisions will be made through peer review by July 8, 2013.

US-Israel Binational Science Foundation Transformative Science Funding Opportunity

This program is dedicated to research driven by ideas that have potential to radically change our understanding of an important scientific concept, or lead to the creation of a new paradigm or a new field of science. 

Applications must be submitted jointly by at least one Israeli and one American scientist.

Transformative Science projects may be up to 3 years in duration and will receive up to $100,000/year.   Pre-proposals will be submitted online using the relevant BSF submissions system, no later than May 7, 2013.  The BSF will be open for submission on April 14, 2013.  Announcement of the applications that are selected for submission of full proposals is expected to be made bymid-July, 2013.  Full proposals will be submitted online using the relevant BSF submission system, not later than Oct. 9, 2013.  Final results are expected mid-February, 2014.

For complete details, consult the BSF website (www.bsf.org.il) under Guidelines and Forms. 

More information available at: http://www.bsf.org.il

Donaghue Foundation Grant Opportunity - Better Health for Elders in Care Facilities

“Another Look:  Better Health for Elders in Care Facilities” will provide funding for health-related research projects that can improve the quality of care and the quality of life for the elderly population in nursing homes or other care facilities.  Specifically, this program invites researchers interested in addressing a particular problem affecting the elderly population in care facilities to analyze data that already exist to address their research question.  New data collection will not be allowed in this program.  A Letter of Intent is due by May 10, 2013.  Based on a review of the letters, selected applicants will be invited to submit a full application.  The Foundation will invest approximately $450,000 in this grant program with awards of up to four two-year projects.

The full grant announcement/letteer of intent instruction and letter of intent form are now available at http://donaghue.org/grant-programs.

For more information, contact the Donaghue Foundation in West Hartford.

More information available at: http://www.donaghue.org

OMeGA Medical Grants Association Orthopaedic Residency Funding Opportunity

OMeGA Medical Grants Association invites orthopaedic residency programs in the Americas to apply for a 2013-2014 residency/general education grant through Friday, May 3, 2013, 5pm CDT. Grants up to $5,000 can be used for educational items including but not limited to:

 

• Books and journals for program use (hard copy or electronic)

• Educational courses, including online courses, self-assessment courses, and other learning aids

• Journal club support (not to conflict with JBJS program)

• Development of novel curricula and/or educational resources

• Skills lab

• Cadaver sessions

• Visiting professors/Grand Rounds speakers

 

Applications with a broader benefit to the residency program are given special consideration.

 

Don’t delay

Visit www.omegamedicalgrants.org to read the help guide, a list of FAQs, and a sample grant recipient agreement.  Access the OMeGA Residency GLM (Grant Lifecycle Manager) to begin the application process.   Click here to learn more. 

 

US-Israel Binational Science Foundation Prof. Rahamimoff Travel Grants

This program supports short, research-related trips for young American scientists to visit Israel and young Israeli scientists to visit the U.S.  It is open to Ph.D. students doing research that requires facilities or expertise no available in their home countries.  Grants are for $4,000. each and the trips are only to a higher education facility in the US (for Israelis) or Israel (for Americans).  Each trip is for a maximum length of 2 months.

Applications must be submitted by email (bsf@bsf.org.il) and must reach the BSF office no later than May 2, 2013.  Final award decisions will appear on the BSF website in mid-July, 2013.

 

Full instruction for submitting Travel Grant application can be obtained from the website in the Buidelines and Forms section

Website:  http://www.bsf.org.il

This program supports short, research-related trips for young American scientists to visit Israel and young Israeli scientists to visit the U.S.  It is open to Ph.D. students doing research that requires facilities or expertise no available in their home countries.  Grants are for $4,000. each and the trips are only to a higher education facility in the US (for Israelis) or Israel (for Americans).  Each trip is for a maximum length of 2 months.

Applications must be submitted by email (bsf@bsf.org.il) and must reach the BSF office no later than May 2, 2013.  Final award decisions will appear on the BSF website in mid-July, 2013.

 

Full instruction for submitting Travel Grant application can be obtained from the website in the Buidelines and Forms section

Website:  http://www.bsf.org.il

Crohn's & Colitis Foundation Funding Opportunity

Please note letters of intent (LOIs) are now being accepted for the CCFA Fall 2013 review cycle. Letters of intent must be submitted electronically, via the link below, and are due no later than Wednesday, May 1, 2013 at 5PM Eastern. Hard copies of LOIs are not required.

 

https://proposalcentral.altum.com/default.asp

 

Those invited to submit full applications must do so no later than Monday, July 1, 2013 at 5PM Eastern.

 

Letters of intent are required for new applications for the Research Fellowship, Career Development and Senior Research Awards. Please note that funding decisions for the Spring 2013 cycle are due to be made in early to mid-May. Resubmitted proposals do not require letters of intent.

 

Thank you in advance for your consideration and please let me know if you have any questions. I can be reached via email at this address or by phone at (646) 943-7505.

 

Joseph O'Keefe, MPA

Director of Grants Administration

The Paul Marks Prize for Cancer Research

2013 Call for Nominations

 

Honoring the legacy of Paul A. Marks, MD, President Emeritus of Memorial Sloan-Kettering Cancer Center and a distinguished scientist, the Paul Marks Prize for Cancer Research recognizes outstanding young investigators who have made significant contributions to increase the understanding of cancer or improve the treatment of the disease through basic or clinical research.

The Paul Marks Prize is awarded every other year to up to three investigators. The first recipients were named in 2001. The winners will present their work at a scientific symposium at Memorial Sloan-Kettering Cancer Center and share a cash award of $150,000.

 

Nominations are now being accepted for the 2013 Paul Marks Prize for Cancer Research. Nominees must be age 45 or younger on the date of the submission deadline, April 30, 2013. Prize winners will be announced in Fall 2013.

 

Nomination Requirements:

• A letter from the nominator outlining the significance of the accomplishments for which the candidate is being recognized.

• A one-page scientific biography of the candidate.

• A list of up to eight of the candidate’s most significant published papers with brief explanations (100 words or less) of the importance of each one.

• The candidate’s curriculum vitae.

• Up to three supporting letters.

 

For further information, please visit: http://www.mskcc.org/research/paul-marks-prize-research or contact: marksprize@mskcc.org.

 

Debra Schaller-Demers, MSOM | Research and Technology Management Division | Memorial Sloan-Kettering Cancer Center
Director, Research Outreach and Compliance (ROC) | RCR Course Director | Administrative Contact Tri-SCI ESCRO  

Mail: 1275 York Avenue, Box 69  New York, NY 10065 | Location: 633 Third Avenue, Suite 1201C, NY, NY 10017

P (646) 227-2282 | C (347) 852-4610 | F (212) 557-8349 | schalled@mskcc.org

RTM Homepage - www.mskcc.org/research/rtm | Tri-Institutional Collaboration Network - http://www.tri-cn.org
SRA Distinguished Facultyand Board Member At-Large - SRA Catalyst Editor-in-Chief - http://sra-catalyst.srainternational.org/

Brain Research Foundation Funding Opportunity

The Brain Research Foundation’s Annual Scientific Innovations Award Program provides funding for innovative science in both basic and clinical neuroscience. This funding mechanism is designed to support creative, exploratory, cutting edge research in well-established research laboratories, under the direction of established investigators.

 

 To be eligible, the nominee must be a tenure-track or tenured professor or associate professor working in the area of studies and brain function in health and disease.  Current major NIH or other peer-reviewed funding is preferred but evidence of such funding in the past three years is essential.  The grant period is for one to two years in the amount of $150,000.

 

 Limit:  One nomination per institution

Intent to Submit Deadline:  April 19, 2013 Internal Screening Deadline: May 3, 2013 Sponsor LOI Deadline:  July 1, 2013

  

Contact information: Larisa Zagorski (Larisa.Zagorski@uconn.edu<mailto:Larisa.Zagorski@uconn.edu>) (860) 486-6378.

Because a limited number of applications can be submitted for this program, an internal screening process may be required.  If you are considering submitting an application, an on-line Notification of Intent to Submit <http://osp.uconn.edu/limited_sub_intent.cfm>  must be completed by the requested Intent to Submit Deadline.

 

We will notify those who submitted Intents to Submit if a full competition is determined to be necessary.  Please refer to the Guidelines <http://osp.uconn.edu/guidelines.php> for the internal screening process and any updates.   Pre-proposals not adhering to these guidelines will be returned.

 

Brain Research Foundation Scientific Innovations Award<http://thebrf.org/Pages/Home/

 

 

Donaghue Foundation Grant Opportunity - Behavioral Economics to Perplexing Problems in Health and Healthcare

“Applying Behavioral Economics to Perplexing Problems in Health and Healthcare” is a partnership with The Robert Wood Johnson Foundation to fund approximately five awards of up to $200,000 for projects that will last up to two years each.  Of particular interest are research proposals that test innovative solutions to the challenge of reducing the use of low-value services in health care and for which academic teams collaborate with an outside organization, corporation, or partner that has a population or infrastructure that can be used to test pioneering and promising behavioral economic approaches.  Call for proposals will close on April 17, 2013.  For more information, you can visit the RWJF website.   You may also contact behealth@upenn.edu or call the Donaghue Office in West Hartford.

ore information available at: http://www.donaghue.org

Cancer Research Institute Irvington Fellowship Program

The Cancer Research Institute is requesting applications for its Postdoctoral Fellowship Program.  The CRI Irvington Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in cancer immunology.  The Institute is seeking hypothesis-drive, mechanistic studies in both immunology and tumor immunology that seek to directly impact our understanding of the immune system's role in cancer risk, tumor initiation, progression, metastasisk, host response to tumors and/or the treatment of cancer.

Deadline:  April 1, 2013

Funding $164,500 over three years

Website:  http://www.cancerresearch.org

American Stroke Assn.-Bugher Foundation Research Funding Opportunities


The Henrietta B. and Frederick H. Bugher Foundation has joined with the American Stroke Association (ASA, a division of the American Heart Association) to support a network of three Centers of Excellence in Stroke Collaborative Research for a period of four years.

The intent of this initiative is to support a collaboration of basic, clinical and population researchers from different specialties whose collective efforts will lead to new approaches, not only to improve the prevention of stroke, but to also expand upon the previous Bugher Stroke initiatives by inviting research on recovery after a stroke; including the areas of repair, regeneration, neuro-plasticity and rehabilitation.

Awards are limited to non-profit institutions in Canada, Mexico and the United States, such as universities and colleges, public and voluntary hospitals, laboratories, research institutes, and other non-profit institutions that can demonstrate the ability to conduct projects and organize a center.

Each of the three centers will receive approximately $2.4 million.

The deadline for the Letter of Intent is April 1, 2013. The deadline for full application submission is June 1, 2013.

The desired characteristics of these centers, the general requirements of the application and the review criteria are described in the Request for Applications (RFA) on our Web site at my.americanheart.org/research.

Charles H. Hood Foundation Child Health Research Awards Program

The Charles H. Hood Foundation was incorporated in 1942 to improve the health and quality of life for children throughout  New England.  Today's research projects encompass many disciplines that have contributed to discoveries in pediatric medicine while launching the careers of promising junior faculty.  The intent of the Award is to support newly independent faculty, provide the opportunity to demonstrate creativity, and assist in the transition to other sources of research funding.  Research projects must be relevant to child health.

Online Application Deadline:  Wednesday, March 27, 2013 at 12:00 noon, U.S. Eastern Time

Application Materials:  www.tmfgrants.org/Hood

Funding Period and Award Amount:  July 1, 2013-June 30, 2015; up to $150,000 awards at $75,000 per year (inclusive of 10% institutional overhead)

Applicant, Project and Geographic Eligibility:  Investigators within five years of their first faculty appointment (inclusive of any independent research positions in a for-profit company)

Research with relevance to child health

Hypothesis-driven clinical, basic science, public health, health services research and epidemiology projects

Non-profit academic, medical or research institutions in New England

United States citizenship or residency is not required

Please direct any questions to 617 695-9439 or GLockwood@hria.org

Macy Faculty Scholars Program
The Josiah Macy Jr. Foundation is seeking applicants for the Macy Faculty Scholars Program, which is designed to foster innovation and develop the next generation of leaders in health professions education.  Up to five early- to mid-career nursing and medicine faculty will be selected to lead new educational reforms at their home institutions over two years.  Scholars are awarded $100,000 per year and are provided opportunities for further career development through national meetings and participation in Macy Foundation activities.  The deadline to apply is 3 p.m. (ET) March 6, 2013.
Website: http://www.macyfoundation.org
FY13 DoD Psychological Health & Traumatic Brain Injury Research Program

Combat Casualty Care Research Program and Joint Program Committee 6 Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program for Fiscal Year 2013 Traumatic Brain Injury Research Award Applications to the Fiscal Year 2013 (FY13) Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program (RP) are being solicited for the Assistant Secretary of Defense for Health Affairs, Defense Health Program (DHP) by the United States Army Medical Research Acquisitions Activity (USAMRAA). The PH/TBI Research Program was initiated in FY07 for the purpose of complementing ongoing Department of Defense (DoD) efforts toward promoting a better standard of care for PH (including post-traumatic stress disorder) and TBI in the areas of prevention, detection, diagnosis, treatment, and rehabilitation. This includes research to benefit Service Members, their family members, veterans, and other beneficiaries of the Military Health System (MHS).

 The Defense Medical Research and Development Program (DMRDP) expects to fund up to six FY13 PH/TBI RP Traumatic Brain Injury Research Award (TBIRA) applications, depending on the quality and number of applications received and the total cost of applications approved for funding. Funding of applications received in response to this Program Announcement/Funding Opportunity is contingent upon the availability of Federal funds for this Program. Funding allotted for this Program Announcement/Funding Opportunity is approximate and subject to change. As of the release date of this Program Announcement/Funding Opportunity, the FY13 Defense Appropriations Bill has not been passed and there is no guarantee that any funds will be made available to support this Program Announcement/Funding Opportunity. The potential funding estimated for this Program Announcement/Funding Opportunity is approximate and subject to change. Up to $12 million (M) in FY13 funds may be available, of which $9M is expected to be reserved for approximately three clinical studies and $3M may be reserved for approximately three applied and or mechanistic (pre-clinical) studies. The executing agent for this Program Announcement/Funding Opportunity is the Office of the Congressionally Directed Medical Research Programs (CDMRP). http://cdmrp.army.mil/funding/phtbi.shtml

Traumatic Brain Injury Research Award

o   Independent investigator at all academic levels (or equivalent) are eligible

o   The intent of this mechanism is to:

o   Promote  new/innovative ideas that have the potential to yield highly impactful data and new avenues of investigation to further the research field of interest;

o   Advance  knowledge regarding the theoretical construct surrounding the traumatic brain injury (TBI) Research Area of interest to increase scientific understanding of certain phenomena or behaviors;

o   Propose new paradigms or challenging existing paradigms; and

o   Address the technical feasibility of promising new devices, behavioral and rehabilitation interventions, therapeutic techniques, clinical guidance, and/or emerging approaches and technologies.

o   Applications should be designed to:

o   Provide objective evidence of induction of structural and functional changes in the brain following TBI that correlate with improved functional outcomes;

o   Maximize functional outcomes, as well as define the mechanisms involved in the structural and functional improvements; and

o   Validate methods to objectively assess structural and functional recovery.  It is recognized that in some cases it may not be possible to precisely define mechanisms or to conduct testing in an animal model.  In such cases, objective measures of improvement in the human condition are paramount.

o   Funding:

o   The maximum allowable total costs for the entire period of performance are $3,000,000 inclusive of indirect costs for clinical studies including clinical trials, and $1,000,000 inclusive of indirect costs for applied and/or mechanistic studies.

o   The maximum period of performance is 3 years,.

o   Subject to availability of funding, approximately three clinical studies and three applied and/or mechanistic (preclinical) studies will be awarded.  All applications must conform to the final program announcements and general application instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.  Requests for e-mail notification of the program announcements release may be sent to help@cdmrp.org<mailto:help@cdmrp.org>  For more information about the Ph/TBI or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).  A pre-application is required and must be submitted through the CDMRP eReceipt website <http://cdmrp.org> (http://cdmrp.org) prior to the pre-application deadline.  Applications must be submitted through the federal government's single-entry portal, Grants.gov<http://grants.gov>

Point of Contact:

CDMRP Help Desk

301-682-5507

help@cdmrp.org<mailto:help@cdmrp.org>

More information available at: http://cdmrp.army.mil/funding/phtbi.shtml

The Connecting Kids to Coverage Outreach and Enrollment Grants (Cycle III)

The Connecting Kids to Coverage Outreach and Enrollment Grants (Cycle III) total $32 million and states, local governments, community-based and non-profit organizations are eligible applicants. You will also find below a reminder of our January 2013 webinars on the Health Care Law 101 in Spanish, Text4Baby and Let’s Move Faith and Communities.

 These grants, funded under the Affordable Care Act, continue efforts to find and enroll eligible children in Medicaid and the Children’s Health Insurance Program (CHIP) that were initially funded under the Children’s Health Insurance Program Reauthorization Act of 2009 (CHIPRA). To learn more about the Children’s Health Insurance Program, go to www.insurekidsnow.gov.

 Grant proposals should focus on one of the following five areas:

 1. Engaging schools in outreach, enrollment and retention activities;

 2. Bridging health coverage disparities by reaching out to subgroups of children that exhibit lower than average health coverage rates;

 3. Designing and executing targeted enrollment strategies to streamline health coverage enrollment for individuals participating in SNAP, WIC or other public benefit programs;

 4. Establishing and developing application assistance resources to provide high quality, reliable Medicaid/CHIP enrollment and renewal services in local communities; and

 5. Conducting training programs to equip communities to help families understand the new application and enrollment system and to deliver effective assistance to families with children eligible for Medicaid and CHIP.

The solicitation for the Connecting Kids to Coverage Outreach and Enrollment Grants, which includes full instructions on how to apply, can be found at http://www.grants.gov/search/search.do;jsessionid=7HLcQrnbZzyKpyvgJkFVpggTRFhWRfxMrWCrdlHXmKWpNGppqZSC!-804278280?oppId=214153&mode=VIEW 

 Proposals are due on February 21, 2013 with grant award notification anticipated on June 1, 2013. Grants are expected to range from $250,000 to $1 million for a two-year period.

 The Centers for Medicare and Medicaid Service is holding two teleconferences to provide interested parties an opportunity to ask questions. The first teleconference is taking place on January 16, 2013 from 2:00 to 3:00 pm Eastern Time. The dates, times, and call-in numbers for this and future teleconferences will be posted on the InsureKidsNow.gov website at www.insurekidsnow.gov/professionals/outreach/grantees.

NIH Obesity Policy Research:  Evaluation and Measures Funding Opportunity FY 2013

Description: The overarching goal of this FOA is to inform public policy and research relevant to (1) diet and physical activity behavior, and (2) weight and health outcomes of Americans. This grant opportunity encourages applicants to:  (1) conduct evaluation research on obesity-related natural experiments (defined here as community and other population-level public policy interventions that may affect diet and physical activity behavior), and/or (2) develop and/or validate relevant community-level measures (instruments and methodologies to assess the food and physical activity environments at the community level).

Eligibility: Non-profit organizations with or without 501(c)(3) status are encouraged to apply. The opportunity is also available to various governmental entities, local organizations, for-profit groups and small businesses. 

Link to Full Announcement: Link to Full Announcement

Last Day to Apply: February 7, 2013

Grant is administered by the: National Institutes of Health

 

2014-15 Core Fulbright Scholar Program Competition

               
Fulbright Scholar Program sends 800+ U.S. faculty and professionals abroad each year. The Catalog of Awards will be available beginning

February 1 at www.catalog.cies.org. To register your interest in the program,join the My Fulbright online community for updates and to access helpful resources for applicants: http://www.cies2.org/s/1064/index.aspx

2013 Blavatnik Awards for Young Scientists

*       The nomination deadline for the 2013 Blavatnik Awards for Young Scientists program is quickly approaching at midnight on January 31, 2013. Please consider submitting nominations for the best and brightest scientists at your institution to compete in this exciting new year of awards. For more information about this program – including a list of past finalists and judges – and about how to nominate for the 2013 program, please visit our website at www.nyas.org/blavatnikawards.

The Blavatnik Awards were created in 2007 to honor the next generation of life and physical scientists, mathematicians, and engineers hailing from the New York tri-state region. These awards congratulate both finalists and winners alike with unrestricted financial prizes; now in its sixth year of competitions, we hope to receive nominations from your institution’s top scientific researchers.

We very much look forward to working with you during the next week and a half of nominations. If you have any questions or need any assistance, please contact Mr. Marley Bauce, Awards Administrator, at (212) 298-8624 or awards@nyas.org.

The New York Academy of Sciences
2013 Blavatnik Awards for Young Scientists

American Heart Assn. Medical Student Fellowship

The American Heart Association Founders Affiliate is sponsoring a Medical Student Fellowship program (2013). The application submission deadline is Thursday, January 31, 2013 at 5:00 pm Eastern Standard Time.

 

Please be advised that students who apply for this program must obtain the sponsorship of an established investigator engaged in appropriate cardiovascular research at a research facility within the Founders Affiliate which includes Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Rhode Island and Vermont.  The American Heart Association is not responsible for providing the students with appropriate institutions and/or sponsors within the Founders Affiliate.

 

This fellowship is being administered at the AHA’s Founders Affiliate New York City office.  For further information please call 212-878-5912.   All email inquiries should be sent to my attention at: mary.gonzalez@heart.org

 

Medical Student Fellowship Program

The purpose of the grant is to encourage medical students to consider a career in cardiovascular research.  The need for new researchers in the health sciences, from basic science to human behaviors, is critical.  This program is designed to provide students at the crossroads of career choices an opportunity to experience research first hand with an established investigator.

Application deadline:     Thursday, January 31, 2013 at 5:00 pm EST.

Award amount:              Student Stipend: $22,000 (which includes 10% indirect costs)

Award duration:             Medical Students generally begin their programs between July 1 & September 1 for a period of 12 months.

 Please read the attached program description and if applicable, complete the application form and send by email no later than Thursday, January 31, 2013 at 5:00 pm Eastern Standard Time.  Also attached is a poster announcement to be posted and shared with other departments/colleagues.

 For more information and online forms, please visit: www.heart.org/foundersaffiliateresearch

 Please don’t hesitate to contact me  if you have any questions.

Mary Gonzalez

Research Coordinator

Founders Affiliate

 American Heart Association

American Stroke Association

122 East 42nd Street, 18th Floor

New York, NY  10168

Phone 212-878-5912

Parkinson's Disease Foundation Summer Student Fellowships

PDF's Summer Fellowship program is used to support students--from advanced undergraduates to graduate and medical students-- in their pursuit of Parkinson's-related summer research projects. Fellows work under the close supervision of a mentor who is an expert in the Parkinson's Disease community and oversees the project. Fellowships are offered for 10 weeks of laboratory work, with an award amount of $4,000.

This award is to be used to support the student's summer research, for example, to defray tuition costs of research credits or to supplement living/housing costs.

 Eligibility:

Undergraduate students, graduate students and medical students are all eligible for summer fellowships.  Each applicant must identify a mentor with whom he or she will conduct the proposed project. This program is open to both national and international applicants.

 Application Instructions, Deadlines, & Start Dates:

-Applications are due Monday, January 28, 2013.

 Complete applications will consist of the following:

-Two page proposal describing the research plan, written by applicant in conjunction with mentor

-Copy of the student's academic transcript

-Statement of interest , written by applicant

-Letter of support, written by the mentor under who the applicant plans to work

-Completed application form

 To Apply:

Please visit the link below to create an account, or log in with an already existing account to apply.

http://grants.pdf.org

 Complete information regarding eligibility and instructions can be found at:

http://www.pdf.org/en/grant_funding_fellow#summer

 Beth A. Vernaleo, Ph.D.

Research Grants Manager

Parkinson's Disease Foundation (PDF)

1359 Broadway, Suite 1509

New York, NY 10018

(212) 923-4700 / (800) 457-6676

American Heart Assn. Winter 2013 Research Funding Opportunities

AHA is accepting applications for research funding for awards that will begin on July 1, 2013.
For awards that began in 2012, AHA’s National Research Program and seven affiliate research programs received 5,661 applications for research support; 978 were funded, for a success rate of 17.3 percent.

AppDeadlines

Next application deadlines:
Founders Affiliate
Great Rivers Affiliate
Greater Southeast Affiliate
Mid-Atlantic Affiliate

Jan. 22
Jan. 23
Jan. 23
Jan. 22

Midwest Affiliate    Jan. 28
National Research Program    Jan. 30
SouthWest Affiliate   Jan. 29
Western States Affiliate  Jan. 29

Jan. 28
Jan. 30
Jan. 29
Jan. 29

Feb. 7 is the deadline for:
Medical Student Research Program (offered by Western States Affiliate only) and
Student Undergraduate Research Program (offered by Midwest, SouthWest, Western States Affiliates)

Focused Research Funding Opportunities Fall 2012

MyocarditisFndn

AHA/Myocarditis Foundation Postdoctoral Fellowship Award
Supports an investigator proposing innovative basic, clinical or translational research projects relevant to the etiology, pathophysiology, diagnosis, treatment epidemiology and/or prevention of myocarditis. Interested parties should submit a postdoctoral fellowship application to their local affiliate.

 AHA/Gerontological Society of America National Hartford Centers of Gerontological Nursing Excellence Postdoctoral Fellowship Award

Special funding is made available from the Gerontological Society of America-National Hartford CGNE to support an investigator proposing innovative basic, clinical or translational research projects relevant to gerontological nursing, aging, cardiovascular disease and /or stroke. In addition to an RN degree, applicants must hold a PhD, DN.Sc. or equivalent degree at the time of award activation.  DNP applicants are not eligible. The chosen awardee will be expected to attend the GSA Leadership Conference both years of the fellowship. Interested parties should submit a postdoctoral fellowship application to their local affiliate.

Jefferson Science Fellowships
Tenured, or similarly ranked, academic scientists, engineers and physicians from U.S. institutions of higher learning, who are U.S. citizens, are eligible to apply for this Fellowship.  Each fellow will spend one year at the U. S. Dept. of State or USAID in Washington, D.C.  Following the fellowship year, the Jefferson Science Fellow will return to his/her academic career, but will remain available to the U.S. government as an experienced consultant for short-term projects.  During the one year assignment at the U.S. Dept. of State/USAID, the salary and benefits of the Fellow will be paid by the academic institution at which the appointment is held.  The academic position of the Fellow, together with all the rights and privileges associated with that position, will be maintained during his or her assignment at the U.S. Dept. of State/USAID.  The Fellow will be paid a per diem of up to $50,000 by the U.S. Dept. of State/USAID to cover local living expenses for a full year.  In addition, $10,000 will be made available to the Fellow for travel associated with their assignments at the U.S. Dept. of State/USAID.  Travel support may also be provided by the Fellow's office or bureau.
An on-line application and detailed instructions on the application process are available on the JSF website:  www.nas.edu/jsf.
Application deadline:  January 14, 2013
Interviews of finalists and selection of awardees:  February/March 2013
JSF Placement week in Washington, D.C.:  June/July 2013
JSF Fellows report to the Office of the Science and Technology Adviser:  August 2013
HHMI New Research Opportunity for Medical Students

*       The Howard Hughes Medical Institute (HHMI) and the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) recently announced a partnership to fund medical students for a year of basic research through HHMI’s Medical Research Fellows Program.  The partnership presents a unique opportunity for students to conduct research in tuberculosis and HIV at K-RITH, a new research institute in Durban, South Africa.  The application deadline is Jan. 11, 2013.  For more information, visit www.hhmi.org/medfellowships.

Howard Hughes Medical Institute Medical Research Fellows Program
The Howard Hughes Medical Institute (HHMI) Competition System is open for applications to the Medical Research Fellows Program.  The program enables students at U.S. medical schools to participate in a yearlong, mentored, basic, translational, or applied biomedical research training experience at an academic or nonprofit institution other than the NIH, or at HHMI’s Janelia Farm Research Campus near Washington, D.C.  For more information, visit www.hhmi.org/medfellowships
Hilda & Preston Davis Found. Postdoctoral Fellowship Program in Eating Disorders Research

2013 Grant Cycle

 The Hilda and Preston Davis Foundation is pleased to announce the 2013 cycle of its Postdoctoral Fellowship Program in Eating Disorders Research. By attracting young scientists to the field, each fellowship may lead to lifetime contributions to understanding the biological causes of eating disorders. The long term goal of the program is to accelerate medical research discoveries that will lead to improved therapies for anorexia nervosa and bulimia nervosa. The awards support postdoctoral fellows working in nonprofit academic or research institutions in the United States.

 Proposals must be focused on relevant aspects of the biological causes of anorexia nervosa and bulimia nervosa as defined by clinical criteria. Examples of funding areas include but are not limited to neural pathways of feeding behavior in animal models; molecular genetic analysis of relevant neural circuit assembly and function; testing of new chemical compounds that might be used in animal models as experimental treatments; and brain imaging technologies that identify neurochemical pathways in patients with these disorders. Clinical psychotherapeutic studies, medication trials, and obesity research are currently outside the scope of this program.

 Application Deadline: Thursday, January 10, 2013 (12:00 Noon Eastern Time)

 Funding Period and Amount:

Up to five three-year awards: July 1, 2013 – June 30, 2016

$43,000 - $63,000 annually

 Please direct questions to 617-279-2240 ext.709 or jbrown@hria.org

The Mary Kay Ash Charitable Foundation

The Mary Kay Ash Charitable Foundation http://www.mkacf.org/Pages/Home.aspx funds innovative, translational research with the goal that these efforts will lead to improvement in the diagnosis, prognosis, prevention, or treatment of ovarian, uterine, breast or cervical cancer. The 2013 MKACF awards -- http://www.mkacf.org/Pages/CancerGrantProgram.aspx -- provide up to $100,000 for a two-year period.

 

 

UConn/UCHC may only submit one grant application. Interested applicants should send a current BioSketch and 2-3 page research abstract (.pdf files) to: orsp@uchc.edu<mailto:orsp@uchc.edu<mailto:orsp@uchc.edu%3cmailto:orsp@uchc.edu> by Tuesday, Jan. 8th.   Pre-proposal applications will be reviewed by the ad-hoc scientific advisory committee, which will select the 2013 nominee.

 

DoD Clinical and Rehabilitative Medicine Research Program

Funding Opportunities for Fiscal Year 2013

lease view in html to activate links.

Applications to the Fiscal Year 2013 (FY13) Defense Medical Research and Development Program (DMRDP) are being solicited for the Assistant Secretary of Defense for Health Affairs, Defense Health Program (DHP), by the U.S. Army Research Acquisitions Activity (USAMRAA). The executing agent for this Program Announcement/Funding Opportunity is the Office of the Congressionally Directed Medical Research Programs (CDMRP). The goal of the DMRDP is to advance the state of medical science in those areas of most pressing need and relevance to today’s battlefield experience. The objectives of the DMRDP are to discover and explore innovative approaches to protect, support, and advance the health and welfare of military personnel, families, and communities; to accelerate the transition of medical technologies into deployed products; and to accelerate the translation of advances in knowledge into new standards of care for injury prevention, treatment of casualties, rehabilitation, and training systems that can be applied in theater or in the clinical facilities of the Military Health System (MHS). Applications from investigators within the military services are highly encouraged, as are applications involving multidisciplinary collaborations among academia, industry, the military services, the Department of Veterans Affairs (VA), and other Federal Government agencies.

 http://cdmrp.army.mil/funding/dmrdp.shtml

 Award Mechanism:

Assistive Technologies Research Award – Pre-application due January 8, 2013

Independent investigators at all academic levels (or equivalent) are eligible to submit applications.

Preproposal is required; application submission is by invitation only.

Key Mechanism Elements:

·         Supports early-phase clinical trials for technologies with the potential to have a major impact on the restoration of vision, hearing, and/or balance following combat-related injuries.

·         Specific focus area is on restorative and rehabilitative assistive technologies for sensory substitution/augmentation of vision, hearing, and/or balance.

·         Studies can range from proof of concept (i.e. first in human) trials through Phase II clinical trials, as well as Class I, II, or III medical device trials/testing.

·         Funding cannot be used for preclinical research studies.

·         Maximum funding of $2M for total costs (direct + indirect).

·         Maximum period of performance is not to exceed 4 years.

 All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism is also available on the Grants.gov website. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

A pre-application (preproposal) is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to application submission.  Applications must be submitted through the federal government's single-entry portal, Grants.gov. 

 Requests for email notification of the release of program announcements may be sent to Help@cdmrp.org.  Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

For more information about the DMRDP or other CDMRP-sponsored programs, please visit the CDMRP website (http://cdmrp.army.mil). If you would like to request a different recipient to these messages please reply back with the corrected information.

Point of Contact:

CDMRP Helpdesk

301-682-5507

help@cdmrp.org

 

HHS-Critical Care Societies Collaborative (CCSC) Awards

For the third year, the U.S. Department of Health & Human Services (HHS) and the Critical Care Societies Collaborative (CCSC)* call for applications from teams of critical care professionals and healthcare institutions with demonstrated systems of excellence for reducing and eventually eliminating targeted healthcare-associated infections (HAIs). 

Targeted HAIs for the 2013 awards cycle are as follows:

·         catheter-associated urinary tract infections (CAUTI);

·         central line-associated bloodstream infections (CLABSI); and,

·         ventilator-associated pneumonia (VAP).

Awards for reducing CAUTI, the most prevalent HAI, are new this year. Hospitals, units, and teams demonstrating sustained reduction or elimination of the targeted HAIs for a minimum of 25 months combined with national leadership in disseminating information about their success are eligible. 

Information about eligibility, selection criteria and the electronic application are available at: www.aacn.org/haiawards2013

Applications must be received by 5 p.m. PT/8 p.m. ET on December 19, 2012

Winners will be announced in spring 2013. Awards will be presented in May 2013 during the American Association of Critical-Care Nurses (AACN) 2013 National Teaching Institute & Critical Care Exposition in Boston, Massachusetts.

For additional information about the application process and awards program, please contact: awards@aacn.org.

AFAR Julie Martin Mid-Career Award in Aging Research
This award, sponsored by the Ellison Medical Foundation, is designed for outstanding mid-career scientists who propose new directions of high importance to biological gerontology.  Proposals in areas where NIH funding is unlikely because the research is high risk are particularly encouraged if they have potential to lead to major new advances in the understanding of basic mechanisms of aging.
The applicant must be an associate professor who was promoted to that position (with or without tenure) after December 1, 2009.  Scientists not previously engaged in aging research, but whose research could lead to novel approaches in aging are eligible.  Scientists already engaged in aging research, but whose proposed research is a new high-risk direction of investigation with a potential high payoff in our understanding of basic aging processes, are also eligible.
Two four-year awards of $500,000 will be made in 2013 at the level of $125,000 per year.  In addition, up to 10 percent ($50,000) may be requested for administrative/indirect costs.
Visit the AFAR Website for complete program information, application instructions and an FAQ.

Link to complete RFP -
http://www.afar.org/research/funding/midcareer/
Primary subject:  Aging
Geographic Funding Area:  National
More information available at:  http://www.afar.org/research/funding/midcareer
U.S.-Israel Binational Science Foundation Funding Opportunity

The BSF is announcing the availability of funds for short scientific trips by young American or Israeli scientists to the other country. In the next round, a total of 10 grants will be awarded, each for $4,000.

 

The deadline for the submission of applications is December 6th 2012. Please follow the instructions given on the BSF website, www.bsf.org.il, under ‘Grant Programs’/’Travel Grants’.

 

Please see the link to the call for proposals below:

 

http://www.bsf.org.il/data/FormsToDownload/BSF-TravelGrant-call.PDF?PageId=251&innerTextID=251
Restorative Transplantation Research (RTR) Research Award Program Announcement
The Assistant Secretary of Defense for Health Affairs, Defense Health Program Research and Development Office is soliciting applications for the Fiscal Year 2012 (FY12) Restorative Transplantation Research (RTR) Program. The RTR program focus is funding innovative projects that have the potential to make a significant impact on improving the function, wellness, and overall quality of life for injured military Service members and veterans, their caregivers and family members, and the American public. The FY12 RTR program challenges the scientific community to design innovative research that will foster new directions for and address neglected issues in the field of RTR-focused research.
Due Date:  December 5, 2012
www.grants.gov
Current Closing Date for Applications: Dec 05, 2012   
Dod Breast Cancer Research Program Postdoctoral Fellowship Award

The Postdoctoral Fellowship Award supports exceptionally talented recent doctoral or medical graduates in their pursuit of innovative, high-impact breast cancer research during their postdoctoral training and allows them to obtain the necessary experience for an independent career at the forefront of breast cancer research. These individuals should be exceptionally talented scientists who have demonstrated that they are the "best and brightest" of their peers. Applicants for this award must exhibit a strong desire to pursue a career in breast cancer research.

Pre-application due Dec. 4, 2012

Confidential Letters of Recommendation and Application due Dec. 18, 2012

California Table Grape Commission Health Research Grant Program

The California Table Grape Commission is pleased to announce its request for Letters of Intent (LOI) to submit a proposal for its 2013-14 Health Research Grant Program. The commission welcomes Letters of Intent from you and other researchers at your institution and asks that you notify other interested researchers about the LOI. This year we will be reviewing Letters of Intent for $30,000 grants that may be applied toward any relevant health issue in which grape consumption may have a beneficial impact.

 All details concerning the submission of a Letter of Intent can be accessed on the commission’s web site at www.grapesfromcalifornia.com. Available documents include: the Request for Letters of Intent Guidelines, a Grape Powder Analysis Report, the Grape Powder Usage Guidelines and a list of previously funded research. Where available, published studies resulting from previously funded research can be accessed for review by the applicant, if planning research in a similar area. The purpose of making this information available is to help ensure that new proposals in an area previously studied, appropriately continue and expand on that work, with effective doses and protocols.

Once again, we are soliciting Letters of Intent first. Following the review of submitted Letters of Intent, finalists will be invited to submit a complete proposal to the commission. Please note: Letters of Intent must be submitted electronically in a single PDF file.

 Deadline for submission of Letters of Intent is Monday, December 3, 2012 at 5 p.m. Pacific Standard Time (PST). Please visit www.grapesfromcalifornia.com for the Request for Letters of Intent Guidelines.

 The major goal of this program is to fund studies that examine the potential health benefits of grape consumption. To facilitate such studies, the California Table Grape Commission developed a freeze-dried grape powder made from fresh California table grapes, which is to be used for work funded by this grant program. The powder is a composite of seeded and seedless red, green and black California grapes. As with fresh grapes, the powder is known to contain simple phenolics, resveratrol, flavans (including catechins), flavonols (including quercetin), and anthocyanins. 2013-14 Health Research Grant Program Page 2 of 2 October 29, 2012

 The commission’s Health Research Grant Program is overseen by a scientific advisory panel of distinguished researchers who will be reviewing the Letters of Intent. In the meantime, any inquiries regarding this process should be directed to healthresearch@grapesfromcalifornia.com.

 

Simons Foundation Autism Research Initiative

Simons Foundation Autism Research Initiative Invites Letters of Intent for Pilot and Research Awards The mission of the Simons Foundation Autism Research Initiative <http://sfari.org/>  is to improve the diagnosis and treatment of autism spectrum disorders by funding, catalyzing, and driving research of the greatest quality. The program is seeking applications for SFARI awards from individuals who will conduct bold, imaginative, rigorous, and relevant research.

 Applications are invited for the following types of awards:

SFARI Pilot Awards are intended for innovative, high-impact proposals requesting support for small-scale projects or early-stage experiments that will build on preliminary data or a prior track record and lead to competitive applications for funding by SFARI or other organizations. Investigators new to the field of autism are encouraged to apply for pilot awards. The maximum budget is $125,000 (including indirect costs) per year for up to two years. (Letters of Intent Deadline: November 30, 2012.)

 SFARI Research Awards are designed for investigators with demonstrated expertise conducting compelling high-impact research on an experimental hypothesis for which, in most cases, preliminary data have already been gathered. The foundation also will consider projects focused on a central hypothesis where success depends on close collaboration between two or more labs. The initiative expects to fund proposals for a maximum of $250,000 per year ( including indirect costs) for up to three years, but under exceptional circumstances will consider proposals at higher levels. (Letters of Intent Deadline: November 30, 2012.)

 In addition to the pilot and research award programs, the SFARI Explorer Award program accepts applications at any time for rapid review and support through a rolling award program. The Explorer Award program provides timely resources on a one-time basis, not to exceed $60,000, including indirect costs, to support focused experiments highly relevant to SFARI's mission.

 All applicants and key collaborators must hold a Ph.D., M.D., or equivalent degree and have a faculty position or equivalent at a college, university, medical school, or other research facility. Applications may be submitted by domestic and foreign nonprofit organizations; public and private institutions such as colleges, universities, hospitals, laboratories, units of state, and local government; and eligible agencies of the federal government. There are no citizenship or country requirements.

 Visit the SFARI Web site for complete program guidelines and application procedures.

 Contact:

Link to Complete RFP <http://sfari.org/funding/grants/2013-rfa>

http://sfari.org/funding/grants/2013-rfa
Gates Foundation TB Vaccine Accelerator Program

The Bill & Melinda Gates Foundation’s TB Vaccine Accelerator Program is requesting applications for projects that will help meet one or both of the following two interrelated goals:

 §  To develop novel approaches to vaccination against Mycobacterium tuberculosis (Mtb), with a particular focus on approaches that aim to induce protection against infection with Mtb

§  To develop models of natural Mtb transmission and methods for defining the relevant molecular and biological characteristics of naturally transmitted mycobacteria and of their interactions with vertebrate hosts

 The prevention of tuberculosis (TB) through the development and deployment of an effective vaccine is a priority of the Bill & Melinda Gates Foundation.  To strengthen the pipeline of vaccine candidates and enable a more rational and accelerated vaccine development process, the foundation, in collaboration with its Product Development Partner Aeras, recently launched the TB Vaccine Accelerator Program.  With the assistance and support of the TB research and development community, a set of obstacles to TB vaccine development—and integrated goals that, collectively, could help to directly understand, overcome or work around these obstacles—have been selected.  Through a research program focused on achieving this defined set of interdependent goals, the TB Vaccine Accelerator aims to address significant challenges in this field.  This Request for Applications (RFA) focuses on two of these goals.

 The complete RFA, along with instructions for submitting a Letter of Inquiry, can be found at:

http://response.notifications.gatesfoundation.org/t?ctl=43EBEBD:2DB63E3FE53D70C20B5746149A1298C6FA43AB057A377F2C&

 Interested applicants are asked to read the RFA document and are invited to submit a Letter of Inquiry before November 26, 2012.

 Please also be sure to check back at www.grandchallenges.org for ongoing funding opportunities.

Gates Foundation Grand Challenges Explorations Initiative

The Bill & Melinda Gates Foundation announced more than $21 million in new grants through its Grand Challenges Explorations initiative. Information on the program and the new global health and development projects being funded can be found at www.grandchallenges.org/about/Newsroom/Pages/GCERound9Grants.aspx.

 We would like to remind you that we are inviting proposals for the following grant opportunities:

                          The Water, Sanitation & Hygiene Program at the Bill & Melinda Gates Foundation is inviting innovators to send letters of inquiry for the Reinvent The Toilet Challenge - RTTC (round 3). Grants will be awarded to research groups interested in contributing to major advances in sanitation in the developing world. Details and application instructions are available at www.gatesfoundation.org/watersanitationhygiene/Pages/loi-round3-reinvent-toilet-challenge.aspx . Questions can be submitted to GDWSHInbox@gatesfoundation.org.  Letters of Inquiry are being accepted online until November 8, 2012 at 11:00 p.m. Pacific Time.

 

      The Grand Challenges in Global Health initiative is accepting letters of inquiry for the new grant program TB Vaccine Accelerator.  This program seeks to develop models of natural Mycobacterium tuberculosis transmission, define key transmission properties, and develop new approaches to vaccination that will protect against infection. Program details and application instructions are available at www.grandchallenges.org/GrantOpportunities/Pages/TBVaccineAccelerator.aspx.  Letters of inquiry are being accepted online until November 26, 2012 at 11:59 a.m. Pacific Time.

 To learn more about the Bill & Melinda Gates Foundation’s work, we invite you to read our 2011 annual report.  In it, CEO Jeff Raikes discusses how the new integrated structure of the foundation’s global programs provides more holistic support to the people we serve. Read more at: http://response.notifications.gatesfoundation.org/t?ctl=4491183:5333922E03F2D8FF5A8E40239370DD5ADD10B7A40AD2C082&

 

Gates Foundation Reinvent the Toilet Challenge Funding Opportunity

The Water, Sanitation, & Hygiene Program at the Bill & Melinda Gates Foundation is inviting innovators to send letters of inquiry for the  following opportunity:

Reinvent The Toilet Challenge - RTTC (round 3).

For details on how to apply, please visit this

website: http://response.notifications.gatesfoundation.org/t?ctl=4414B84:5333922E03F2D8FFB2B8F41137EC71DAD67BBDE479481AC1&

 We are calling for a new set of innovative ideas to support our effort to reinvent the toilet. Grants will be awarded to exceptional research groups interested in contributing to major advances in human sanitation in the developing world.

 Successful applicants will participate in the next phase of the Reinvent the Toilet Challenge by designing, prototyping and testing  entirely stand-alone, self-contained, practical sanitation modules which intake bodily wastes or fecal sludge collected from pit latrines and septic tanks and swiftly dispose of them  without any incoming water piping, outgoing sewer piping or electric or gas utility services.  These modules must intake all outputs of the serviced population  – ultimately at single-residence scales (smaller-scale individual family toilet solutions) or group of households (larger-scale neighborhood fecal sludge processor solutions)– with minimal module footprints and assured biosafety. The anticipated capital and operational cost for the final products (commercial units) is expected to be less than $0.05/user/day, both for the family and neighborhood solutions.   The design should anticipate the effects and fate of complementary sanitary products entering the system such as paper, cloth, sand, and other personal hygiene products and chemicals.

 Letters of inquiry are being accepted online until Thursday, November 8, 2012 11:00 PM Pacific Standard Time. A full description of the topic and application instructions is available at http://response.notifications.gatesfoundation.org/t?ctl=4414B85:5333922E03F2D8FFB2B8F41137EC71DAD67BBDE479481AC1&

 If you have questions regarding this grant opportunity, please email us at RTTC@gatesfoundation.org.

 We are happy to learn of your interest to engage with us. While we do review all inquiries, due to the large volume of questions we receive, we may be unable to respond to you personally before the close date of the call for proposals. Thank you for your commitment to solving one the world's greatest health and development challenges.

Visit our site

http://response.notifications.gatesfoundation.org/t?ctl=4414B86:5333922E03F2D8FFB2B8F41137EC71DAD67BBDE479481AC1&

 

Gates Foundation Grant Opportunities - New Grand Challenges Explorations Topics

The Bill & Melinda Gates Foundation is now accepting grant proposals for Round 10 of Grand Challenges Explorations, an initiative to encourage innovative and unconventional global health and development solutions. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for-profit companies.

 Two-page grant proposals are being accepted online until November 7, 2012 on the following topics:

 * Labor Saving Innovations for Women Smallholder Farmers

* New Approaches in Model Systems, Diagnostics, and Drugs for Specific Neglected Tropical Diseases

* New Approaches for the Interrogation of Anti-malarial Compounds

* Aid is Working. Tell the World.

Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million. Full descriptions of the topics and application instructions are available at: www.grandchallenges.org/gce

To learn more about the Grand Challenges Explorations program and the Grand Challenges in Global Health program:

 * View our Interactive Map that gives information on 813 grants that have been awarded for projects in 49 countries: www.grandchallenges.org/Pages/GrantsMap.aspx

* Meet the Grand Challenges community through videos at www.grandchallenges.org/Pages/VideoGalleries.aspx and project slideshows at www.grandchallenges.org/Pages/PhotoGalleries.aspx

 We look forward to receiving innovative ideas from around the world and from all disciplines. If you have a great idea, apply here: www.grandchallenges.org/gce. If you know someone who may have a great idea, please forward this message.

 Thank you for your commitment to solving the world's greatest health and development challenges.

 Visit our site

http://response.notifications.gatesfoundation.org/t?ctl=43BC2E3:5333922E03F2D8FFE9604773A4D55A8723297EC805CEC61E&

 

DoD Psychological Health & Traumatic Brain Injury Research Pgm. Funding Opportunities 2012

In support of Presidential Executive Order 13625 of August 31, 2012, the Department of Defense (DoD) and the Department of Veterans Affairs (VA) are contributing more than $100 million to fund two new consortia aimed at improving diagnosis and treatment of mild Traumatic Brain Injury (mTBI) and Post-Traumatic Stress Disorder (PTSD).

 Applications to the Fiscal Year 2012 (FY12) Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program (RP) Consortium to Alleviate PTSD (CAP) Award funding mechanism and the Chronic Effects of Neurotrauma Consortium (CENC) Award are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program (DHP), in collaboration with the Department of Veterans Affairs Office of Research and Development. 

FY12 PH/TBI program announcements and application instructions for the following award mechanisms are posted and available for download on Grants.gov.

 http://cdmrp.army.mil/funding/phtbi.shtml

 Award Mechanism:

Consortium to Alleviate PTSD (CAP) Award

This funding opportunity allows DoD, VA, and other investigators to apply

Preproposal is required; application submission is by invitation only.

Key Mechanism Elements:

·         Intended to support a PTSD-focused Consortium aimed at improving the health and well-being of Service Members and Veterans impacted by PTSD.

·         Objectives:  (1) significantly advance treatment strategies for PTSD including interventions for early, chronic, and latent onset cases and (2) identify and confirm clinically relevant biomarkers as diagnostic and prognostic indicators of PTSD and co-occurring disorders.

·         Focus Areas:  Research activities must be focused on PTSD and common co-occurring psychiatric or medical conditions (detailed list provided in solicitation).

·         Studies must focus primarily on the clinical application of biomarker-based research (diagnostic-, prognostic-, and treatment-focused).

·         Applications must propose a minimum of four (4) studies reflective of the Consortium’s objectives and Focus Areas.

·         The maximum period of performance is 5 years.

·         The maximum allowable total costs for the entire period of performance are $20.336M via the DoD.

·         Up to an additional $5M per year for 5 years will be provided by the VA to VA sites, depending upon availability of funds.


Chronic Effects of Neurotrauma Consortium (CENC) Award

Preproposal is required; application submission is by invitation only.

This funding opportunity allows DoD, VA, and other investigators to apply

Key Mechanism Elements:

·         Intended to support establishment of a comprehensive understanding of the chronic sequelae associated with neurotrauma, primarily focused on mTBI/concussion.

·         Objectives:  (1) establish the association of the chronic effects of mTBI and common comorbidities, (2) determine whether there is a causative effect of chronic mTBI/
concussion on neurodegenerative disease and other comorbidities, (3) identify diagnostic and prognostic indicators of neurodegenerative disease and other comorbidities associated with mTBI/concussion, and (4) develop and advance methods to treat and rehabilitate chronic neurodegenerative disease and comorbid effects of mTBI/concussion.

·         Focus Areas:  The Consortium must also propose activities that include the majority of comorbidities associated with the chronic effects of neurotrauma (examples provided in Program Announcement/Funding Opportunity).

·         The research studies must evaluate chronic (defined here as greater than 3 months), anatomic, molecular, and physiological changes related to neurotrauma.

·         Applications must include an initial set of proposed studies agreed upon by the Consortium participants, which are reflective of the Consortium’s Objectives and aligned Focus Areas. The maximum period of performance is 5 years.

·         The maximum period of performance is 5 years.

·         The maximum allowable total costs for the entire period of performance are $37.175M via the DoD.

·         Up to an additional $5M per year for 5 years will be provided by the VA to VA sites, depending upon availability of funds.

 All applications submitted must conform to the final program announcements, which are posted on Grants.gov and the CDMRP website (http://cdmrp.army.mil).

 A pre-application (preproposal) is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to proposal submission due date of October 25, 2012. Applications must be submitted through the federal government's single-entry portal, Grants.gov.  Individual program announcements and required forms can also be found on the Grants.gov website.

 For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or 301-682-5507

 For more information about the PH/TBI or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 If you would like to request a different recipient to these messages please reply back to CDMRP.PublicAffairs@amedd.army.mil with the corrected information.

 Point of Contact:

CDMRP Helpdesk

301-682-5507
help@cdmrp.org
Conn. Dept. of Public Health Biomedical Research Funding Opportunities

The DPH has released RFP 2013-0903 seeking proposals for biomedical research projects in the fields of heart disease, cancer and other tobacco-related diseases, diabetes and Alzheimer’s disease.

 Contract Period: April 1, 2013 to march 31, 2015

Deadline for Submission: October 23, 2012

 Letter of Intent Due: September 11, 2012 by 4pm

Deadline for Questions: September 14, 2012 by 4pm

The Request for Proposals is available in electronic format from Ct. Dept. of Public Health "Request for Proposals" web page:

http://www.ct.gov/dph/cwp/view.asp?a=3152&q=389676&dphNav_GID=1601

State Contracting Portal:  http://www.biznet.ct.gov/SCP_Search/Default.aspx?AccLast=1

A printed copy of the RFP can be obtained from:

Charles Nathan, Principal Health Care Analyst

Conn. Dept. of Public Health

410 Capitol Ave., MS# 13-PWD

P.O. Box 340308

Hartford, CT 06134-0308

Tel: 860 509 8070

 

 

The Cancer Research Institute-Irvington Institute Fellowship Program

Dear Colleague:

The Cancer Research Institute is requesting applications for its Postdoctoral Fellowship Program. The Cancer Research Institute-Irvington Institute Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in cancer immunology. The Institute is seeking hypothesis driven, mechanistic studies in both immunology and tumor immunology that seek to directly impact our understanding of the immune system’s role in cancer risk, tumor initiation, progression, metastasis, host response to tumors and/or the treatment of cancer. 

 Deadline: October 1, 2012

Funding: $164,500 over three years.

Click here to apply.

 Sincerely,

 Lynne A. Harmer


Director of Grants Administration

Cancer Research Institute

 Inquiries may be directed to grants@cancerresearch.org.

   Charles H. Hood Foundation Child Health Research Awards Program

The Charles H. Hood Foundation was incorporated in 1942 to improve the health and quality of life for children throughout New England. Today's research projects encompass many disciplines that have contributed to pediatric discoveries while launching the careers of promising junior faculty. The intent of the Award is to support newly independent faculty, provide the opportunity to demonstrate creativity, and assist in the transition to other sources of research funding. Research projects must be relevant to child health.

 Online Application Deadline

Monday, September 24, 2012, at noon (U.S. Eastern Time)

Application Materials

www.tmfgrants.org/Hood

 Funding Period and Award Amount

·         January 1, 2013 - December 31, 2014

·         Up to five $150,000 awards at $75,000 per year
(inclusive of 10% institutional overhead)

 Applicant, Project and Geographic Eligibility

 ·         Investigators within five years of their first faculty appointment (inclusive of any independent research positions in a for-profit company)

·         Research with relevance to child health

·         Hypothesis-driven clinical, basic science, public health, health services research and epidemiology projects

·         Nonprofit academic, medical or research institutions in New England

·         United States citizenship or residency is not required

·          

 Please direct any questions to 617-695-9439 or GLockwood@hria.org.

 

DoD Psychological Health and Traumatic Brain Injury Research Program Funding Opportunities

Applications to the Fiscal Year 2012 (FY12) Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program (RP) are being solicited for the Assistant Secretary of Defense for Health Affairs, Defense Health Program (DHP) by the United States Army Medical Research Acquisitions Activity (USAMRAA).  The PH/TBI Research Program was established in FY07 for the purpose of complementing ongoing Department of Defense (DoD) efforts toward promoting a better standard of care for PH (including post-traumatic stress disorder [PTSD]) and TBI in the areas of prevention, detection, diagnosis, treatment, and rehabilitation.  This includes research to benefit Service Members, their family members, Veterans, and other beneficiaries of the Military Health System (MHS).

 FY12 PH/TBI program announcements and application instructions for the following award mechanisms are posted and available for download on Grants.gov. http://cdmrp.army.mil/funding/phtbi.shtml

 Award Mechanism:

 Traumatic Brain Injury Research Award

Eligibility Information: Independent investigators at all academic levels (or equivalent).

Preproposal is required; application submission is by invitation only.

Key Mechanism Elements:

·     The intent of this mechanism is to:

o Promote new/innovative ideas that are still in the early stages of development and have the potential to yield highly impactful data and new avenues of investigation to further the field of interest;

o Advance  knowledge regarding the theoretical construct surrounding the TBI Research Area of interest to increase scientific understanding of certain phenomena or behaviors;

o Propose new paradigms or challenging existing paradigms; and

o Address the technical feasibility of promising new products, pharmacologic agents, behavioral and rehabilitation interventions, diagnostic and therapeutic techniques, clinical guidance, and/or emerging approaches and technologies.

·     Clinical trials are NOT allowed.

·     Applications MUST specifically address the following research area:

o Identify and Characterize Mechanisms of Traumatic Brain Injury-related Neurodegenerative Diseases, including chronic traumatic encephalopathy, with emphasis on those mechanisms of injury that may be amenable to targeted therapy approaches, including biomarkers that would identify mechanistic targets of therapeutic approaches.

Applications that include meaningful and productive collaborations between two investigators are encouraged.

 All applications submitted must conform to the final program announcements, which are posted on Grants.gov and the CDMRP website (http://cdmrp.army.mil).

 A pre-application (preproposal) is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to proposal submission due date of September 21, 2012. Applications must be submitted through the federal government's single-entry portal, Grants.gov.  Individual program announcements and required forms can also be found on the Grants.gov website.

 For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or 301-682-5507

 For more information about the PH/TBI or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 If you would like to request a different recipient to these messages please reply back to CDMRP.PublicAffairs@amedd.army.mil with the corrected information.

 Point of Contact:

 CDMRP Helpdesk, 301-682-5507
help@cdmrp.org

 

Patient-centered Outcomes Research Institute (PCORI) Funding Announcement
PCORI Releases Second Funding Announcement
The Patient-Centered Outcomes Research Institute (PCORI) has announced its second round of funding requests to support clinical comparative effectiveness research.  The PCORI funding announcements will solicit proposals for well-designed, rigorous research targeting diverse topics and conditions of concern to patients and their caregivers.  Up to $96 million in research funding will be distributed through PCORI funding mechanisms this year.  Funding announcement deadlines are Oct. 15 for required letters of intent and Dec. 17 for full proposals.  Application materials are available on the PCORI Web site (www.pcori.org).
Susan G. Komen Breast Cancer Research Funding Opportunities

Greetings,

Susan G. Komen for the Cure® is excited to announce the release of Requests for Applications (RFAs) for Investigator-Initiated, Career Catalyst Research, and Challenge Grants: Breast Cancer and the Environment.  RFAs are available at http://ww5.komen.org/ResearchGrants/FundingOpportunities.html or https://proposalcentral.altum.com/.

DEADLINES AT A GLANCE
Investigator-Initiated and Career Catalyst Research Grants

Pre-Applications Due – September 10, 2012, 5 p.m., Eastern Time
Full-Applications Due (invitation only) – December 17, 2012, 5 p.m., Eastern Time

Challenge Grants: Breast Cancer and the Environment

Pre-Applications Due – September 10, 2012, 5 p.m., Eastern Time
Full-Applications Due (invitation only) – December 17, 2012, 5 p.m., Eastern Time

RFA DETAILS
Challenge Grants

  • Investigator Initiated Research:  Breast Cancer and the Environment
  • Career Catalyst Research:  Breast Cancer and the Environment

These Challenge Grants are a specialized focus area for the Investigator-Initiated Research (IIR) and Career Catalyst Research (CCR) Grants described below.  Susan G. Komen for the Cure and its Scientific Advisory Board requested that the Institute of Medicine (IOM) review the current evidence on environmental risk factors for breast cancer, consider gene-environment interactions in breast cancer, explore evidence-based actions that might reduce the risk of breast cancer, and recommend research needed in these areas.  Please see our statement about and a link to the IOM report for additional information.  At the conclusion of their report, the IOM issued 13 recommendations for further research, of which three have been chosen by the Komen Scientific Advisory Board as the subject of Challenge Grants:

  • Studies of Occupational Cohorts and Other Highly Exposed Populations,
  • New Exposure Assessment Tools, and 
  • Minimizing Exposure to Ionizing Radiation.

Investigator-Initiated (IIR) Grants
IIR Grants provide up to $1,000,000 over four years to stimulate exploration of new ideas and novel approaches in breast cancer research and clinical practice that will lead to reductions in breast cancer incidence and mortality within the next decade.  This year’s research areas are as follows:

  • Prevention/Early DetectionNew Strategies for Early Detection;
  • Novel Therapeutics and Resistance Therapeutic Implications of Tumor Genomics;
  • Biology of Breast CancerImplications of the Immune System in Breast Cancer Biology; and
  • Disparities in Breast Cancer Outcomes Outcomes of Specific Populations after Diagnosis.

Career Catalyst Research (CCR) Grants
CCR Grants provide unique opportunities for scientists in the early stages of their career to achieve research independence with an independent award of up to $450,000 over three years.  CCR investigators lead a research project addressing an important question in breast cancer research and complete a self-defined career development plan with support from a mentor committee.  CCRs provide support for hypothesis-driven research projects that have significant potential to advance our understanding of breast cancer and lead to reductions in breast cancer incidence and/or mortality within the next decade.  Studies focusing on quality of life or survivorship issues are not appropriate for this mechanism.

--
At this time, Komen does not plan to release RFAs for Promise Grants and Training Grants including Post-baccalaureate Training in Disparities Research Grants or Postdoctoral Fellowships.  Details about Komen’s Research Programs and other funding opportunities are available at: http://www.komen.org.

FY2012 DoD Orthopaedic Program Announcements

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides research funding for peer reviewed Defense Health Programs executed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP). 

 This e-mail is to notify the research community of the recently released funding opportunities from the Peer Reviewed Orthopaedic Research Program.

 Detailed descriptions of each of the funding opportunities, evaluation criteria, and submission requirements can be found in the respective Program Announcements. Each Program Announcement is available electronically for downloading from the Grants.gov website (http://www.grants.gov), and will be available within 48 hours on the CDMRP website (http://cdmrp.army.mil/funding/prgdefault.shtml) and the CDMRP eReceipt System (https://cdmrp.org).

 Peer Reviewed Orthopaedic Research Program newly released Program Announcements:

 ·         Idea Development Award

·         Translational Research Partnership Award

·         Clinical Trial Award

 

All current and previous funding opportunities are available on the CDMRP website (http://cdmrp.army.mil).

 Subsequent notifications will be sent when additional funding opportunities are released. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 

DoD Peer Reviewed Orthopaedic Research Program

Please view this message in html.

 The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $30 million (M) to the Department of Defense Peer Reviewed Orthopaedic Research Program (PRORP). The PRORP seeks to fund innovative, high-impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat or combat-related activities. This program is administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 The FY12 PRORP Focus Areas are:

·         Improvement of moisture management and residual limb skin care at the prosthetic socket interface.

·         Improvement of the rate of nerve regeneration.

·         Strategies to inhibit neuromas at surgical/amputation sites.

·         The treatment of segmental bone injury in weight-bearing locations, including utilization of the Masquelet technique for bioactive membrane formation and identification of the best bone graft options. Clinical and mature translational studies only; development of novel bone void filler products are not of interest.

·         The comparative effectiveness of local strategies to minimize surgical site infection, including local application of antibiotics, debridement techniques, and subatmospheric wound dressings.

·         Treatment and management of heterotopic ossification. Mature translational studies only; the development and/or validation of new animal models of heterotopic ossification are not of interest.

·         Mitigation of the negative effects of immobility for polytrauma patients, excluding spinal cord injury.

·         Short-term and long-term outcomes in limb salvage populations.

·         Prevention or treatment of post-traumatic joint stiffness and contracture in the ankle, knee, and/or elbow.

All applications are required to address at least one Focus Areas as specified in each program announcement.  Note that Focus Areas may differ among the three between program announcements/funding opportunities.  Full details of FY12 PRORP Focus Areas will be included in each program announcements.

 FY12 PRORP program announcements and application instructions for the following award mechanisms have been posted and are available for download on Grants.gov.

 http://cdmrp.army.mil/funding/prorp.shtml

  Award Mechanism

Clinical Trial Award

 Independent Investigators at or above the level of Assistant Professor (or equivalent) – Preproposal due June 27, 2012.

·         Preproposal is required; application submission is by invitation only

·         Supports the rapid implementation of clinical trials that will have a significant impact on military combat-related orthopaedic injuries

·         Preliminary data are required

·         Military/Veteran study population highly encouraged

Maximum funding of $2.5M for direct costs (plus indirect costs)

Period of performance up to 5 years

Nested Career Development Option: Additional funds may be requested to support the mentored career development of an active duty military research- or physician-scientist at an early career stage.

Nested Career Development: Additional direct costs of $225K for total combined direct costs of $2.725M

 

Translational Research Partnership Award - Preproposal due June 27, 2012

Independent investigators at all academic levels (or equivalent)

·         Preproposal is required; application submission is by invitation only

·         Supports the development of multidisciplinary translational research partnerships between clinicians and laboratory scientists to accelerate the movement of promising research hypotheses into clinical applications

·         Minimum of 2 PIs required; maximum of 3 PIs allowed

·         At least one partner must be a laboratory scientist and at least one partner must be a clinician

·         At least one partner must have significant experience in orthopaedic research or orthopaedic medicine

·         Preliminary and/or published data are required

·         Does not support definitive clinical trials, but limited clinical testing is permissible

·         All applications must have a direct relevance to orthopaedic injuries sustained during combat or combat-related activities

Maximum combined funding of $750K for direct costs (plus indirect costs)

Period of performance up to 3 years

Nested Career Development Option:  Additional funds may be requested to support the mentored career development of an active duty military research- or physician-scientist at an early career stage

Nested Career Development: Additional direct costs of $225K for total combined direct costs of $975K

 Idea Development Award - Preproposal due June 27, 2012

Independent investigators at all academic levels (or equivalent)

·         Supports conceptually innovative, high-risk/high gain research

·         Emphasis is on Innovation and Military Benefit

·         Preliminary data are not required

·         Clinical trials not allowed

Maximum funding of $500K for direct costs (plus indirect costs)

Period of performance up to 3 years

Nested Career Development Option:  Additional funds may be requested to support the mentored career development of an active duty military research- or physician-scientist at an early career stage

Nested Career Development: Additional direct costs of $225K for total combined direct costs of $725K

 All applications submitted must conform to the final program announcements, which are posted on Grants.gov and the CDMRP website (http://cdmrp.army.mil).

 A pre-application (preproposal) is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to proposal submission due date of June 27, 2012. Applications must be submitted through the federal government's single-entry portal, Grants.gov.  Individual program announcements and required forms can also be found on the Grants.gov website.

 For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or 301-682-5507

 For more information about the PRORP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 If you would like to request a different recipient to these messages please reply back to CDMRP.PublicAffairs@amedd.army.mil with the corrected information.

 Point of Contact:

 CDMRP Helpdesk

301-682-5507
help@cdmrp.org

US-Israel Binational Science Foundation Workshop Grants

The program

  • The workshop program is aimed at enabling leading American and Israeli scientists to meet in small groups and an intimate atmosphere to discuss state-of-the-art science. It is hoped that these encounters will lead to new collaborations between Israeli and American scientists, including new submissions of proposals to the regular BSF grants program.
  • The 2012 BSF workshop program will focus on bringing together Israeli, American and Palestinian scientists for the purpose of facilitating the development of partnership research projects. Please note that, as such, the present Call is not for a traditional workshop in which advances in a specific topic are discussed, but rather for creating an opportunity for the scientists to start preparing new research proposals. Applications for conventional workshops will not be approved.
  • Participation in BSF workshops is generally limited to Israeli and American scientists only, even if the participation of the other scientist(s) is supported by other sources. The BSF will not give partial or full support to international seminars, workshops or conferences. However, given the focus of the current workshop program, the BSF encourages and will support the participation of Palestinians in addition to Americans and Israelis.
  • Participation by other scientists may be accepted with prior approval by the BSF, if their participation will significantly enhance the goals of the workshop. However, BSF funds may not be used to support the participation of scientists other than Americans, Israelis and Palestinians.
  • The workshop may be held in Israel, the U.S. or in another location, such as another East Mediterranean or Middle East country. Locations such as Aqaba, East Jerusalem, Cyprus, etc., which may facilitate the participation of Palestinians, are encouraged.
  • Further details can be found in the current Call for Proposals

Eligibility
  • Submission of applications must be made together by American and Israeli scientists.
  • Scientists working in a non-profit organization, government institution or a for-profit enterprise are all eligible for submission.

Budget
  • The budget for each workshop is expected to be in the range of $25- 50,000.
  • Additional funds are welcome, and may be required if the BSF funding appears to be insufficient for the proposed program.
  • The BSF does not allow institutional overhead and/or scientists’ summer salaries (including for the organizers), or honorariums to participants.

Submission details
  • Applications will be submitted online using the relevant BSF web-based submission system.
  • Be sure to download the full instructions for submitting a Workshop application from the website in the Guidelines and Forms section.
  • The website will be open for submission beginning August 6, 2012.
  • The deadline for submission is September 6, 2012, 5pm Israel time (10 am EST).
  • Decisions will be announced by Feb. 20, 2013.


Fondation Leducq Research Programs 2012-2013
The Fondation Leducq, a French non-profit organization dedicated to promoting international research in cardiovascular and neurovascular disease, is issuing a call for applications for its two major grant programs, the Transatlantic Networks of Excellence and the Career Development Award.   
 
Transatlantic Networks of Excellence
Application due date:  September 14, 2012
 
This program awards up to U.S. $6 million over five years to internationally collaborative research teams who work together to advance our knowledge and treatment of cardiovascular and neurovascular disease. 
 
Career Development Award
Application due date: September 11, 2012
 
This program provides 6 to 24 months of support to individual junior or senior European or North American investigators who wish to perform cardiovascular or neurovascular research on the opposite side of the Atlantic.  
 
Information about both programs can be found on our website, www.flcq.org.
 
You have received this message because of your potential interest in the Fondation Leducq grant programs, and your contacts with others who might be so interested.  The Fondation Leducq would be grateful if you would pass this information on to anyone you believe might benefit.  We appreciate your helping us to fulfill our mission in cardiovascular and neurovascular research.
 


Gates Vaccine Innovation Award

Do you know someone who is improving vaccine delivery in the developing world? Now is the time to nominate that person or group of people for the second annual Gates Vaccine Innovation Award. Time is running out -- the deadline for nominations is August 31, 2012.

 

The Gates Vaccine Innovation Award is open to individuals from any discipline who work on the delivery of vaccines. Candidates from academic institutions, governments, health care facilities, research institutions, non-profit organizations and for-profit companies may be nominated.

 

We are looking for ideas, big or small, that have resulted in tangible improvements in immunization coverage in developing countries.

 

We invite you to nominate individuals or groups of individuals who have achieved significant improvements in the prevention, control, or elimination of vaccine preventable diseases through immunization.

 

The winning nomination will be recognized with a $250,000 award.

Read about the 2012 Gates Vaccine Innovation Award winner Dr. Asm Amjad Hossain here.

Thank you for your continued support of this important award.

 

Bill & Melinda Gates Foundation

PO Box 23350

Seattle, WA 98102

Gates Foundation Vaccine Innovation Award

Criteria

We recognize that innovation in the delivery of vaccines can take many shapes. We are looking for ideas big or small that have resulted in tangible improvements in immunization coverage in developing country communities.

Nominees will be assessed on three broad criteria:

  • Developing country impact – The nominee should have contributed to the prevention, control, or elimination of vaccine-preventable disease through significant improvements in immunization quality and coverage among mothers and children in developing countries.

  • Innovation and creativity – The nominee should have applied imaginative and pioneering approaches to overcome difficult challeges to immunizing children and achieving impact. Innovation is not the same as invention. Even simple ideas applied in creative ways to overcome real-world challenges can be considered innovative.

  • Scale – The nominee’s innovation should be at scale or suitable to be implemented at scale within the nominee’s country and around the world.

If you are unable to complete the online nomination form, please download and complete this form. Please submit downloaded nominations via email to vaccine-innovation-award@gatesfoundation.org, or via fax to +1-206-494-7042.

Nominations will be accepted through 11:59 PM Pacific Standard Time on August 31, 2012

Qualifications

In order to qualify for consideration:

  • Nominations must be related to vaccine delivery and meet the criteria above
  • Nomination forms must be completed in English
  • The three essay questions should be answered within the font and word-limit requirements
Please note that nominations focused on innovation in research & development are not eligible for consideration. This award is focused only on achieving impact through innovative systems, processes, tools, and technologies leading to better immunization.

To get started, read the Rules and Guidelines document (PDF). It contains detailed information on all aspects of the Gates Vaccine Innovation Award. You may need to download Adobe Reader to view PDF documents. Please also read the Terms of Use, and Privacy Policy. Any information submitted by you or on your behalf with respect to the Gates Vaccine Innovation Award (including your nomination, contact information and any related documentation and communications) will be subject to and handled in accordance with the provisions outlined in these three documents.

Tips for Nominators

Following are some tips for those wishing to submit nominations:

  • Nominations must represent an innovative approach to vaccine delivery work that has demonstrated impact. Note: There are other avenues of funding for equally important research. See current Bill & Melinda Gates Foundation grant opportunities here.

  • Nominations will be reviewed by a panel with broad expertise and a track record in identifying innovations. These reviewers may not be deep experts in your field. Ideas should be described in clear language without the use of technical jargon unique to a particular field.

  • Documentation of the innovation does not need to be sent with the initial nomination form. However, credible evidence supporting the validity of a project or sufficient proof of innovation may be requested at a later date. We will need to contact the nominee prior to the prize being issued.

  • Nominators should review the policies, guidelines, terms, and conditions associated with this award.
Please contact: vaccine-innovation-award@gatesfoundation.org for additional information.

The winner of the first Gates Vaccine Innovation Award was announced in Bill Gates’ 2012 annual letter. The 2012 Award recognizes the work of Dr. Asm Amjad Hossain, a former district immunization and surveillance medical officer in Bangladesh.

Burroughs Wellcome Investigators in the Pathogenesis of Infectious Diseases Funding Opportunity

The goal of the program is to provide opportunities for accomplished investigators still early in their careers to study the pathogenesis of infectious disease at its most fundamental level – the points where human and microbial systems connect.  The program supports research that sheds light on the fundamentals that affect the outcomes of this encounter: how colonization, infection, commensalism and other relationships play out at levels ranging from molecular interactions to systemic ones. 

 Limit: Up to two candidates; three candidates if one nominee holds a D.V.M.; and a single additional nomination for working in a pathogenic helminthes, mycology, or reproductive science. 

Intent to Submit Deadline:  8/24/2012

Internal Screening Deadline:  9/4/2012

Sponsor Deadline:  11/1/2012

Submit e-proposals to: Larisa.Zagorski@uconn.edu

PEW Scholars Program in the Biomedical Sciences

The Pew Scholars Program in the Biomedical Sciences provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level.

 

Limit:  one nomination

Intent to Submit Deadline:  8/24/2012

Internal Screening Deadline: 9/4/12

Sponsor Deadline:  11/1/2012

Submit e-proposals to: Larisa.Zagorski@uconn.edu

DHHS, APIC and SHEA Partnership in Prevention Award

The U.S. Department of Health and Human Services (HHS) has partnered with the Association for Professionals in Infection Control and Epidemiology, Inc (APIC) and the Society for Healthcare Epidemiology of America (SHEA) to create the Partnership in Prevention Award.

 The nature and purpose of the Partnership in Prevention Award is to highlight and promote the work of one hospital that has achieved sustainable improvements based on the concepts of the “National Action Plan to Prevent Healthcare-Associated Infections: Roadmap to Elimination” and is helping to achieve the goals outlined by the HHS Partnership for Patients

 Preventing healthcare-associated infections (HAIs) requires a multidisciplinary, team-based approach – involving facility-level executive leaders, clinical leaders, infection control and prevention experts, and others.

 The award program intends to recognize prevention leaders in the U.S. acute care community who have achieved wide-scale reduction and progress toward elimination of targeted HAIs. It also intends to showcase the outstanding efforts of clinicians, hospital executives, and hospital facilities who have improved clinical practice through utilization of evidence-based guidelines, achieved and maintained superior prevention results, and advanced best practices to improve patient safety.

Nominations for the award will be accepted through August 1, 2012, and the award announcement will take place October 15, 2012 during the 2012 International Infection Prevention Week.  Additional information, including application instructions and eligibility criteria, can be viewed on the Office of Healthcare Quality HAI Initiative website. 

 We invite you to nominate your team.  If you have any questions about the awards, please email the Partnership in Prevention Award team at awards@apic.org.

We look forward to seeing the great nominations highlighting the important work you do to prevent HAIs.

Application Instructions and Eligibility Criteria
Fulbright-Management Center Innsbruck Visiting Professorship

We are pleased to announce the Fulbright-Management Center Innsbruck Visiting Professorship for 2013-2014 and request your applications by August 1, 2012.
The Fulbright-Management Center Innsbruck Visiting Professorship is open to faculty members at US universities with distinguished scholarly accomplishments and interdisciplinary interests to work in one or more of the following fields:  Business, Management, Economics, Social Sciences, Business Law, Information Technology, Engineering or Life Sciences.  For more information about the various disciplines and programs offered at MCI, please refer to www.mci.edu.

It is a 4 month tenure and will commence on October 1, 2013 or March 1, 2014.

Fulbright-MCI Visiting Professors receive 5,000 euros per month maintenance award and 800 euros travel grant.  In addition, the MCI Award includes a housing stipend of up to 800 euros per month. 
Further details can be found at http://catalog.cies.org/viewAward.aspx?n+3142.

The Fulbright Scholar Program for 2013-2014 is Open

The Fulbright Scholar Program is offering teaching, research or combination teaching/research awards in over 125 countries for the 2013-2014 academic year. Opportunities are available for college and university faculty and administrators as well as for professionals, artists, journalists, scientists, lawyers, independent scholars and many others. There are awards in 45 specific academic disciplines as well as 167 awards open to all disciplines.

 Interested faculty and professionals are encouraged to participate in one of our weekly webinars. Each deals with a topic germane to the 2013-2014 competition, from regional and discipline information to how to fill out an application. For more information, visit our website at http://www.cies.org/Webinar/<http://www.cies2.org/redirect.aspx?linkID=910&eid=69053>.

 The application deadline for most awards is August 1, 2012.  U.S. citizenship is required.  For other eligibility requirements and detailed award descriptions visit our website at http://www.cies.org/us_scholars/us_awards/<http://www.cies2.org/redirect.aspx?linkID=909&eid=69053> or contact us at scholars@iie.org<mailto:scholars@iie.org>.

 Andy Riess, Ph.D.

Assistant Director for Outreach and Communications Council for International Exchange of Scholars A Division of the Institute of International Education

1400 K Street, NW, Suite 700

Washington, D.C.  20005-2403

www.iie.org/cies<http://www.cies2.org/redirect.aspx?linkID=908&eid=69053>

scholars@iie.org<mailto:scholars@iie.org>

 Fulbright Scholar Program

1400 K Street NW, Suite 700

Washington, DC 20005

DoD Duchenne Muscular Dystrophy Research Program Funding Opportunities

Defense Health Program

Department of Defense Duchenne Muscular Dystrophy Research Program (DMDRP)

Funding Opportunities for Fiscal Year 2012

 

Applications for the Duchenne Muscular Dystrophy Research Program (DMDRP) are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program. The DMDRP was established in 2011 to provide support for research of exceptional scientific merit and to promote the understanding, diagnosis and treatment of DMD. Fiscal Year 2011 (FY11) appropriations for the DMDRP totaled $4 million (M). The FY12 appropriation is $3.2M.

 The vision of the FY12 DMDRP is to extend and improve the function, quality of life, and lifespan for all individuals diagnosed with DMD. As such, the DMDRP is seeking to fund research to accelerate the development and clinical testing of new therapeutics and increase our understanding of successes and failures in clinical trials.

 http://cdmrp.army.mil/funding/dmdrp.shtml

 Investigator-Initiated Research Award – Pre-application due July 25, 2012

Principal Investigator:  Must be at or above the level of Assistant Professor (or equivalent)

Optional Qualified Collaborator:  Must be at or above the level of Assistant Professor (or equivalent)

Optional Nested Resident or Medical Student Trainee:  Resident trainee must be enrolled in an accredited residency program.  Medical student trainee must be enrolled in a nationally accredited (or equivalent) medical school.  Trainees must be able to devote a minimum of 40% level of effort.

Supports translational research that will have an impact on extending and improving the function, quality of life, and life span for all individuals diagnosed with DMD

Preliminary data required

   Clinical trials not allowed

Maximum period of performance is 3 years

Maximum allowable funding is $525K in direct costs ($675K in direct costs if requesting an Optional Collaborator)

Nested traineeship:  Additional maximum of $75K for residents or $55K for medical students in direct and indirect costs over a one-year period of performance

 Therapeutic Idea Award – Pre-application due July 25, 2012

Independent Investigator at or above the level of Assistant Professor (or equivalent)

Supports early-stage research relative to novel therapeutic development for DMD

Innovation and impact are primary criteria

Preliminary data are not required

Studies should be hypothesis-based

Maximum period of performance is 2 years

Maximum allowable funding for the entire period of performance is $300K in direct costs

 All applications must conform to the final Program Announcements and application instructions available for electronic downloading from the Grants.gov website.  The applications package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline of July 25, 2012.  Applications must be submitted through the federal government’s single-entry portal, Grants.gov.

 Requests for email notification of the Program Announcements release may be sent to help@cdmrp.org.  Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

 For more information about the DMDRP or other CDMRP-sponsored programs, please visit the CDMRP website (http://cdmrp.army.mil).

 Point of Contact:

CDMRP Help Desk

help@cdmrp.org

301-682-5507

 

AHA Myocarditis Joint Postdoctoral Fellowship Award & Pediatric Cardiomyopathy Joint Research Award

approvedstamp

Funding Decisions to be Available by Mid-June
Applicants for awards that will begin on July 1 will be notified by email to log onto Grants@Heart to obtain critiques, scores and funding status by mid-June.

July Deadlines Looming
Full descriptions of AHA research programs being offered for July 2012 deadlines (January 1, 2013 award start date) are now posted: funding opportunities.

All application deadlines below are now 5 pm Central Daylight Savings Time:
Founders Affiliate - July 20                                  Great Rivers Affiliate - July 20
Greater Southeast Affiliate - July 19                     Midwest Affiliate - July 19
National Center - July 17                                     SouthWest Affiliate - July 18
Western States Affiliate - July 18                         Mid-Atlantic Affiliate - no programs are offered in July
Undergraduate Programs (Great Rivers and Greater Southeast Affiliates) - September 18
Reference documents to support fellowship and SDG applications are due by Friday, August 10.

foundationicon

Myocarditis Joint Postdoctoral Fellowship Award
The Myocarditis Foundation is partnering with the American Heart Association to fund a postdoctoral fellow proposing innovative basic, clinical or translational research projects relevant to the etiology, pathophysiology, diagnosis, treatment epidemiology and/or prevention of myocarditis. Interested parties should submit a postdoctoral fellowship application to their local affiliate; a designee for this award will be chosen from the pool of awardees.

 

childrensicon

Pediatric Cardiomyopathy Joint Research Award
The Children's Cardiomyopathy Foundation (CCF) has partnered with the American Heart Association to fund a research award for investigators conducting research specific to pediatric cardiomyopathy.  CCF will provide $35,000 per year for two years to fund one AHA Beginning Grant-in-Aid or one Grant-in-Aid related to pediatric cardiomyopathy research. The AHA will provide the balance of the funds needed to fully fund the selected award

 

 

AHA Research Programs Offered for July Deadlines

Full descriptions of AHA research programs being offered for July 2012 deadlines (January 1, 2013 award start date) are now posted. All application deadlines below are now 5 pm Central Daylight Savings Time:

 Founders Affiliate - July 20                                Great Rivers Affiliate - July 20

Greater Southeast Affiliate - July 19                  Midwest Affiliate - July 19

National Center - July 17                                   SouthWest Affiliate - July 18

Western States Affiliate - July 18                        Mid-Atlantic Affiliate - no programs are offered in July

Undergraduate Programs (Great Rivers and Greater Southeast Affiliates) - September 18

Reference documents to support fellowship and SDG applications are due by Friday, August 10.

AHA Summer 2012 Research Programs Now Available

New!  Beginning with July 2012 deadlines the application deadline time has changed to 5:00 p.m. Central Daylight Savings Time.

 

An applicant must either be an American Heart Association Professional Member or pay $100 per application submission. Read more about this requirement.

 Grants@Heart is the AHA online system for application submission. The system is available 24/7 with internet connection and a web browser

 Grants Officer Help Documents

The role off the Grants Officer is very important in the application process. It is the Grants Officer who submits the applications to the AHA on behalf of the applicant. Help is available for the G.O. on our Web site.

 Summer 2012 Programs  

• Undergraduate Student Research Program

• Health Sciences Fellowship

• Clinical Research Program

• Beginning Grant-In-Aid

• Scientist Development Grant

• Established Investigator Award

• Grant-In-Aid

• Innovative Research Grant  

• Predoctoral Fellowship

• Postdoctoral Fellowship

Read about our programs and eligibility requirements. 

American Heart Association

Attn: Email Subscriptions Group

7272 Greenville Ave. Dallas, TX 75231

FY12 DoD CDMRP SCIRP Funding Opportunities

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $9.6 million to the Department of Defense Spinal Cord Injury Research Program (SCIRP).  The SCIRP challenges the scientific community to design innovative research that will foster new directions for and address neglected issues in the field of SCI-focused research.

 The vision of the SCIRP is to advance the treatment of spinal cord injury and its consequences.  This program is administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 The FY12 SCIRP award mechanisms are listed in the table below.  Mechanism-specific Program Announcements/Funding Opportunities, including areas of encouragement, the intent of the award mechanism, eligibility, and submission deadlines, and General Application Instructions, are posted on the Grants.gov and CDMRP websites (http://www.grants.gov and http://cdmrp.army.mil, respectively).

 Clinical Trial Award – Pre-application due July 3, 2012

Independent investigators at all academic levels
(or equivalent)

·        Fund phase 0, I, or II clinical trials (no longer limited to rehabilitation studies)

·        Preclinical data required for all clinical trial applications

·        Comparative effectiveness studies are encouraged

·        Clinical expertise required by Principal Investigator (PI)

Preproposal required; application submission by invitation only

·        Maximum funding of $750,000 in direct costs (plus indirect costs)

Period of performance should not exceed 4 years

 

Investigator-Initiated Research Award - Pre-application due July 3, 2012

Independent investigators at all academic levels
(or equivalent)

·        Fund research that will make an original and important contribution to the field of SCI research or patient care.

·        Clinical trials not allowed

·        Preliminary data required

Preproposal required; application submission by invitation only

·        Maximum funding of $400,000 in direct costs (plus indirect costs)

Period of performance should not exceed 3 years

 

Translational Research Award - Pre-application due July 3, 2012

Independent investigators at all academic levels
(or equivalent)

·        Fund studies that accelerate the movement of promising ideas in SCI research into clinical applications

·        New for FY12:  Now supporting individual investigators; no longer limited to multidisciplinary partnerships

·        Clinical trials not allowed

·        Preliminary data required

Preproposal required; application submission by invitation only

·        Maximum funding of $750,000 in direct costs (plus indirect costs)

Period of performance should not exceed 3 years

 All applications must conform to the requirements specified in the Program Announcements/Funding Opportunities on Grants.gov and the CDMRP website (http://cdmrp.army.mil).  

 A pre-application (preproposal) is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior July 3, 2012.  Applications must be submitted through the federal government's single-entry portal, Grants.gov.  Individual program announcements and required forms are available on the Grants.gov website.

 Requests for email notification of the release of program announcements may be sent to Help@cdmrp.org.  Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

 If you would like to request a different recipient to these messages please reply back with the corrected information to PublicAffairs@amedd.army.mil.

 

FY 2013 DoD Armed Forces Institute of Regenerative Medicine II (AFIRM II) Funding Opportunities

The U.S. Army Medical Research and Materiel Command (USAMRMC), with the Office of Naval Research (ONR), the Air Force Medical Service, the Office of Research and Development - Department of Veterans Affairs (VA), the National Institutes of Health (NIH), and the Office of the Assistant Secretary of Defense for Health Affairs (the Sponsors) are soliciting applications for the AFIRM II program. The AFIRM II program is anticipated to be funded in Fiscal Year 2013 (FY13).

One of the goals of the program is to position promising technologies and therapeutic/restorative practices for entrance into human clinical trials. The intent of the AFIRM II program is to fund basic through translational regenerative medicine research and development. Activities acceptable under this award may include basic scientific research, development of animal models, preclinical studies required for initiation of FDA-regulated human clinical trials, and Phase I – II human clinical trials. Therefore, it is not the intent to fund human clinical trials as a major component of this program. Pending the availability of funds, it is anticipated that additional human clinical trials will be solicited, evaluated, selected, and funded separately from the AFIRM II program in open competition.

The Offeror is required to submit only to the focus area(s) described in the program announcement in which they have relevant expertise. Therefore, successful application (s) may include submissions to one, several or all five focus area(s).

e Government anticipates that Offerors will assemble an expert team from multiple academic institutions and/or industry partners to satisfy the objectives of the AFIRM II Program Announcement. Responses should demonstrate the ability to manage a diverse team of medical and scientific professionals in an outcome-driven environment that efficiently designs, tests, compares, and evaluates discoveries leading to the selection of promising technologies for translation to investigational human studies. Therefore, the Offeror’s organization may be comprised of a program management group, and one or more of the following: a) academic and clinical research institutions, b) commercial development partners, and c) not-for-profit enterprises. If there are multiple awards made (i.e., multiple consortia), the Government fully expects research collaboration across and among consortia.

It is envisioned that integration of basic science, translational and clinical research efforts will be necessary to advance effective regenerative medicine treatments for combat-related injuries. The Offeror’s organization should actively seek out and establish partnerships with industry to ensure that the technical innovations emerging from the research will transition into clinical applications and result in FDA approved treatments.

Offerors are encouraged to seek collaboration with Government laboratories and Medical Centers/Medical Treatment Facilities such as those in the Army, Navy, Air Force, NIH and VA, if mutually beneficial.

AHA/ASA/American Brain Foundation Lawrence M. Brass, M.D., Stroke Research Postdoctoral Fellowship Award

The American Heart/Stroke Association also established a partnership with the American Brain  Foundation to support an AHA fellowship awarded to an individual interested in embarking on an academic career in vascular nurology or stroke.  The recipient will be chosen from the pool of fefllowship awrdees. More information on Focused Research Programs Need Help with your Application?

• The Applicant Information Guide contains comprehensive tips for completing your submission • Call our applicant help line at 214-360-6107, select option • Submit your question to apply@heart.org

"Which institution name should I select?"

The FO and GO drop-downs are searchable by Institution.  Select from the "Institution Where Work Will be Done" section of the Advanced Profile. Ask your institutional officers which institution name they selected when they registered. Grant Officers - Once an application is "Submitted to GO" in Grants@Heart, the Grant Officer must review and submit it to AHA, prior to the AHA deadline. Grant Officer Help Sponsors - The applicant will send you information regarding documents that he or she needs in order to complete the application. Fellows will upload the documents you prepare into their applications prior to submission to the institutional grants office. Sponsors must click the link in the email sent by Grants@Heart to access the application. 

 

American Heart Assn. Program Offerings for July 2012 Deadlines
New!  Beginning with July 2012 deadlines the application deadline has changed to 5:00 p.m. Central Daylight Savings Time.  Read more in the FAQ's
 
The method for applying for funding is Web-based, using our electronic system, Grants@Heart.  Our research customers (applicants, grants officers, fiscal officers, peer reviewers, awardees) use the Grants@Heart system.  

To help you prepare for applying, it is recommended that you: 
Quick view of SUMMER 2012 programs. 
FOCUSED RESEARCH PROGRAMS

The American Heart Association frequently partners with outside organizations to help support outstanding research in areas focused on topics important to cardiovascular disease and stroke.  Currently we are working with the Myocarditis Foundation and Philips Healthcare Systems and accepting applications for postdoctoral fellowships in the areas of myocarditis and resuscitation research.  If you are interested in applying for one of these co-sponsored awards, please submit a postdoctoral fellowship application to your local affiliate. 
 
Myocarditis FoundationAHA/Myocarditis Foundation Postdoctoral Fellowship Award
Supports an investigator proposing innovative basic, clinical or translational research projects relevant to the etiology, pathophysiology, diagnosis, treatment epidemiology and/or prevention of myocarditis.  
 
PediatricAHA/Children’s Cardiomyopathy Foundation Pediatric Joint Research Award
Applications to the Beginning Grant-in-Aid or Grant-in-Aid programs conducting pediatric cardiomyopathy research will be considered for the AHA/CCF Pediatric Joint Research Award.
   
Predoctoral Fellowship
Helps students initiate careers in cardiovascular and stroke research by providing research assistance and training.
Offered by: FoundersGreater SoutheastMidwest, SouthWest and Western States Affiliates
Career Stage: gaining credentials – doctoral student
Postdoctoral Fellowship
Helps trainees initiate careers in cardiovascular and stroke research while obtaining significant research results under the supervision of a sponsor or mentor; supports individuals before they are ready for some stage of independent research.
Offered by: Founders, Great Rivers, Greater SoutheastMidwest, SouthWest and Western States Affiliates
Career Stage: directed step - postdoctoral fellow


Clinical Research Program
Encourages early career investigators who have appropriate and supportive mentoring relationships to engage in high quality introductory and pilot clinical studies that will guide future strategies for reducing cardiovascular disease and stroke while fostering new research in clinical and translational science, and encouraging community- and population-based activities.
Offered by National Founders and Greater Southeast Affiliates
Career Stage: directed step/first independent step - masters degree. Healthcare professionals with a masters degree or certain doctoral degrees.
Beginning Grant-In-Aid
Promotes the independent status of promising beginning scientists.  
Offered by: Great RiversSouthWest and Western States Affiliates
Career Stage: First independent step – instructor, assistant professor or other first academic appointment or equivalent.

Scientist Development Grant
Supports highly promising beginning scientists in their progress toward independence by encouraging and adequately funding research projects that can bridge the gap between completion of research training and readiness for successful competition as an independent investigator.
Offered by: National and Founders Affiliate
Career Stage: First independent step – instructor, assistant professor or other first academic appointment or equivalent

Established Investigator Award
To support mid-career investigators with unusual promise and an established record of accomplishments; candidates have a demonstrated commitment to cardiovascular or cerebrovascular science as indicated by prior publication history and scientific accomplishments.  A candidate's career is expected to be in a rapid growth phase.
Offered by: National,
Career Stage: Intermediate level - assistant professor, associate professor or equivalent  (entry not more than 9 years after first academic appointment)
Grant-In-Aid
Encourages and adequately funds the most innovative and meritorious research projects from independent investigators. 
Offered by: Offered by: FoundersSouthWest and Western States Affiliates
Career Stage: First independent step, intermediate level or recognized investigator – instructor, assistant professor or other first academic appointment or equivalent, associate professor or equivalent, professor or equivalent. Applicants are expected to be independent investigators.
 Innovative Research Grant
To support highly innovative, high-risk, high-reward research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and stroke research.
Offered by: National
Career Stage: First independent step, intermediate level or recognized investigator – instructor, assistant professor or other first academic appointment or equivalent, associate professor or equivalent, professor or equivalent. 

Contact us at apply@heart.org or
214-360-6107 for questions and
inquiries about programs. 
 
Mailing Address:
American Heart Association
Division of Research Administration
AHA National Center
7272 Greenville Avenue
Dallas, TX  75231-4596
 

DoD Autism Research Program Funding Opportunities for FY2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $5.12 million (M) to the Department of Defense Autism Research Program (ARP). The vision of the ARP is to improve the lives of individuals with autism spectrum disorders (ASD) now. This program is administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

http://cdmrp.army.mil/funding/arp.shtml

Idea Development Award – Pre-application due June 20, 2012

Eligibility - Investigators at all academic levels (or equivalent).

Key Mechanism Elements

Preproposal is required; application submission is by invitation only.

Supports the development of innovative, high-impact ideas that advance the understanding of ASD and lead to improved outcomes.

Preliminary data are required.

Clinical trials are not allowed.

Multiple Principal Investigator (PI) Option: Up to three investigators may collaborate on a single application, each of whom will be recognized as a PI and receive a separate award.

Investigators are encouraged to submit their data to the National Database for Autism Research (NDAR), a secure bioinformatics platform for data-sharing.

FY12 Areas of Interest (Encouraged)

Improved sub-grouping of individuals with ASD to inform the mechanisms, natural history, and response to treatment (e.g., biomarkers, risk factors, sex ratio).

Identification of therapeutic targets, excluding new gene discovery.

Psychosocial research across the lifespan, including influences on brain function/structure.

Co-morbid conditions across the lifespan, especially sleep disorders and gastrointestinal issues.

Funding

Maximum funding for the entire period of performance is $400,000 in direct costs (plus indirect costs).

For multiple PIs, the combined funding for all PIs for the entire period of performance may not exceed $400,000 in direct costs (plus indirect costs).

Maximum period of performance is 3 years.

 Pilot Award – Pre-application due date June 20, 2012

Eligibility - Investigators at all academic levels (or equivalent)

Key Mechanism Elements

Preproposal is required; application submission is by invitation only.

Supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ASD forward.

Preliminary data are not allowed.

Clinical trials are not allowed.

Not intended to support the continuation of existing studies or the next logical extension and/or incremental step.

Projects involving human subjects or human biological substances must be either exempt under Title 32, Code of Federal Regulations, Part 219, Section 101(b) (32 CFR 219.101[b]) or eligible for expedited review (32 CFR 219.110 or 21 CFR 56.110).

FY12 Areas of Interest (Encouraged)

Improved sub-grouping of individuals with ASD to inform the mechanisms, natural history, and response to treatment (e.g., biomarkers, risk factors, sex ratio).

Identification of therapeutic targets, excluding new gene discovery.

Psychosocial research across the lifespan, including influences on brain function/structure.

Co-morbid conditions across the lifespan, especially sleep disorders and gastrointestinal issues.

Funding

Maximum funding for the entire period of performance is $100,000 in direct costs (plus indirect costs).

Maximum period of performance is 2 years.

All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism is also available on the Grants.gov website. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline, June 20, 2012. Applications must be submitted through the federal government's single entry portal, Grants.gov.

Requests for email notification of the Program Announcements release may be sent to help@cdmrp.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

For more information about the ARP or other CDMRP-sponsored programs, please visit the CDMRP website (http://cdmrp.army.mil). If you would like to request a different recipient to these messages please reply back with the corrected information.

If you would like to request a different recipient to these messages please reply back with the corrected information to Publicaffairs@amedd.army.mil.

Point of Contact:

CDMRP Help Desk

help@cdmrp.org

301-682-5507

 

DoD Peer Reviewed Cancer Research Program Funding Opportunities for FY 2012

Please view in html to activate links.

The Fiscal Year 2012 (FY12) Defense Appropriation Act provides for $12.8 million (M) to the Department of Defense (DoD) Peer Reviewed Cancer Research Program (PRCRP) to research cancers not addressed in breast, prostate, lung (excluding mesothelioma), and ovarian cancer research programs currently executed by the DoD U.S. Army Medical Research and Materiel Command (USAMRMC). The funds provided are directed to be used to conduct research for the following topic areas:

· Blood cancers

· Colorectal cancer

· Genetic cancer research

· Kidney cancer

· Listeria vaccine for cancer

· Melanoma and other skin cancers

· Mesothelioma

· Pancreatic cancer

· Pediatric brain tumors

 The program is administered by the USAMRMC through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 FY12 PRCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.

http://cdmrp.army.mil/funding/prcrp.shtml

 Visionary Postdoctoral Fellowship Award – Pre-application due date June 19, 2012

Eligibility - Principal Investigator: M.D./Ph.D. graduate with a total of less than 4 years of postdoctoral research experience

Mentor(s): Independent investigator at the level of Assistant Professor or equivalent at the time of the award

 Key Mechanism

Research must be in one or more of the FY12 PRCRP Topic Areas

Supports training of postdoctoral fellow in the laboratory of an early-career investigator (mentor) with expertise in one or more of the FY12 PRCRP Topic Areas

Supports training of postdoctoral fellow to include a budget option for research supplies

Applications must not address breast, prostate, lung (excluding mesothelioma), or ovarian cancer research

Preliminary data not required

Clinical trials will not be supported

 Funding

Maximum funding for the entire period of performance is $240,000 for direct costs (plus indirect costs)

Maximum period of performance is 3 years

 Career Development Award – Pre-application due date June 19, 2012

Eligibility - Principal Investigator: Independent investigator at the level of Assistant Professor or equivalent at the time of the award

 Key Mechanism Elements

Research with emphasis in discovery must be in one or more of the FY12 PRCRP Topic Areas

Supports investigator in the early stages of their career

Applications must not address breast, prostate, lung (excluding mesothelioma), or ovarian cancer research

Preliminary data not required

Clinical trials will not be supported

 Funding

Maximum funding for the entire period of performance is $240,000 for direct costs (plus indirect costs)

Maximum period of performance is 2 years

 All proposals must conform to the final Program Announcement and General Application Instructions (including deadlines) that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can also be found on Grants.gov.

 A pre-application is required and must be submitted through the CDMRP eReceipt website http://cdmrp.org  prior to proposal submission dues date of June 19, 2012. Applications must be submitted through the federal government's single-entry portal, Grants.gov http://www.grants.gov

Requests for email notification regarding release of the Program Announcements may be sent to help@cdmrp.org. For more information about the PRCRP or other CDMRP-administered programs, please visit the CDMRP website http://cdmrp.army.mil 

 If you would like to request a different recipient to these messages please reply back to CDMRP.PublicAffairs@amedd.army.mil with the corrected information.

 Point of Contact:

CDMRP Help Desk

301-682-5507

help@cdmrp.org

 

PCORI Funding Announcements

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors approved $96 million in funding announcements<http://lists.aamc.org/t/170799/22674/17186/22/> for patient-centered outcomes research at last week’s board meeting.  The funding announcements mark the first time PCORI has posted calls for proposals since the initial call for pilot projects in the fall of 2011.  Letters of intent are due June 15, with full proposals due July 31.  The board also approved a final version of the National Priorities for Research and Research Agenda for release.  In response to public comments, the revision emphasizes the decision to retain a broad scope of interest rather than addressing specific diseases or conditions.  The agenda<http://lists.aamc.org/t/170799/22674/17205/23/> will guide future requests for proposals.

 

Thome Foundation Alzheimer's Disease Drug Discovery Research Program Funding 2012

Initial Research Proposal Deadline:

Tuesday, June 15, 2012

12:00 Noon US Eastern Time

Award Amount and Funding Period:

Two-year projects of $200,000

(inclusive of 10% indirect costs)

 Funding begins on or before December 31, 2012 See the Eligibility Criteria and Application Information:  

www.tmfgrants.org/ThomeAD

For information about the Thome Foundation's broader mission and funding, please visit:  www.bankofamerica.com/grantmaking.

 Edward N. & Della L. Thome Memorial

Foundation, Bank of America, N.A., Trustee, Awards Program in Alzheimer's Disease Drug Discovery Research

The Edward N. & Della L. Thome Memorial Foundation was created in 2002 to advance the health of older adults through the support of direct service projects and medical research on diseases and disorders affecting older adults. In keeping with the Foundation's mission, we are pleased to announce the Awards Program in Alzheimer's disease (AD) research. The goal of the 2012 Awards Program is to support pilot studies towards innovative drug discovery research that will lead to improved therapies for individuals suffering from Alzheimer's disease.

As steward of the Thome Memorial Foundation, Bank of America, N.A. works with the Scientific Review Committee selected by The Medical Foundation division, to decide on the most qualified candidates. The 2012 Awards Program supports pilot studies in preclinical development and design of novel small molecules and compounds for the therapeutic control of validated targets in Alzheimer's disease.  Consideration will be given to research based on the amyloid hypothesis and alternative pathogenic mechanisms.

Genetic studies, biomarker research, neuro-imaging, clinical studies, basic research and new target discovery are currently outside the scope of this Program.

     Bank of America Merrill Lynch is a marketing name for the Retirement & Philanthropic Services (RPS) businesses of Bank of America Corporation. Banking and fiduciary activities are performed globally by banking affiliates of Bank of America Corporation, including Bank of America, N.A., Member FDIC

 The Edward N. & Della L. Thome Memorial Foundation Awards Program is administered by The Medical Foundation division.

Please direct questions to 617-279-2240, x710 or LLam@hria.org.

 

Howard Hughes Medical Institute Biomedical Research Competition

 

The Howard Hughes Medical Institute (HHMI) will appoint up to 30 new biomedical researchers through a national open competition for researchers who study significant biological problems in all of the biomedical disciplines as well as in adjacent fields such as biophysics, chemical biology, biomedical engineering, and computational biology.  Patient-oriented researchers are also welcome to apply.  Those selected will receive a five-year appointment to HHMI, which is renewable pending favorable scientific review. Applications must be submitted by June 13, 2012. To learn more, visit http://www.hhmi.org/news/HHMI20120315.html.

Juvenile Offender Reentry Program Evaluation Solicitation

The National Institute of Justice (NIJ) is seeking proposals to evaluate up to five juvenile offender demonstration projects funded under the Second Chance Act of 2007. The grantee will measure the processes, outcomes, costs, and impacts of juvenile offender reentry programs funded in 2010 by the Office of Juvenile Justice and Delinquency Prevention (OJJDP), with the goal of assessing the effectiveness of the Second Chance Act in reducing recidivism among juvenile offenders.

 To view the complete solicitation visit: https://ncjrs.gov/pdffiles1/nij/sl001017.pdf

DoD Lung Cancer Research Program Funding Opportunities  FY2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $10.2 Million (M) to the Department of Defense Lung Cancer Research Program’s (LCRP) to support innovative, high-impact lung cancer research.  The LCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 http://cdmrp.army.mil/funding/lcrp.shtml

 Concept Award will be released at a later time.  Deadlines for the Concept award are not known at this time.

 Idea Development Award – preapplication due May 30, 2012

Independent investigators at or above the level of an Assistance Professor (or equivalent); must be within 10 years of first faculty appointment.

Supports new ideas that are in the early stages of development which represent innovative, high-risk/high-gain research that could lead to critical discoveries or major advances that will accelerate progress toward eradicating deaths from lung cancer.

            Emphasis is on Innovation and Impact.

            Preliminary data required, but may be from outside of lung cancer.

            Clinical trials are not allowed.

Maximum funding of $350K for direct costs (plus indirect costs).

Maximum period of performance is 2 years.

 Translational Research Partnership Award - preapplication due May 30, 2012

Investigators at or above the level of Assistant Professor (or equivalent).

Partnership: One investigator must be a laboratory scientist, and the other must be a clinician.

Supports partnership[s between clinicians and laboratory scientists that accelerate the movement of promising ideas in lung cancer into clinical applications.

Preliminary data required, but may be from outside of lung cancer.

Clinical trials are not allowed.

Optional Nested Clinical Fellow or Resident Traineeship.

Maximum combined funding of $900K for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

Nested traineeships:  Additional maximum of $75K in direct and indirect costs over a one-year period of performance.

 All applications must conform to the Program Announcements and application instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline of May 30, 2012.  Applications must be submitted through the federal government’s single-entry portal, Grants.gov.

 Requests for email notification of the Program Announcements release may be sent to help@cdmrp.org.  

 For more information about the LCRP or other CDMRP-sponsored programs, please visit the CDMRP website (http://cdmrp.army.mil).

 Point of Contact:

CDMRP helpdesk

301-682-5507

help@cdmrp.org

 

U.S. Dept. of Justice OJP Releases 2012 Program Plan

The Office of Justice Programs (OJP) has launched a new, searchable online document of current funding opportunities and new initiatives, the OJP Program Plan. It features the latest and most complete information regarding both competitive and noncompetitive grants, training and technical assistance, research, and other resources available to the justice community.

The Program Plan is divided into 9 thematically organized sections:

 ·         Initiatives to Address a Wide Range of Criminal and Juvenile Justice Issues

·         Breaking the Cycles of Mental Illness, Substance Abuse, and Crime

·         Preventing and Intervening in Juvenile Offending and Victimization

·         Managing Offenders To Reduce Recidivism and Promote Successful Reentry

·         Effective Interventions To Address Violence, Victimization, and Victims’ Rights

·         Enhancing Law Enforcement Initiatives

·         Supporting Innovation in Adjudication

·         Advancing Technology To Prevent and Solve Crime

·         Innovations in Justice Information Sharing Also available, instructions on how to apply for Continuation and Formula Grants and assistance, a Glossary of acronyms and definitions, answers to Frequently Asked Questions, and an alphabetical Index of the programs found in the Plan.

 

PAR-12-155:  Integrative Omics Data Analysis for Discovery in Lung Diseases (R01)

·         PAR-12-155: Integrative Omics Data Analysis for Discovery in Lung Diseases (R01)

Please note that most links to RFAs, PAs, and Guide Notices will take you to the NIH Web site. RFPs will take you to FedBizOpps. Links to RFPs will not work past their proposal receipt date. Archived versions of RFPs posted on FedBizOpps can be found on the FedBizOpps site using the FedBizOpps search function. Under “Document to Search,” select Archived Documents

The National Heart, Lung, and Blood Institute (NHLBI) invites applications to: (1) generate systems-level models of pulmonary pathobiology through integrative analyses of existing omics (e.g., genomics, transcriptomics, proteomics, metabolomics) data; and (2) experimentally test novel predictions of these models using human tissues/cells and/or mammalian animal models.The National Heart, Lung, and Blood Institute (NHLBI) invites applications to: (1) generate systems-level models of pulmonary pathobiology through integrative analyses of existing omics (e.g., genomics, transcriptomics, proteomics, metabolomics) data; and (2) experimentally test novel predictions of these models using human tissues/cells and/or mammalian animal models.The National Heart, Lung, and Blood Institute (NHLBI) invites applications to: (1) generate systems-level models of pulmonary pathobiology through integrative analyses of existing omics (e.g., genomics, transcriptomics, proteomics, metabolomics) data; and (2) experimentally test novel predictions of these models using human tissues/cells and/or mammalian animal models.The National Heart, Lung, and Blood Institute (NHLBI) invites applications to: (1) generate systems-level models of pulmonary pathobiology through integrative analyses of existing omics (e.g., genomics, transcriptomics, proteomics, metabolomics) data; and (2) experimentally test novel predictions of these models using human tissues/cells and/or mammalian animal models.

Letter of Intent Due Date

May 19, 2012

Application Due Date

June 19, 2012

 Website:                  http://grants.nih.gov/grants/guide/pa-files/PAR-12-155.html

DoD Peer Reviewed Orthopaedic Research Program Funding Opportunities FY2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $30 million (M) to the Department of Defense Peer Reviewed Orthopaedic Research Program (PRORP). The PRORP seeks to fund innovative, high-impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat or combat-related activities. This program is administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 The FY12 PRORP Focus Areas are:

·         Improvement of moisture management and residual limb skin care at the prosthetic socket interface.

·         Improvement of the rate of nerve regeneration.

·         Strategies to inhibit neuromas at surgical/amputation sites.

·         The treatment of segmental bone injury in weight-bearing locations, including utilization of the Masquelet technique for bioactive membrane formation and identification of the best bone graft options. Clinical and mature translational studies only; development of novel bone void filler products are not of interest.

·         The comparative effectiveness of local strategies to minimize surgical site infection, including local application of antibiotics, debridement techniques, and subatmospheric wound dressings.

·         Treatment and management of heterotopic ossification. Mature translational studies only; the development and/or validation of new animal models of heterotopic ossification are not of interest.

·         Mitigation of the negative effects of immobility for polytrauma patients, excluding spinal cord injury.

·         Short-term and long-term outcomes in limb salvage populations.

·         Prevention or treatment of post-traumatic joint stiffness and contracture in the ankle, knee, and/or elbow.

All applications are required to address at least one Focus Areas as specified in each program announcement.  Note that Focus Areas may differ between program announcements/funding opportunities.  Full details of FY12 PRORP Focus Areas will be included in the program announcements when they are released.

 FY12 PRORP program announcements and application instructions for the following award mechanisms (including deadlines) are anticipated to be posted and available for download on Grants.gov in mid May 2012.

 Award Mechanism

Clinical Trial Award

 Independent Investigators at or above the level of Assistant Professor (or equivalent)

·      Preproposal is required; application submission is by invitation only

·      Supports the rapid implementation of clinical trials that will have a significant impact on military combat-related orthopaedic injuries

·      Preliminary data are required

·      Military/Veteran study population highly encouraged

Nested Career Development Option: Additional funds may be requested to support the mentored career development of an active duty military research- or physician-scientist at an early career stage.

Maximum funding of $2.5M for direct costs (plus indirect costs)

Period of performance up to 5 years

Nested Career Development: Additional direct costs of $225K for total combined direct costs of $2.725M

 Translational Research Partnership Award

Independent investigators at all academic levels (or equivalent)

·      Preproposal is required; application submission is by invitation only

·      Supports the development of multidisciplinary translational research partnerships between clinicians and laboratory scientists to accelerate the movement of promising research hypotheses into clinical applications

·      Minimum of 2 PIs required; maximum of 3 PIs allowed

·      At least one partner must be a laboratory scientist and at least one partner must be a clinician

·      At least one partner must have significant experience in orthopaedic research or orthopaedic medicine

·      Preliminary and/or published data are required

·      Does not support definitive clinical trials, but limited clinical testing is permissible

·      All applications must have a direct relevance to orthopaedic injuries sustained during combat or combat-related activities

Nested Career Development Option:  Additional funds may be requested to support the mentored career development of an active duty military research- or physician-scientist at an early career stage

Maximum combined funding of $750K for direct costs (plus indirect costs)

Period of performance up to 3 years

Nested Career Development: Additional direct costs of $225K for total combined direct costs of $975K

 Idea Development Award

Independent investigators at all academic levels (or equivalent)

·       Supports conceptually innovative, high-risk/high gain research

·       Emphasis is on Innovation and Military Benefit

·       Preliminary data are not required

·       Clinical trials not allowed

·       Nested Career Development Option:  Additional funds may be requested to support the mentored career development of an active duty military research- or physician-scientist at an early career stage

·         Maximum funding of $500K for direct costs (plus indirect costs)

·         Period of performance up to 3 years

·         Nested Career Development: Additional direct costs of $225K for total combined direct costs of $725K

 Information in this press release is being provided to allow investigators time to plan and develop proposals. All applications submitted must conform to the final program announcements, which will be posted on Grants.gov and the CDMRP website (http://cdmrp.army.mil) at a later date. Submission deadlines are not available until the program announcements are released.

 A pre-application (preproposal) is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to proposal submission. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Individual program announcements and required forms will also be found on the Grants.gov website.

 Requests for email notification of the release of program announcements may be sent to Help@cdmrp.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

 For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or 301-682-5507

 For more information about the PRORP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

If you would like to request a different recipient to these messages please reply back to CDMRP.PublicAffairs@amedd.army.mil with the corrected information.

Point of Contact:

 CDMRP Public Affairs

301-619-9783
CDMRP.PublicAffairs@amedd.army.mil

 

Gates Foundation Grant Opportunities

The Bill & Melinda Gates Foundation is inviting innovators to apply for two grant opportunities:

1. Grand Challenges Explorations, an initiative to encourage innovative and unconventional global health and development solutions, is now accepting grant proposals for its latest application round. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for profit companies.

Proposals are being accepted online until May 15, 2012 on the following topics:

o New Approaches for the Interrogation of Anti-malarial Compounds o Aid is Working. Tell the World o Design New Approaches to Optimize Immunization Systems o Explore New Solutions in Global Health Priority Areas o Protect Crop Plants from Biotic Stresses From Field to Market Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million. Full descriptions of the new topics and application instructions are available at: www.grandchallenges.org/explorations.

If you have questions regarding this grant opportunity, please email us at GCEHelp@gatesfoundation.org.

2. The HIV Diagnostics team is now accepting Letters of Inquiry for the identification of novel biomarkers that can be used effectively to measure HIV incidence at the population level. We are looking for biomarkers that could be used alone or in combination, and that are at the initial development stage. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for profit companies.

 Proposals are being accepted online until Friday, May 18, 2012 10:00 AM Pacific Standard Time. Individual grants will not exceed US $1 million. A full description of the new topic and application instructions are available at http://www.gatesfoundation.org/hivaids/Pages/loi-biomarkers-hiv-incidence-measurement.aspx .

 If you have questions regarding this grant opportunity please email us at HIVDiagnostics@gatesfoundation.org. We are looking forward to receiving innovative ideas from around the world and from all disciplines.

Gates Foundation Reinvent the Toilet Challenge

The Bill & Melinda Gates Foundation is inviting innovators to send letters of inquiry for the following opportunity:

 Reinvent The Toilet Challenge — RTTC (round 2)<http://www.gatesfoundation.org/watersanitationhygiene/Pages/rfloi-reinvent-the-toilet-challenge.aspx>

 We are calling for a new set of innovative ideas to support our effort to reinvent the toilet. Grants will be awarded to exceptionally highly-qualified research groups interested in contributing to major advances in human sanitation in the developing world. These R&D efforts will comprise a new phase of the Foundation’s Reinvent the Toilet Challenge: fast-paced designing, prototyping and demonstrating-in-operation of entirely stand-alone, self-contained, eminently-practical sanitation modules which intake bodily wastes and swiftly dispose of them definitively — without any incoming water piping, outgoing sewer piping or electric or gas utility services. These modules must intake all outputs of the serviced population — ultimately at single-residence scales — with minimal module footprints and assured biosafety. Thus, chemical and mechanical engineering approaches are preferred.

 Letters of inquiry are being accepted online until Thursday, May 10, 2012 10:00 AM Pacific Standard Time. A full description of the topic and application instructions is available at http://www.gatesfoundation.org/reinvent-the-toilet-loi<http://www.gatesfoundation.org/watersanitationhygiene/Pages/rfloi-reinvent-the-toilet-challenge.aspx>.

 If you have questions regarding this grant opportunity, please email us at GDWSHInbox@gatesfoundation.org<mailto:GDWSHInbox@gatesfoundation.org>. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for profit companies. We are looking forward to receiving innovative ideas from around the world and from all disciplines. If you have a great idea, please apply. If you know someone else who may have a great idea, please forward this message.

 Thank you for your commitment to solving one the world's greatest health and development challenges.

 Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives.

 Visit our site<http://www.gatesfoundation.org> | Privacy Policy<http://www.gatesfoundation.org/about/Pages/privacy-policy.aspx>

U. S. Dept. of Labor Research Funding Opportunity FY 2012

Title: Senior Community Service Employment Program National Grants for Program Year (PY) 2012 - SGA-DFA-PY-11-04
Description:
The purpose of this grant is to aid low-income older individuals who want to enter or re-enter the workforce with the goals of promoting useful opportunities in community service job training and to move participants into unsubsidized employment at the end of the program.

Eligibility: Non-profit organizations with or without 501(c)(3) status, Federal public agencies, or Tribal organizations and consortiums that have the ability to administer a multi-State program that meets the eligibility and responsibility requirements outlined in 20 CFR part 641 subpart D (see Full Announcement).

Funding: Estimated Total Program Funding is $346 million.

Link to Full Announcement: Link to Full Announcement

Last Day to Apply: May 10, 2012

Grant is administered by the: U.S. Department of Labor

DoD Prostate Cancer Research Program Funding Opportunities FY 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $12.8 million (M) to the Department of Defense Neurofibromatosis Research Program (NFRP) and also provided for $5.1M to the Tuberous Sclerosis Complex Research Program (TSCRP) to the  to support innovative, high-impact research. The mission of the NFRP is to promote research directed toward the understanding, diagnosis, and treatment of NF1, NF2 and Schwannomatosis.  The mission the TSCRP aims at understanding the pathogenesis of TSC and to translate these findings to the care of individuals with TSC.  These programs are administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

 Please inform researchers at the University of Connecticut Health Center interested in the Neurofibromatosis and/or Tuberous Sclerosis Complex that their FY12 award mechanisms have been released.   FY12 NFRP and TSCRP program announcements and general application instructions are available on Grants.gov.  Required pre-application due dates for all of the NFRP and TSCRP award mechanisms occur on May 10, 2012, 5:00 p.m. Eastern time.

 This information can be found at the following links: http://cdmrp.army.mil/funding/nfrp.shtml and http://cdmrp.army.mil/funding/tscrp.shtml

 The Program Announcement summaries for both NFRP and TSCRP are listed below:

NEUROFIBROMATOSIS:  (4 Program Announcements)

Clinical Trial Awards

Independent investigators at or above the level of Assistant Professor (or equivalent) Pre-application (Letter of Intent) is required and due May 10, 2012.

Supports Phase 0,I, II clinical trials relevant to NF and/or Schwannomatosis.  Combinations of phases are permitted.

Preclinical data is required.

Phase I or pilot clinical trial data required for Phase II clinical trial applications.

Maximum funding of $900,000 for direct costs Indirect costs may be proposed in accordance with your institution's negotiated rate agreement.

Maximum period of performance is 4 years.

 Exploration - Hypothesis Development Awards All level of experience are eligible.

Pre-application (Letter of Intent) is required and due May 10, 2012.

Supports the initial exploration of innovative, untested research and pursue serendipitous observations.

Preliminary data is encouraged but not required.

Projects involving human subjects or human anatomical substances must be exempt under 32 CFR 219.101(b) or eligible for expedited review under 32 CFR 219.110 or 21 CFR 56.110.

Clinical trials are not allowed.

Maximum funding of $100,000 for direct costs Indirect costs may be proposed in accordance with your institution's negotiated rate agreement.

Maximum period of performance is 2 years.

 Investigator-Initiated Research Awards

Principal Investigator (PI) must be an independent investigator at or above the level of Assistant Professor (or equivalent).

Optional Qualified Collaborator:  Must be at or above the level of Assistant Professor (or equivalent).

Optional Nested Postdoctoral Traineeship: Must have 3 years or less of postdoctoral experience at the time of application.

Pre-application (Letter of Intent) is required and due May10, 2012.

Fund basic and clinically oriented research relevant to NF and/or Schwannomatosis.

Preliminary data required.

Clinical trials are not allowed.

Maximum funding of $525,000 for direct costs ($675,000 in direct costs if requesting an Optional Qualified Collaborator or Postdoctoral Fellow).

Indirect costs may be proposed in accordance with your institution's negotiated rate agreement.

Maximum period of performance is 3 years.

 New Investigator Awards

Applicant must be either an independent investigator at or below the level of Assistant Professor.(or equivalent) or an established independent investigator at or above the level of Assistant Professor seeking to transition into a career in NF research.

To be eligible, applicants may not have received more than $300,000 in direct costs for NF research as a PI of one or more federally funded, non-mentored peer reviewed grants.

Pre-application (Letter of Intent) is required and due May 10, 2012.

Fund investigators in the early stages of their careers or established investigators seeking to transition into a career in NF research.

Experience in NF research is allowed, but not required.

Preliminary data required.

Clinical trials are not allowed.

Maximum funding of $400,000 in direct costs.

Indirect costs may be proposed in accordance with your institution's negotiated rate agreement.

Maximum period of performance is 3 years

 TUBEROUS SCLEROSIS COMPLEX  (3 Program Announcements)

Clinical Trial Awards

Independent investigators at or above the level of Assistant Professor (or equivalent) Pre-application (Letter of Intent) is required and due May 10, 2012.

Supports Phase 0,I, II clinical trials relevant to TSC.  Combinations of phases are permitted.

Preliminary data is required.

Phase I or pilot clinical trial data required for Phase II clinical trial applications.

Maximum funding of $1,000,000 for direct costs.

Indirect costs may be proposed in accordance with your institution's negotiated rate agreement.

Maximum period of performance is 4 years.

 Exploration - Hypothesis Development Awards Independent investigators, including junior faculty but excluding postdoctoral fellows (or equivalent).

Pre-application (Letter of Intent) is required and due May 10, 2012.

Supports the initial exploration of innovative, untested research and pursue serendipitous observations.

Preliminary data is encouraged but not required.

Projects involving human subjects or human anatomical substances must be exempt under 32 CFR 219.101(b) or eligible for expedited review under 32 CFR 219.110 or 21 CFR 56.110.

Clinical trials are not allowed.

Maximum funding of $100,000 for direct costs.

Indirect costs may be proposed in accordance with your institution's negotiated rate agreement.

Maximum period of performance is 2 years.

 Idea Development Awards

Principal Investigator (PI) must be an independent investigator with a documented faculty appointment (or equivalent).

Optional Qualified Collaborator:  Must be at or above the level of Assistant Professor (or equivalent).

Optional Nested Postdoctoral Traineeship: Must have 3 years or less of postdoctoral experience at the time of application.

Pre-application (Letter of Intent) is required and due May 10, 2012.

Encourages high impact, innovative research that will drive the field of TSC research forward.

Preliminary data is required.

Clinical trials are not allowed.

Maximum funding of $425,000 for direct costs ($575,000 in direct costs if requesting an Optional Qualified Collaborator or Postdoctoral Fellow).

Indirect costs may be proposed in accordance with your institution's negotiated rate agreement.

Maximum period of performance is 3 years All applications must conform to the program announcement and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 

A pre-application (Letter of Intent) is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

 Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the NFRP, TSCRP,  or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or 301-682-5507.

 

DoD FY12 OCRP Outcomes Consortium Development Pre-applications

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $16M for the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP) Ovarian Cancer Research Program (OCRP).

Pre-applications for the FY12 OCRP Outcomes Consortium Development Award are due 9 May 2012.  The OCRP Outcomes Consortium Development Award supports a multi-institutional research effort conducted by leading ovarian cancer researchers and consumer advocates that specifically focuses on identifying and understanding predictors of disease outcomes in ovarian cancer patients. This effort will be executed through two separate award mechanisms: this FY12 Outcomes Consortium Development Award, which will enable the consortium to lay the groundwork for the research project, including proof of concept, and the FY14 Outcomes Consortium Award, which will support the execution of the full research project.

 A detailed description of this funding opportunity (W81XWH-12-OCRP-OCDA), and its evaluation criteria and submission requirements can be found in the Program Announcement which is available electronically for downloading from the Grants.gov website (http://www07.grants.gov/search/search.do?&mode=VIEW&flag2006=false&oppId=153473), the CDMRP website (http://cdmrp.army.mil/funding/prgdefault.shtml) and the CDMRP eReceipt System (https://cdmrp.org).

 

U. S. Dept. of Labor Research Funding Opportunities FY 2012

*       Title: Serving Adult and Youth Ex-Offenders through Strategies Targeted to Characteristics Common to Female Ex-Offenders
Description:
The purpose of this grant is to improve the outlook for ex-offenders adjusting back into long-term employment in the labor market after incarceration by using an integrated strategy that includes empowerment and self-development, workforce development, education, case management, and partnerships with the state and local criminal justice agencies that serve adults or youth. Strong career development is essential with the goal of placing all ex-offenders in post-secondary education, apprenticeship programs, or vocational training.

Eligibility: Non-profit organizations with 501(c)(3) status, state or local government, or any Indian and Native American entity eligible under WIA Section 166. Applicants must serve pre- and post-release ex-offenders. Services must be targeted to female ex-offenders, but be eligible to male ex-offenders as well. Services may be to either youth or adults, but not both.

Funding: Estimated Total Program Funding is $12 million. 8 individual grants will be given. Applicants may submit proposals up to $1.5 million.

Link to Full Announcement: Link to Full Announcement

Last Day to Apply: May 4, 2012

Grant is administered by the: U.S. Department of Labor

Herbert W. Nickens Awards Nomination Cycle Opens

The AAMC is soliciting nominations for the annual Herbert W. Nickens faculty fellowship and medical student scholarships.  The Nickens awards recognize outstanding contributions to efforts that address inequities in medical education and health care.  For more information, contact Angela Moses at 202-862-6203 or e-mail NickensAwards@aamc.org.  Nominations for the awards must be received by May 4, 2012.

Prof. R. Rahamimoff Travel Grants for Young Scientists

Prof. R. Rahamimoff Travel Grants for Young Scientists`, a special program supporting short, research related trips of PhD students and Post-Docs, both Americans to Israel, and Israelis to the U.S. You can find the CALL using the link: http://www.bsf.org.il/data/FormsToDownload/BSF-TravelGrant-call.PDF

DoD Peer Reviewed Cancer Research Program Funding Opportunities for FY 2012

The Fiscal Year 2012 (FY12) Defense Appropriation Act provides for $12.8 million (M) to the Department of Defense (DoD) Peer Reviewed Cancer Research Program (PRCRP) to research cancers not addressed in breast, prostate, lung (excluding mesothelioma), and ovarian cancer research programs currently executed by the DoD U.S. Army Medical Research and Materiel Command (USAMRMC). The funds provided are directed to be used to conduct research for the following topic areas:

·         Blood cancers

·         Colorectal cancer

·         Genetic cancer research

·         Kidney cancer

·         Listeria vaccine for cancer

·         Melanoma and other skin cancers

·         Mesothelioma

·         Pancreatic cancer

·         Pediatric brain tumors

The program is administered by the USAMRMC through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

FY12 PRCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website by early May 2012.

http://cdmrp.army.mil/pubs/press/2012/12prcrppreann.shtml

Visionary Postdoctoral Fellowship Award

Eligibility

Principal Investigator: M.D./Ph.D. graduate with a total of less than 4 years of postdoctoral research experience

Mentor(s): Independent investigator at the level of Assistant Professor or equivalent at the time of the award

Key Mechanism

Research must be in one or more of the FY12 PRCRP Topic Areas

Supports training of postdoctoral fellow in the laboratory of an early-career investigator (mentor) with expertise in one or more of the FY12 PRCRP Topic Areas

Supports training of postdoctoral fellow to include a budget option for research supplies

Applications must not address breast, prostate, lung (excluding mesothelioma), or ovarian cancer research

Preliminary data not required

Clinical trials will not be supported

Funding

Maximum funding for the entire period of performance is $240,000 for direct costs (plus indirect costs)

Maximum period of performance is 3 years

 Career Development Award

Eligibility

Principal Investigator: Independent investigator at the level of Assistant Professor or equivalent at the time of the award

Key Mechanism Elements

Research with emphasis in discovery must be in one or more of the FY12 PRCRP Topic Areas

Supports investigator in the early stages of their career

Applications must not address breast, prostate, lung (excluding mesothelioma), or ovarian cancer research

Preliminary data not required

Clinical trials will not be supported

Funding

Maximum funding for the entire period of performance is $240,000 for direct costs (plus indirect costs)

Maximum period of performance is 2 years

Information in this pre-announcement is being provided to allow investigators time to plan and develop proposals. All proposals must conform to the final Program Announcement and General Application Instructions (including deadlines) that will be available for electronic downloading from the Grants.gov website in early May 2012. The application package containing the required forms for each award mechanism will also be found on Grants.gov.

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to proposal submission. Applications must be submitted through the federal government's single-entry portal, Grants.gov.  Due dates are not available until the Program Announcement is released in early May.

Requests for email notification regarding release of the Program Announcements may be sent to help@cdmrp.org. For more information about the PRCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact: CDMRP Public Affairs
301-619-9783
CDMRP.PublicAffairs@amedd.army.mil
DoD Autism Research Program Pre-Announcement of Funding Opportunities for FY2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $5.12 million (M) to the Department of Defense Autism Research Program (ARP). The vision of the ARP is to improve the lives of individuals with autism spectrum disorders (ASD) now. This program is administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

The ARP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY12 ARP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in May 2012. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.

http://cdmrp.army.mil/pubs/press/2012/12arppreann.shtml

Idea Development Award

Eligibility - Investigators at all academic levels (or equivalent).

Key Mechanism Elements

Preproposal is required; application submission is by invitation only.

Supports the development of innovative, high-impact ideas that advance the understanding of ASD and lead to improved outcomes.

Preliminary data are required.

Clinical trials are not allowed.

Multiple Principal Investigator (PI) Option: Up to three investigators may collaborate on a single application, each of whom will be recognized as a PI and receive a separate award.

Investigators are encouraged to submit their data to the National Database for Autism Research (NDAR), a secure bioinformatics platform for data-sharing.

FY12 Areas of Interest (Encouraged)

Improved sub-grouping of individuals with ASD to inform the mechanisms, natural history, and response to treatment (e.g., biomarkers, risk factors, sex ratio).

Identification of therapeutic targets, excluding new gene discovery.

Psychosocial research across the lifespan, including influences on brain function/structure.

Co-morbid conditions across the lifespan, especially sleep disorders and gastrointestinal issues.

Funding

Maximum funding for the entire period of performance is $400,000 in direct costs (plus indirect costs)

For multiple PIs, the combined funding for all PIs for the entire period of performance may not exceed $400,000 in direct costs (plus indirect costs)

Maximum period of performance is 3 years

 Eligibility - Investigators at all academic levels (or equivalent)

Key Mechanism Elements

Pilot Award

Preproposal is required; application submission is by invitation only.

Supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ASD forward.

Preliminary data are not allowed.

Clinical trials are not allowed.

Projects involving human subjects or human biological substances must be either exempt under Title 32, Code of Federal Regulations, Part 219, Section 101(b) (32 CFR 219.101[b]) or eligible for expedited review (32 CFR 219.110 or 21 CFR 56.110).

FY12 Areas of Interest (Encouraged)

Improved sub-grouping of individuals with ASD to inform the mechanisms, natural history, and response to treatment (e.g., biomarkers, risk factors, sex ratio).

Identification of therapeutic targets, excluding new gene discovery.

Psychosocial research across the lifespan, including influences on brain function/structure.

Co-morbid conditions across the lifespan, especially sleep disorders and gastrointestinal issues

Funding

Maximum funding for the entire period of performance is $100,000 in direct costs (plus indirect costs)

Maximum period of performance is 2 years

All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be made available on the Grants.gov website in the month of May. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline, which will be available when the program announcement is released in May. Applications must be submitted through the federal government's single entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released.

Requests for email notification of the Program Announcements release may be sent to help@cdmrp.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

For more information about the ARP or other CDMRP-sponsored programs, please visit the CDMRP website (http://cdmrp.army.mil). If you would like to request a different recipient to these messages please reply back with the corrected information.

Point of Contact:
CDMRP Public Affairs
301-619-9783

March of Dimes Prevention of Birth Defects Research Grants

We invite all qualified scientists with faculty appointments or the equivalent, at universities, hospitals and research institutions, to submit applications for research grants directed at the prevention of birth defects. Research subjects appropriate for support by the March of Dimes include basic biological processes governing development, genetics, clinical studies, studies of reproductive health, environmental toxicology, and social and behavioral studies.*

*In Social and Behavioral Sciences, we are interested in applications proposing research that advances our understanding of – and therefore our ability to prevent – the cognitive and behavioral risks that affect outcomes of pregnancy, the perinatal period, and subsequent child development. Because change in behavior is an important component of several of our campaigns, we are interested in studies that address this method of prevention.

Potential applicants should submit electronically the required administrative information and a Letter of Intent addressed to the Senior Vice President for Research and Global Programs summarizing the proposed studies via our online system at http://researchgrants.marchofdimes.com/loi.

The Letter of Intent must include the following information in this order:

1. The objective.

2. The relevance to birth defects or reproductive health.

3. The hypothesis or hypotheses to be tested.

4. Preliminary data.

5. A statement of the methods of procedure.

6. A plan for evaluating the results.

7. Current financial support: list each current grant or contract for the conduct of this research. If there are no other grants, state “NONE.”

8. If this is a request for a renewal of a current March of Dimes grant or if you hold a Basil O’Connor Starter Scholar Research Award, it must include a summary of its progress.

The online process must be completed by April 30, 2012. Please do not include References Cited with your Letter of Intent.

These grants do not cover the recipient’s or other faculty salaries, but do provide salary support for technical help. The grants are awarded for a three-year period. For your information, the financial characteristics of the previous year’s grant cycle are as follows:

(Per Year) AVERAGE: $103,431 MEDIAN: $101,432 RANGE: $55,655 TO $145,099

The Letters of Intent will be evaluated by a scientific advisory committee, and applications will be invited from those whom the committee recommends. Our decision will be transmitted to the candidates no later than July 15, 2012, and those who are invited to apply will have to do so beginning September 15, 2012. The applicants will be informed of the decisions regarding their applications as soon as they have been made, but no later than April 30, 2013. Funding will be initiated on June 1, 2013.

The address for our online system is http://researchgrants.marchofdimes.com/loi.

Please e-mail any inquiries to ResearchGrantsSupport@marchofdimes.com.
DoD Breast Cancer Research Program Funding Opportunities for FY 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $120 million (M) to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact breast cancer research.  The BCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

 Please inform researchers interested in breast cancer funding opportunities that the Congressionally Directed Medical Research Programs (CDMRP) has released the following Breast Cancer Research Program (BCRP) funding mechanisms for Fiscal Year 2012.  Please consider sending this News Release on to your bio-medical, life science independent investigators focused on breast cancer research. 

 Clinical Translational Research Award

Eligibility: Investigators at or above the level of Assistant Professor (or equivalent).

Key Mechanism Elements:

*Supports the acceleration of research with a high potential for direct clinical translation that will result in significant improvements over current approaches to breast cancer prevention and/or therapy.

*Applications will be supported in two stages.  Stage I will enable completion of preclinical translational studies and Food and Drug Administration approvals (if needed).  Stage II will initiate and execute the prospective clinical trial *Preliminary data are required.

*Preproposal is required; application submission is by invitation only.

Maximum funding of $12M for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 Era of Hope Scholar Award

Eligibility: Independent, non-mentored investigators within 6 years of their last mentored position as of the application submission deadline.

Key Mechanism Elements:

*Supports exceptionally talented, creative early-career scientists who have demonstrated that they are the "best and brightest" in their fields.

*Individuals should exhibit strong potential for leadership in the breast cancer community.

Maximum funding of $2.5M for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 Idea Award

Eligibility: Investigators at all academic levels (or equivalent).

Key Mechanism Elements:

*Supports innovative, high-risk/high-reward research ideas that have extraordinary potential to yield highly impactful data.

*Innovation and Impact are the most important review criteria. 

*Preliminary data are allowed, but not required.

*Partnering Principal Investigator (PI) Option supports combining expertise of two PIs to more effectively address a research question.

*Preproposal is required; limit of one preproposal per PI; application submission is by invitation only.

*Maximum funding of $375K for direct costs (plus indirect costs).

Period of performance not to exceed 2 years.

 Impact Award

Eligibility: Investigators at or above the level of Assistant Professor (or equivalent).

Key Mechanism Elements:

*Supports unique research projects that focus on scientific and clinical breast cancer issues, which, if successfully addressed, could ultimately have a major impact on the understanding, prevention, and/or treatment of breast cancer.

*Preproposal is required; application submission is by invitation only.

Maximum funding of $2M for direct costs (plus indirect costs). 

Period of performance not to exceed 5 years.

 Innovator Award

Eligibility: Associate Professor or above (or equivalent).

Key Mechanism Elements:

*Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field.

*Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the end of breast cancer.

*Nomination is required and self-nominations are accepted; application submission is by invitation only.

Maximum funding of $5M for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 Postdoctoral Fellowship Award

Eligibility: Principal Investigator:  Doctoral graduates (Ph.D. or M.D.).  Clinical investigators are eligible to apply.  Must have no more than 2 years experience in the proposed research setting and no more than 4 years of postdoctoral research experience as of the application deadline.

Mentor or formal co-mentor must have breast cancer research experience, including current funding and publications.

Key Mechanism Elements:

*Supports the training of exceptionally talented recent doctoral graduates.

*Individualized training program and mentorship should prepare the PI for an independent career at the forefront of breast cancer research.

*Proposed research should address a critical problem in breast cancer research.

Maximum funding of $300K for direct costs ($100K per year; plus indirect costs).

Period of performance not to exceed 3 years.

 Transformative Vision Award

Eligibility: Independent investigators at any academic level (or equivalent).

Key Mechanism Elements:

*Supports a research effort to realize a vision for dramatically affecting the prevention or treatment of breast cancer as quickly as possible.

*Teams must include consumer advocates who will be integrated into the planning and implementation of the research project.

*Applications with multiple PIs are allowed; however, PIs should have demonstrated experience in successfully leading large, focused projects.

*Preproposal is required; application submission is by invitation only.

Period of performance not to exceed 5 years.

Maximum funding of $12M for direct costs (plus indirect costs).

 All applications must conform to the final program announcements and application instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

 Due dates range from April 26, 2012 to May 3, 2012 depending on the award mechanism.  Please review the program announcement to determine the appropriate due dates.

 http://cdmrp.army.mil/funding/bcrp.shtml

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline.  Applications must be submitted through the federal government's single-entry portal, Grants.gov.  Requests for email notification of the program announcements release may be sent to help@cdmrp.org.  For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 Point of Contact:

CDMRP Public Affairs

301-619-9783

CDMRP.PublicAffairs@amedd.army.mil

DoD Prostate Cancer Research Program Funding Opportunities FY 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $80 million (M) to the Department of Defense Prostate Cancer Research Program (PCRP) to support innovative, high-impact prostate cancer research. The mission of the PCRP is to eliminate death and suffering from prostate cancer. This program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

Please inform researchers at the University of Connecticut Health Center interested in the Prostate Cancer Research Program that eleven award mechanisms have been released.   FY12 PCRP program announcements and general application instructions are available on Grants.gov.  Preapplication due dates vary from April 24 - July 26, please confirm the appropriate date for the mechanism you are interested in.

 This information can be found at the following link: http://cdmrp.army.mil/funding/pcrp.shtml

 The Program Announcement summaries are listed below in three categories: Emphasis on Impact, Emphasis on Innovation, Emphasis on Training

 EMPHASIS ON IMPACT:  (5)

Biomarker Development Award

Independent investigators at or above the level of Assistant Professor (or equivalent) Pre-Application (Preproposal) is required and due May 3, 2012; application submission is by invitation only.

Supports high-impact research aimed at qualifying and validating prostate cancer biomarkers for rapid transfer to clinical practice.

Applications that address validation of multiple biomarkers are highly encouraged.

Multi-institutional efforts are highly encouraged.

Presentation of preliminary data demonstrating biomarker qualification and validation on test samples is required.

PIs must demonstrate availability and accessibility of samples and /or data, and are encouraged to utilize pre-existing biospecimen banks.

Studies are expected to be initiated within 6 months of the award date.

Maximum funding of $2.25M for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

 Clinical Exploration Award

Independent investigators at or above the level of Assistant Professor (or equivalent) Pre-Application (Preproposal) is required and due May 3, 2012; application submission is by invitation only.

Supports rapid execution of hypothesis-based, early phase clinical trials or studies correlative to existing clinical trials to examine interventions that could have a major impact on prostate cancer clinical management.  It is anticipated that proposed studies will explore innovative and untested concepts to provide scientific rationale or initial proof-of-principle for larger clinical trials in prostate cancer.

Interventions may include drugs, devices, biologics, surgical procedures, behavior modifications, or other.

Investigational New Drug or Investigational Device Exemption approvals, if applicable, must be in place before submission of the application.

Clinical trials are expected to be initiated within 12 months of the award date.

Maximum funding of $450K for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

 Health Disparity Research Award (Modified!) Established Investigators: Independent investigators at or above the level of Assistant Professor (or equivalent); or New Investigators: Investigators that meet the following criteria at the application submission deadline date:

Have the freedom to pursue individual aims without formal mentorship.

Have not previously received a PCRP Health Disparity Research Award.

Have either completed at least 3 years of postdoctoral training or fellowship or are within 5 years of having begun first independent faculty position (or equivalent).

Pre-application (Letter of Intent) is required and due July 26, 2012.

Supports new ideas for prostate cancer disparity research that have the potential to make an important contribution to reducing and ultimately eliminating disparities in prostate cancer incidence, morbidity, and mortality.

Preliminary data are encouraged, but not required.

New Investigator Option supports applicants early in their faculty appointments or in the process of developing independent research careers.

Qualified Collaborator Option supports a higher level of funding for PIs who include a collaborator that significantly contributes to the research project such that it could not otherwise be accomplished and contributes a minimum 10% level of effort to the project.

Nested Training Option supports predoctoral and postdoctoral training for individuals committed to pursuing careers as independent investigators in prostate cancer health disparity research Maximum funding of $450K for direct costs (plus indirect costs).

If applying for the Qualified Collaborator Option, maximum funding of $600K for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

Additional funds can be requested if including the Nested Training Option.

 Laboratory - Clinical Transition Award

Independent investigators at or above the level of Assistant Professor (or equivalent) Pre-Application (Preproposal) is required and due May 3, 2012; application submission is by invitation only.

Supports product-driven preclinical studies of promising novel lead agents (including devices) that have the potential to revolutionize prostate cancer clinical care.

PIs are expected to demonstrate within the application (1) a validated target, (2) access to either one lead agent or a limited number of lead agents for optimization, and (3) the agent's mechanism of action..

The presentation of preliminary data is required to demonstrate validated target availability and distribution in relevant human tissues and substantive information from model systems that supports potential efficacy of the lead agent(s) in humans.

Supports research that ranges from preclinical study through cGMP production.

Maximum funding of $1.5M for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

 Transformative Impact Award

Independent investigators at or above the level of Assistant Professor (or equivalent) Pre-Application (Preproposal) is required and due May 3, 2012; application submission is by invitation only.

Supports prostate cancer research efforts with near-term, transformative impact for prostate cancer patients.

Research efforts based on team science are expected, with support by a lead PI with demonstrated success in leading large, focused projects.

Consistent with the goal of near-term benefit for patients, the scope of the research effort must include translational studies, clinical research, and/or clinical trials.

Applicants must demonstrate that they are prepared to initiate the study immediately upon receiving the award (i.e., as of the award date).

Maximum funding of $5.5M for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

 EMPHASIS ON INNOVATION (3)

Exploration - Hypothesis Development Award Investigators at or above postdoctoral fellow (or equivalent).

Pre-application (Letter of Intent) is required and due June 6, 2012.

Supports the exploration of highly innovative, untested, potentially groundbreaking concepts in prostate cancer.

Emphasis is on innovation; potential impact may be difficult to predict.

Human subject studies are permitted provided the studies are exempt or eligible for expedited review.

Preliminary data are strongly discouraged.

Peer and programmatic reviews are blinded to the identities of the PI, collaborators and their institutions.

Maximum funding of $75K for direct costs (plus indirect costs).

Maximum period of performance is 1 year.

 Idea Development Award

Established Investigators: Independent investigators at or above the level of Assistant Professor (or equivalent); or New Investigators: Investigators that meet the following criteria at the application submission deadline date:

Have the freedom to pursue individual aims without formal mentorship.

Have not previously received a PCRP Idea Development Award.

Have either completed at least 3 years of postdoctoral training or fellowship or are within 5 years of having begun first independent faculty position (or equivalent).

Pre-Application (Preproposal) is required and due April 24, 2012; application submission is by invitation only.

Supports new ideas that represent innovative, high-risk/high-gain approaches to prostate cancer research, and have the potential to make an important contribution to eliminating death and suffering from prostate cancer.

Preliminary data are encouraged but not required.

Innovation and Impact are the most important review criteria.

Clinical trials are not allowed.

New Investigator Option supports applicants early in their faculty appointments or in the process of developing independent research careers.

Established PIs:  Maximum funding of $375K for direct costs (plus indirect costs).

New Investigator Option:  Maximum funding of $225K for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

 Synergistic Idea Development Award

Independent investigators at or above the level of Assistant Professor (or equivalent) Pre-Application (Preproposal) is required and due May 3, 2012; application submission is by invitation only.

Supports new or existing partnerships between two or three independent investigators to address a central innovative question or problem in prostate cancer that may include high risk, provided there is a potential for significant impact.

Preliminary data are encouraged but not required.

Synergy, Innovation, and Impact are the most important review criteria.

Clinical trials are not allowed.

Maximum funding of $750K for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

 EMPHASIS ON TRAINING: (3)

Collaborative Undergraduate Historically Black Colleges and Universities (HBCU) Student Summer Training Program Award Independent investigators at or above the level of Assistant Professor (or equivalent) with a proven record in prostate cancer research and training.

Pre-application (Letter of Intent) is required and due June 6, 2012.

Supports new or existing summer training programs for undergraduate HBCU students at host institutions with thriving prostate cancer research programs.

Must enroll a minimum of four undergraduate HBCU trainees per year.

Host institution must have a record of achievement in prostate cancer research and training.

Maximum funding of $185K for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

 Physician Research Training Award

At the time of application submission, the PI must be either:

In the last year of an accredited medical residency or medical fellowship program; or Within 3 years of having initiated an appointment as Instructor, Assistant Professor, or equivalent Pre-application (Letter of Intent) is required and due June 6, 2012.

Supports training of physicians with clinical duties for careers in prostate cancer research.

PIs must demonstrate a commitment to a career at the forefront of prostate cancer research and clinical practice.

PIs must have a designated mentor with an established research program in prostate cancer Institutions must provide at least 40% protection of PI's time for research.

Projects that focus on providing training in basic research are highly encouraged.

Maximum funding of $130K per year for direct costs (plus indirect costs).

Maximum period of performance is 4 years.

 Postdoctoral Training Award

By December 31, 2012, the PI must:

Have successfully defended a doctoral thesis or posses an M.D. degree.

Have 3 years or less of postdoctoral fellowship experience.

Pre-application (Letter of Intent) is required and due June 6, 2012.

Supports prostate cancer research training opportunities for postdoctoral trainees who are recent doctoral graduates.

PIs must have a designated mentor who is an experienced prostate cancer researcher.

Maximum of $115K for direct costs (plus indirect costs up to a maximum rate of 8%).

Maximum period of performance is 2 years.

All applications must conform to the program announcement and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

 Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the PCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil). For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or 301-682-5507.

 

DoD Multiple Sclerosis Research Program Funding Opportunities FY 2012

Defense Health Program

Department of Defense Multiple Sclerosis Research Program Funding Opportunities for Fiscal Year 2012 The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $3.8 million to the Department of Defense Multiple Sclerosis Research Program (MSRP). This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 The MSRP challenges the scientific community to design innovative research relevant to the prevention, etiology, pathogenesis, assessment, and treatment of multiple sclerosis (MS). The vision of the MSRP is to prevent the occurrence, cure, reverse, or slow the progression, and lessen the personal and societal impact of MS. The FY12 MSRP specifically encourages applications that address critical needs of the MS community as listed below:

 Pathophysiological basis of disease progression:

Biological mechanisms of cortical damage in MS Pathological basis of cognitive impairment in MS New and/or improved measures for evaluating cognition in clinical research Treatment strategies for cognitive deficits including, but not limited to new or repurposed agents, and rehabilitation

 

Gene-environment interactions in MS:

Environmental influences that modify specific genetic pathways associated with MS disease risk and/or progression Maternal environment influences on MS risk in genetically susceptible offspring Genetic influences on biological processes that are relevant to MS and responsive to environmental factors Epigenetic changes due to environmental exposures and their impact on biological processes that are relevant to MS

 Technological development of hardware and/or software instruments for clinical research data capture and modeling:

Development and validation of measuring tools for real-time assessment of patient outcomes relevant to MS progression or activity Development of in vivo biosensors relevant to MS Novel integrated analysis and modeling of multidisciplinary MS patient data sets (clinical, neuroscience, endocrine, genomic, exomic, transcriptomic, proteomic, microbiomic data, etc.) to better understand MS disease activity, progression, and clinical outcomes.

 Please inform researchers interested in the Multiple Sclerosis Research Program that two award mechanisms have been released.   FY12 ALSRP program announcements and general application instructions are available on Grants.gov.

 

http://cdmrp.army.mil/funding/msrp.shtml

 Idea Award - Pre-announcement due date is April 24, 2012

Eligibility: Investigators at or above the level of Assistant Professor (or equivalent) Supports conceptually innovative, high-risk/potentially high-reward research that could ultimately lead to critical discoveries in understanding the causes and progression of MS and/or improvements in patient care and/or quality of life.

Preliminary data that are relevant to MS and the proposed research project should be included Clinical trials are not allowed Preproposal submission is required; application submission is by invitation only Maximum funding of $400,000 in direct costs (plus indirect costs) Period of performance not to exceed 2 years

 All applications must conform to the program announcement and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline of April 24, 2012. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

 

DoD Ovarian Cancer Research Program Funding Opportunities 2012

 The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $16 million (M) to the Department of Defense Ovarian Cancer Research Program (OCRP) to support innovative, high-impact ovarian cancer research. The OCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

 Full program announcements and application instructions can be found at the following link:

 http://cdmrp.army.mil/funding/ocrp.shtml

 Outcomes Consortium Development Award - Pre-application due date May 9, 2012 Must be an independent investigator at the Assistant Professor level or above (or equivalent).

Supports both the development of a consortium that will specifically focus on identifying and understanding predictors of disease outcomes in ovarian cancer patients and the proof of concept.

Funded applicants will be eligible to compete for a full Consortium Award to be offered in FY14.

Preproposal is required; application submission is by invitation only.

Maximum funding of $400K for direct costs (plus indirect costs).

Period of performance not to exceed 2 years.

All applications must conform to the program announcement and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline of April 24, 2012. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

 Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or 301-682-5507.

 

DoD Bone Marrow Failure Funding Opportunities FY2012

Defense Health Program

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $3.2 million (M) to the Department of Defense Bone Marrow Failure Research Program (BMFRP) to promote innovative research focused on bone marrow failure (BMF). This program is administered by the U.S. Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

 Please inform researchers interested in the Bone Marrow Failure Research Program that two award mechanisms have been released.   FY12 BMFRP program announcements and general application instructions are available on Grants.gov.

 http://cdmrp.army.mil/funding/bmfrp.shtml

Idea Award - Pre-application due date April 18, 2012 Investigators at or above the level of Assistant Professor (or equivalent).

Supports innovative ideas and high-impact approaches to bone marrow failure research.

Should include relevant preliminary data.

Clinical trials will not be supported.

Maximum funding of $360,000 in direct costs (plus indirect costs).

Period of performance not to exceed 3 years.

 Postdoctoral Fellowship Training Award - Pre-application due date April 18, 2012 At the time of application submission, Principal Investigators must have:

Successfully completed the requirements for a doctoral degree; and a total of less than 4 years postdoctoral research experience (excluding clinical residency or clinical fellowship training); and at least 75% protected time for research.

Supports exceptionally talented recent doctoral graduates in their pursuit of potentially high-impact BMF research.

Mentor should possess expertise and experience as a BMF researcher.

Training program and mentorship should prepare the postdoctoral fellow for an independent career at the forefront of BMF research.

Should include relevant preliminary data.

Clinical trials will not be supported.

Maximum funding of $120,000 in direct costs (plus indirect costs).

Period of performance not to exceed 2 years.

All applications must conform to the program announcement and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline of April 18, 2012. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

 Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the BMFRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or 301-682-5507.

 

DoD Peer Reviewed Medical Research Program Funding Opportunities FY 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides research funding for the peer reviewed programs managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP). 

 This e-mail is to notify the research community of the recently released funding opportunities from the Peer Reviewed Medical Research Program.

 Detailed descriptions of each of the funding opportunities, evaluation criteria, and submission requirements can be found in the respective Program Announcements. Each Program Announcement is available electronically for downloading from the Grants.gov website (http://www.grants.gov), and will be available within 48 hours on the CDMRP website (http://cdmrp.army.mil/funding/prgdefault.shtml) and the CDMRP eReceipt System (https://cdmrp.org).

---------------------------------------------------------------------

Peer Reviewed Medical Research Program newly released Program Announcements:

-          Clinical Trial Award

-          Discovery Award

-          Technology/Therapeutic Development Award

 All current and previous funding opportunities are available on the CDMRP website (http://cdmrp.army.mil).

 Subsequent notifications will be sent when additional funding opportunities are released. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

  Department Of Defense Peer Reviewed Medical Research Program

Funding Opportunities For Fiscal Year 2012

 The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $50 million (M) to the Department of Defense Peer Reviewed Medical Research Program (PRMRP). The vision of the PRMRP is to improve the health and well-being of all military service members, veterans, and beneficiaries. The PRMRP challenges the scientific and clinical communities to address one of the FY12 congressionally directed topic areas with original ideas that foster new directions in basic science and translational research; novel product development leading to improved therapeutic or diagnostic tools; or clinical trials that address an immediate clinical need. This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 Congressionally Directed Topic Areas: The FY12 PRMRP will solicit research applications for the following 22 topics areas: Arthritis, Composite Tissue Transplantation, Dystonia, Drug Abuse, Epilepsy, Food Allergies, Fragile X Syndrome, Hereditary Angioedema, Inflammatory Bowel Disease, Interstitial Cystitis, Listeria Vaccine for Infectious Diseases, Lupus, Malaria, Nanomedicine for Drug Delivery Science, Neuroblastoma, Osteoporosis and Related Bone Disease, Paget's Disease, Polycystic Kidney Disease, Post-Traumatic Osteoarthritis, Scleroderma, Tinnitus, and Tuberculosis.

 Military Relevance: Relevance to the health care needs of the military service members, veterans, and beneficiaries is a key feature of each FY12 PRMRP award mechanism.

 This information can be found at the following link: http://cdmrp.army.mil/funding/prmrp.shtml.  Please distribute it to medical investigators at the University of Connecticut Health Center.

 The Program Announcement summaries are listed below:

 PRMRP :  (4 Program Announcements)

 Clinical Trial Awards

Assistant Professor level or above (or equivalent) are eligible to apply.

Pre-application (Letter of Intent) is required and due June 6, 2012, 5:00 p.m. Eastern time.

Supports the rapid implementation of clinical trials of novel interventions with the potential to have a significant impact on patient care in the topic of interest. 

Clinical Trial is expected to be initiated within 12 months of award date. 

Maximum funding of $2.2M for direct costs (plus indirect costs).

Maximum period of performance is 5 years.

 Discovery Awards

All investigators are eligible.

Pre-application (Letter of Intent) is required and due May 9, 2012, 5:00 p.m. Eastern time.

Supports the exploration of a highly  innovative new concept or untested theory in the topic area of interest.  

Inclusion of preliminary data is strongly discouraged

Clinical trials will not be funded.

Maximum funding of $125,000 for direct costs (plus indirect costs).

Maximum period of performance is 18 months.

 Investigator-Initiated Research Awards

Assistant Professor level or above (or equivalent) are eligible to apply.

Partnering Principal Investigator option available.

Pre-application (pre-proposal) is required and due April 10, 2012, 5:00 p.m. Eastern time..

Supports research that will make an original and important contribution to the field of research or patient care in the topic area of interest.

Clinical trials are not allowed.

Maximum funding of $750,000 for direct costs (plus indirect costs). 

Maximum period of performance is 3 years.

 Technology/Therapeutic Development Awards

Assistant Professor level or above (or equivalent) are eligible to apply.

Pre-application (Letter of Intent) is required and due June 6, 2012, 5:00 p.m. Eastern time..

Supports the development of new diagnostics or therapies that have the potential to make a strong clinical impact in the topic area of interest.

Product-oriented:  Device, Drug, Clinical guidance/guidelines.

Clinical trials are not allowed.

Maximum funding of $1.5M for direct costs (plus indirect costs). 

Maximum period of performance is 3 years

 All applications must conform to the program announcement and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application (a pre-proposal or Letter of Intent as designated) is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

 Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the PRMRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or 301-682-5507.

March of Dimes Grant Support for Projects Related to Causes of Prematurity

The March of Dimes seeks applications requesting grant support for projects related to causes of prematurity. Research proposals of new paradigms based on strong conceptual frameworks are invited. The intent is to provide new insights into the large, and increasing, proportion of preterm deliveries in which the cause (and thus the means of prevention) remains elusive. The proposals need to consider especially, but not be limited to, genetics, gene-environment interactions, and animal models. We encourage novel approaches. Applicants must be members of not-for-profit institutions.

Potential applicants should submit electronically the required administrative information and a Letter of Intent addressed to the Senior Vice President for Research and Global Programs summarizing the proposed studies via our online system at http://researchgrants.marchofdimes.com/pri.

The Letter of Intent must include the following information in this order:

1. The objective.

2. The relevance to causes of preterm birth.

3. The hypothesis or hypotheses to be tested.

4. Preliminary data.

5. A statement of the methods of procedure.

6. A plan for evaluating the results.

7. Current financial support: list each current grant or contract for the conduct of this research. If there are no other grants, state “NONE.”

8. If this is a request for a renewal of a current March of Dimes grant or if you hold a Basil O’Connor Starter Scholar Research Award, it must include a summary of its progress.

The online process must be completed by April 15, 2012. Please do not include References Cited with your Letter of Intent.

These grants do not cover the recipient’s or other faculty salaries, but do provide salary support for technical help. The grants are awarded for a three-year period. For your information, the financial characteristics of the previous year's grant cycle are as follows:

(Per Year) AVERAGE: $156,668 MEDIAN: $154,800 RANGE: $136,399 TO $195,052

The Letters of Intent will be evaluated and applications will be invited from those who are selected. Our decision will be transmitted to the candidates no later than May 15, 2012. Those who are invited to apply will have to do so on or before July 15, 2012. The applicants will be informed of the decisions regarding their applications no later than January 1, 2013. Funding will be initiated on March 1, 2013.

____________________________________________

This award is designed to support young scientists just embarking on their independent research careers and is limited, therefore, to those holding recent faculty appointments. The applicants’ research interests should be consonant with those of the Foundation.

Deans, Chairs of Departments, or Directors of Institutes/Centers should submit nominations for this award addressed to the Senior Vice President for Research and Global Programs. In addition, the following information must be provided via our online system at http://researchgrants.marchofdimes.com/boc. The entire process must be completed by March 15, 2012.

The information required is:

§  Title of the proposed research project.

§  Nominator’s name, academic appointment, mailing address, telephone and FAX numbers and e-mail address.

§  Candidate’s name, academic appointment, mailing address, telephone and FAX numbers and e-mail address.

§  Candidate’s curriculum vitae in NIH format.

§  An abstract of the proposed research.

The Letter of Nomination (due by March 15, 2012) may be submitted by post, facsimile or e-mail. If submitted by e-mail, it must include the file containing the Letter of Nomination as an attachment and be sent to BOCNominations@marchofdimes.com. The nomination letter should contain information about the candidate’s faculty appointment, independence, and facilities available, including his/her laboratory space.

The submissions will be reviewed for appropriateness of the qualifications of the applicant. Our decision will be transmitted to the candidates, and those who are invited to apply will have to do so beginning June 30, 2012. Our scientific advisory committee will conduct the final review of the proposals in October 2012, and the candidates will be informed of the decisions shortly thereafter. The funding cycle begins on February 1, 2013.

These grants do not cover the recipient’s salary, but do provide salary support for technical help. They may not exceed $75,000 per year, and are awarded for two years.

Basil O’Connor applicants may not be recipients of a major grant (e.g. an RO1, or other grant exceeding $200,000 a year) at the time of the application. Candidates may not simultaneously submit an application for any other March of Dimes research program. Those who have previously submitted an application to the March of Dimes are not eligible for a Basil O’Connor Award, but may apply for a regular research grant.

The address for our online system is HTTP://RESEARCHGRANTS.MARCHOFDIMES.COM/LOI.

Please e-mail any inquiries to ResearchGrantsSupport@marchofdimes.com.
DoD Gulf War Illness Research Funding Opportunities for Fiscal Year 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $10 million (M) to the Department of Defense Gulf War Illness Research Program (GWIRP) to support innovative, high-impact research into Gulf War Illness. The Department of Defense Gulf War Illness Research Program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

 Please inform researchers interested in Gulf War Illness Research Programs that three award mechanisms have been released. FY12 GWIRP program announcements and general application instructions are available on Grants.gov.

http://cdmrp.army.mil/funding/gwirp.shtml

 Investigator-Initiated Research Award - Pre-application is due April 9, 2012 Independent investigators at all academic levels are eligible to apply.

Supports new ideas in basic and clinical developmental research focusing on Gulf War Illness (GWI).

Preliminary data are not required, and if provided, do not necessarily have to come from the GWI research field.

Clinical trials are not allowed under this mechanism.

The maximum allowable funding for the entire period of performance is $600,000 for direct costs.

The maximum period of performance is 3 years.

More cost-effective studies not requesting the full funding amount are encouraged.

 Innovative Treatment Evaluation Award - Pre-application is due April 9, 2012 Independent investigators at all academic levels are eligible to apply.

Supports exploratory or small-scale studies evaluating potential treatments not previously studied in GWI.

Pilot Phase II or Phase I/II trial combinations are permitted.

Preliminary data are not required, though proposed studies must be supported by logical rationale.

The maximum allowable funding for the entire period of performance is $450,000 for direct costs.

The maximum period of performance is 3 years.

More cost-effective studies not requesting the full funding amount are encouraged.

Clinical Trial Award - Pre-application is due April 9, 2012 Independent Investigators at all academic levels Supports larger, more definitive Phase II or III clinical trials focusing on treatments for GWI.

Preliminary/preclinical data are required, indicating potential substantial benefit for veterans with GWI.

Pilot or exploratory studies focusing on treatments lacking preclinical/preliminary data should submit to the Innovative Treatment Evaluation Award.

The maximum allowable funding for the entire period of performance is $1,400,000 for direct costs.

Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.

The maximum period of performance is 4 years.

More cost-effective studies not requesting the full funding amount are encouraged.

All applications must conform to the final program announcements and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline of April 9, 2012. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

 Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the GWIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or 301-682-5507.

 

DoD Amyotrophic Lateral Sclerosis Research Funding Opportunities for FY 2012

Department of Defense Amyotrophic Lateral Sclerosis Research Program Funding Opportunities for Fiscal Year 2012

 

Applications for the Amyotrophic Lateral Sclerosis Research Program (ALSRP) are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program.  The ALSRP was established in 2007 to provide support for research of exceptional scientific merit aimed at preclinical assessment of therapeutics for amyotrophic lateral sclerosis (ALS).  Appropriations for the ALSRP from FY07 through FY11 totaled $25.5 million (M).  The FY12 appropriation is $6.4M.

 

The goal of ALSRP is to promote the introduction of improved therapies for ALS by encouraging ALS investigators to undertake preclinical studies of novel and existing agents.  This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 

Please inform researchers interested in the Amyotrophic Lateral Sclerosis Research Program that two award mechanisms have been released.   FY12 ALSRP program announcements and general application instructions are available on Grants.gov.

 

http://cdmrp.army.mil/funding/alsrp.shtml

 

Therapeutic Development Award - Pre-application due date is April 9, 2012  Independent investigators at all academic levels Supports preclinical development of therapeutics for ALS.

Specific focus areas include development of high-throughput screens up to IND-enabling studies and cGMP for later clinical trials.

Preliminary data are required, relevant to the phase of preclinical development.

Clinical trials are not allowed under this mechanism.

The Maximum period of performance is 3 years.

The maximum allowable funding for the entire period of performance is $1,500,000 in direct costs. 

More cost-effective studies not requesting full funding amount are encouraged.

Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.

 

Therapeutic Idea Award - Pre-application due date is April 9, 2012 Independent investigators at all academic levels Supports early-stage research relative to novel therapeutic development for ALS.

Studies should be hypothesis-based.

Innovation and impact are primary criteria.

Preliminary data are not required.

The maximum period of performance is 2 years.

The maximum allowable funding for the entire period of performance is $400,000 in direct costs.

Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.

 

All applications must conform to the final program announcements and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline of April 9, 2012. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

 

BSF Transformative Science Competition

The BSF would like to remind you that the final date for submission of a pre-proposal to the 3rd round of our Transformative Science program is April 2, 2012.  In each of the previous rounds some 50+ pre-proposals were submitted, and 8-12 of them were allowed to be submitted as full proposals.  In the first round two programs were approved, each for a grant of $300,000.  In the second round, an additional two programs have been recommended to the BSF board for approval at its Feb. 7-8 meeting.
Please consult the BSF website www.bsf.org.il (outbind://5/www.bsf.org.il) for details and submission instructions.  The BSF site will be opened for submission of pre-proposals on March 11, 2012.
Additional Contact Info:
Dr. Yair Rotstein, Executive Director
U.S. - Israel Binational Science Foundation
8 Hamarpeh St.
P.O.B. 45086
Jerusalem, 91450
Israel
Tel:  972-2-5828239, ext. 105
Cellular:  972-52-6020454
Fax:  972-2-5828306
www.bsf.org.il (outbind://5/www.bsf.org.il)
DoD Peer Reviewed Research Funding Opportunities

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides research funding for the peer reviewed programs managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP).

 This e-mail is to notify the research community of the recently released funding opportunities from the following programs:

 Neurofibromatosis Research Program (NFRP)

 Prostate Cancer Research Program (PCRP)

 Tuberous Sclerosis Complex Research Program (TSCRP)

 Detailed descriptions of each of the funding opportunities, including submission requirements and evaluation criteria, can be found in the respective Program Announcements. Each Program Announcement is available electronically for downloading from the Grants.gov website (http://www.grants.gov).  Program Announcements will also be available on the CDMRP website (http://cdmrp.army.mil/funding/prgdefault.shtml) and the CDMRP eReceipt System (https://cdmrp.org) within the next two business days.

----------------------------------------------------------------------

Neurofibromatosis Research Program (NFRP)

-          Clinical Trial Award

-          Exploration-Hypothesis Development Award

-          Investigator-Initiated Research Award

-          New Investigator Award

 Prostate Cancer Research Program (PCRP)

-          PCRP Awards That Emphasize Impact:

o   (NEW for FY12) Biomarker Development Award

o   (NEW for FY12) Clinical Exploration Award

o   Laboratory-Clinical Transition Award

o   Health Disparity Research Award

o   (NEW for FY12) Transformative Impact Award

-          PCRP Awards That Emphasize Innovation:

o   Exploration-Hypothesis Development Award

o   Idea Development Award

o   Synergistic Idea Development Award

-          PCRP Awards That Emphasize Training:

o   Collaborative Undergraduate HBCU Student Summer Training Program Award

o   Physician Research Training Award

o   Postdoctoral Training Award

Tuberous Sclerosis Complex Research Program

-          Clinical Trial Award

-          Exploration-Hypothesis Development Award

-          Idea Development Award

 Subsequent notifications will be sent when additional funding opportunities are released. A listing of all current CDMRP funding opportunities can be obtained on the Grants.gov website by performing a search using CFDA Number 12.420.

 

DoD Lung Cancer Research Program Funding Opportunities for FY2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $10.2 Million (M) to the Department of Defense Lung Cancer Research Program's (LCRP) to support innovative, high-impact lung cancer research.  The LCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 The LCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY12 LCRP Program Announcements and General Application Instructions for the following mechanisms are anticipated to be posted on Grants.gov in April 2012.  Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.

 http://cdmrp.army.mil/pubs/press/2012/12lcrppreann.shtml

 Concept Award

Investigators at all academic levels (or equivalent) Supports highly innovative, untested, potentially groundbreaking concepts in lung cancer.

Emphasis in on innovation.

Presentation of preliminary data is not consistent with the intent of the Concept Award mechanism and is discouraged.

Human subject studies are permitted provided the studies are exempt or eligible for expedited review.

Maximum funding of $100K for direct costs (plus indirect costs).

Maximum period of performance is 1 year.

 Idea Development Award

Independent investigators at or above the level of an Assistance Professor (or equivalent); must be within 10 years of first faculty appointment.

Supports new ideas that are in the early stages of development which represent innovative, high-risk/high-gain approaches to lung cancer research.

Emphasis is on Innovation and Impact.

Preliminary data required, but may be from outside of lung cancer.

Clinical trials are not allowed.

Maximum funding of $350K for direct costs (plus indirect costs).

Maximum period of performance is 2 years.

 Translational Research Partnership Award Investigators at or above the level of Assistant Professor (or equivalent).

Supports partnerships between clinicians and laboratory scientists that accelerate ideas in lung cancer into clinical applications.

Preliminary data required, but may be from outside of lung cancer.

Clinical trials are not allowed.

Non-Traditional Partnerships are encouraged.

Optional Nested Clinical Fellow or Resident Traineeship.

Maximum combined funding of $900K for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

Nested traineeships:  Additional maximum of $75K in direct and indirect costs over a one-year period of performance.

 All applications must conform to the final Program Announcements and application instructions that will be available for electronic downloading from the Grants.gov website.  The applications package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline.  Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. 

 For more information about the LCRP or other CDMRP-sponsored programs, please visit the CDMRP website (http://cdmrp.army.mil).

 Point of Contact:

CDMRP Public Affairs

301-619-9783

CDMRP.PublicAffairs@amedd.army.mil

 


DoD Ovarian Cancer Research Program Funding Opportunities for Fiscal Year 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $16 million (M) to the Department of Defense Ovarian Cancer Research Program (OCRP) to support innovative, high-impact ovarian cancer research. The OCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

 FY12 OCRP program announcements and general application instructions for the following award mechanisms have been posted on Grants.gov website.  Application deadlines begin in April, please refer to the specific Program Announcement for due dates.

 Full program announcements and application instructions can be found at the following link: http://cdmrp.army.mil/funding/ocrp.shtml

 Ovarian Cancer Academy Award - pre-application due April 17, 2012 Early-Career investigator must be within the first 3 years of his/her first faculty position (or equivalent) at the time of award. The first faculty position (or equivalent) may be either tenure-track or non-tenure track.

Designated Mentor must be an independent ovarian cancer researcher and at the same institution as the Early-Career Investigator.

Supports the addition of new early-career investigators to the unique, interactive virtual academy that will provide intensive mentoring, national networking, and a peer group for junior faculty.

Designated Mentor who is an experienced ovarian cancer researcher with ovarian cancer funding is required for Early-Career Investigators.

Preliminary data are required.

Institutional match of $50,000 per year is required.

Preproposal is required; application submission is by invitation only.

Maximum funding of $725K for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 Pilot Award - pre-application due April 9, 2012 Investigators at or above the postdoctoral level (or equivalent).

Supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward.

Innovation and Impact are important review criteria.

Preliminary data are not required, but allowed.

Clinical trials are not allowed.

Preproposal is required; application submission is by invitation only.

Maximum funding of $250K for direct costs with additional $50K for optional nested Teal Scholar (plus indirect costs).

Period of performance not to exceed 2 years.

 Teal Innovator Award - pre-application due April 17, 2012 Investigators at the level of Professor (or equivalent), and must be recognized in his/her field.

Supports a visionary individual from any field principally outside of, but not exclusive of, ovarian cancer to focus their creativity, innovation, and leadership on ovarian cancer research.

Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the elimination of ovarian cancer.

Preproposal is required; application submission is by invitation only.

Maximum funding of $2.5M for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 Synergistic Translational Leverage Award pre-application due April 17, 2012 Investigators at or above the level of Assistant Professor (or equivalent).

Supports multidisciplinary partnership between two investigators who will leverage existing human-based resources to address high-impact research ideas or unmet needs in ovarian cancer.

Must clearly define the synergistic components that will facilitate and accelerate progress in a way that could not be accomplished through independent efforts.

Structured to accommodate two Principal Investigators (PIs); the Initiating PI is responsible for the majority of the tasks associated with application submission, and the other PI is the Partnering PI.

Preliminary data are required.

Clinical trials are allowed.

Preproposal is required; application submission is by invitation only.

Maximum funding of $500K for direct costs plus indirect costs).

Period of performance not to exceed 3 years.

 All applications must conform to the program announcement and application instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

 Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 Point of Contact:

CDMRP Public Affairs

301-619-9783

CDMRP.PublicAffairs@amedd.army.mil

 

DoD Breast Cancer Research Program Funding Opportunities for FY 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $120 million (M) to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact breast cancer research.  The BCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

 Please inform researchers interested in breast cancer funding opportunities that the Congressionally Directed Medical Research Programs (CDMRP) has released the following Breast Cancer Research Program (BCRP) funding mechanisms for Fiscal Year 2012.  Please consider sending this News Release on to your bio-medical, life science independent investigators focused on breast cancer research. 

 Clinical Translational Research Award

Eligibility: Investigators at or above the level of Assistant Professor (or equivalent).

Key Mechanism Elements:

*Supports the acceleration of research with a high potential for direct clinical translation that will result in significant improvements over current approaches to breast cancer prevention and/or therapy.

*Applications will be supported in two stages.  Stage I will enable completion of preclinical translational studies and Food and Drug Administration approvals (if needed).  Stage II will initiate and execute the prospective clinical trial *Preliminary data are required.

*Preproposal is required; application submission is by invitation only.

Maximum funding of $12M for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 Era of Hope Scholar Award

Eligibility: Independent, non-mentored investigators within 6 years of their last mentored position as of the application submission deadline.

Key Mechanism Elements:

*Supports exceptionally talented, creative early-career scientists who have demonstrated that they are the "best and brightest" in their fields.

*Individuals should exhibit strong potential for leadership in the breast cancer community.

Maximum funding of $2.5M for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 Idea Award

Eligibility: Investigators at all academic levels (or equivalent).

Key Mechanism Elements:

*Supports innovative, high-risk/high-reward research ideas that have extraordinary potential to yield highly impactful data.

*Innovation and Impact are the most important review criteria. 

*Preliminary data are allowed, but not required.

*Partnering Principal Investigator (PI) Option supports combining expertise of two PIs to more effectively address a research question.

*Preproposal is required; limit of one preproposal per PI; application submission is by invitation only.

*Maximum funding of $375K for direct costs (plus indirect costs).

Period of performance not to exceed 2 years.

 Impact Award

Eligibility: Investigators at or above the level of Assistant Professor (or equivalent).

Key Mechanism Elements:

*Supports unique research projects that focus on scientific and clinical breast cancer issues, which, if successfully addressed, could ultimately have a major impact on the understanding, prevention, and/or treatment of breast cancer.

*Preproposal is required; application submission is by invitation only.

Maximum funding of $2M for direct costs (plus indirect costs). 

Period of performance not to exceed 5 years.

 Innovator Award

Eligibility: Associate Professor or above (or equivalent).

Key Mechanism Elements:

*Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field.

*Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the end of breast cancer.

*Nomination is required and self-nominations are accepted; application submission is by invitation only.

Maximum funding of $5M for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 Postdoctoral Fellowship Award

Eligibility: Principal Investigator:  Doctoral graduates (Ph.D. or M.D.).  Clinical investigators are eligible to apply.  Must have no more than 2 years experience in the proposed research setting and no more than 4 years of postdoctoral research experience as of the application deadline.

Mentor or formal co-mentor must have breast cancer research experience, including current funding and publications.

Key Mechanism Elements:

*Supports the training of exceptionally talented recent doctoral graduates.

*Individualized training program and mentorship should prepare the PI for an independent career at the forefront of breast cancer research.

*Proposed research should address a critical problem in breast cancer research.

Maximum funding of $300K for direct costs ($100K per year; plus indirect costs).

Period of performance not to exceed 3 years.

 Transformative Vision Award

Eligibility: Independent investigators at any academic level (or equivalent).

Key Mechanism Elements:

*Supports a research effort to realize a vision for dramatically affecting the prevention or treatment of breast cancer as quickly as possible.

*Teams must include consumer advocates who will be integrated into the planning and implementation of the research project.

*Applications with multiple PIs are allowed; however, PIs should have demonstrated experience in successfully leading large, focused projects.

*Preproposal is required; application submission is by invitation only.

Period of performance not to exceed 5 years.

Maximum funding of $12M for direct costs (plus indirect costs).

 All applications must conform to the final program announcements and application instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

 Due dates range from April 26, 2012 to May 3, 2012 depending on the award mechanism.  Please review the program announcement to determine the appropriate due dates.

 

http://cdmrp.army.mil/funding/bcrp.shtml

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline.  Applications must be submitted through the federal government's single-entry portal, Grants.gov.  Requests for email notification of the program announcements release may be sent to help@cdmrp.org.  For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 Point of Contact:

CDMRP Public Affairs

301-619-9783

CDMRP.PublicAffairs@amedd.army.mil

Gates Foundation Funding Opportunities

The Bill & Melinda Gates Foundation and its funding partners in the Grand Challenges family of grant programs are inviting innovators to apply for three new grant opportunities:

 1.         Grand Challenges Explorations, an initiative to encourage innovative and unconventional global health and development solutions, is now accepting grant proposals for its latest application round. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for profit companies.

 Proposals are being accepted online until May 15, 2012 on the following topics:

o          New Approaches for the Interrogation of Anti-malarial Compounds - NEW

o          Aid is Working. Tell the World - NEW

o          Design New Approaches to Optimize Immunization Systems

o          Explore New Solutions in Global Health Priority Areas

o          Protect Crop Plants from Biotic Stresses From Field to Market

 

Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million. Full descriptions of the new topics and application instructions are available at: www.grandchallenges.org/explorations.

 2.         Saving Lives at Birth: A Grand Challenge for Development has launched its second call for innovative prevention and treatment approaches for pregnant women and newborns in poor, hard-to-reach communities around the world. In this round, the Saving Lives at Birth partners will fund transformative approaches that cut across three main domains: (i) science & technology; (ii) service delivery; and (iii) demand-side innovation.

The deadline is April 2, 2012. Details on how to apply for a grant can be found at www.savinglivesatbirth.net.

 3.         Grand Challenges Canada is seeking proposals for Rising Stars in Global Health, a program looking for emerging innovators from developing countries with bold ideas with big impact to address real-world global health challenges.

 The deadline is March 23, 2012. Details and application instructions are available at http://bit.ly/sFPYsT.

 We are looking forward to receiving innovative ideas from around the world and from all disciplines. If you have a great idea, please apply. If you know someone else who may have a great idea, please forward this message.

Thank you for your commitment to solving the world's greatest health and development challenges.

 

Charles H. Hood Foundation Child Health Research Awards Program

The Charles H. Hood Foundation was incorporated in 1942 to improve the health and quality of life for children throughout New England. Today's research projects encompass many disciplines that have contributed to pediatric discoveries while launching the careers of promising junior faculty. The intent of the Award is to support newly independent faculty, provide the opportunity to demonstrate creativity, and assist in the transition to other sources of research funding. Research projects must be relevant to child health.

Online Application Deadline

Thursday, March 22, 2012 at 12:00 Noon (U.S. Eastern Time)

Application Materials www.tmfgrants.org/Hood

Funding Period and Award Amounto:p>

§  July 1, 2012 - June 30, 2014

§  Up to five $150,000 awards at $75,000 per year

((inclusive of 10% institutional overhead)

Applicant, Project and Geographic Eligibilityo:p>

§  Investigators within five years of their first faculty appointment

§  Research with relevance to child health

§  Hypothesis-driven clinical, basic science, public health, health services research and epidemiology projects

§  Nonprofit academic, medical or research institutions in New England

§  UUnited States citizenship or residency is not required


Please direct any questions to 617-695-9439 or GLockwood@hria.org/a>

Prostate Cancer Foundation - A. David Mazzone Awards Program

The A. David Mazzone Awards Program (a non-Federal funding opportunity) is now accepting applications for its second year of funding. Two of these award categories will be funded by DF/HCC in the amount of $100,000 to $500,000 per project. The third award category, provided by the Dana-Farber/Harvard Cancer Center (DF/HCC) in conjunction with the Prostate Cancer Foundation (PCF), will fund $1,000,000 per project.

Funding opportunities are being offered in the following nine Prostate Cancer research categories:

1. DF/HCC RFAs Open Nationally:
High Impact, High Impact Trials, Project Development, Disparities Research, Community Outreach Research, and Lupron-Treatable Disease and Conditions.

2. DF/HCC RFAs Intended for DF/HCC Member Institutions:
Career Development, Pre- and Post-Doctoral Training Program Awards

Application information for DF/HCC applications only
One page letter of intent due by March 5, 2012.
Proposal submission deadline:
4:59 p.m. EST, Friday, April 6, 2012.
Program summary and Full RFAs Text: A David Mazzone Awards Program
Letter of Intent and Application submission Web site: https://mazzone.dfci.harvard.edu/
Please direct questions to: jhincapie@partners.org

3. Prostate Cancer Foundation RFAs:
A. David Mazzone-PCF Challenge Award
Submit proposal online to: http://www.pcfscience.org.
The PCF website will start accepting applications after February 15, 2012.
Please direct questions to applications@pcf.org.
Deadline for applications: 11:59 PM Pacific Time, Friday, MARCH 16, 2012.

____________________________________________________

Howard R. Soule, PhD
Executive Vice President
Chief Science Officer
Prostate Cancer Foundation
P: 310.570.4596 | C: 310.780.2873
1250 Fourth Street, Santa Monica, CA 90401
hsoule@pcf.org | www.pcf.org
2012 PCF-Mazzone Challenge Award

The Prostate Cancer Foundation (PCF) is pleased to announce the PCF-Honorable A. David Mazzone Special Challenge Award Research Program 2012. These two-year awards will provide a total of $1 million per team. Challenge Awards support large-scale research projects. Proposals must be from teams of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. A team may be assembled from one institution, or several institutions, from across the globe.

These awards focus on funding Treatment Sciences: Investigations of new ideas in man or laboratory support of a high impact clinical investigation.

Please refer to the complete RFA link for details on eligibility requirements and application submission guidelines.

Complete RFA (PDF)

IMPORTANT:

The online application submission form will go live at www.pcfscience.org after February 15, 2012.

The deadline for application submission is March 16, 2012.

New Scholars Program in Aging - Limited Submission Opportunity Announced

Because a limited number of applications can be submitted for the following program, an internal screening process will be required. If you are considering submitting an application for the program listed below an on-line Notification of Intent to Submit must be completed by the requested Intent to Submit Deadline.

 When submitting pre-proposals for the internal screening process, be sure to check the Guidelines for updates. Pre-proposals not adhering to these guidelines and instructions will be returned. 

New Scholars Program in Aging

The Ellison Medical Foundation New Scholars Program is to support new investigators of outstanding promise in the basic biological sciences relevant to understanding lifespan development processes and age-related diseases and disabilities.  The award is intended to provide significant support to new investigators needed to permit them to become established in the field of aging.  The New Scholars Program provides awards of up to $100,000 per year for a four year period for successful candidates.

Limit:  Two candidates may be nominated

Intent to Submit Deadline:  12/9/2011

Internal Screening Deadline:  12/23/2011

Sponsor Deadline:  3/1/2012

Lymphatic Research Foundation Postdoctoral Fellowship Awards Program

2012 Grant Cycle

The Lymphatic Research Foundation (LRF) is pleased to announce the 2012 Grant Cycle of the LRF Postdoctoral Fellowship Awards Program. The goal of the Program is to expand and strengthen the pool of outstanding junior investigators in the field of lymphatic research. The awards will support investigators who have recently received their doctorates, a critical point in career development when young scientists choose their lifelong research focus.  

LRF, a not-for-profit organization, is committed to promoting and supporting basic, translational and clinical research, and to fostering an interdisciplinary field of research that will result in improved understanding and/or advances in the prevention, diagnosis, and treatment of lymphatic diseases, lymphedema, and related disorders.

Examples of funding areas include but are not limited to basic, translational or clinical investigations into normal and aberrant lymphatic endothelial biology; mechanisms of normal and pathological lymphangiogenesis; imaging lymphatic function and structure; animal models of lymphatic system disorders; and the cross-talk between the lymphatic and the immune systems.

Projects in lymphocyte biology, leukemia, lymphoma and conditions secondary to lymphedema such as cutaneous infections are outside the scope of this program.

Funding Period and Amount of Award

July 1, 2012 - June 30, 2014

Two-year fellowships from

$82,000 - $95,000  (U.S. currency)

Application Deadline

January 10, 2012

1:00 p.m. Eastern Time (GMT-5) 

Application Guidelines and Instructions

www.tmfgrants.org/LRF

Eligibility

Applicants must hold a Ph.D. and/or M.D. or equivalent degree and have completed no more than three years of full-time postdoctoral research experience by July 1, 2012. The research project must be conducted under the supervision of a mentor who is an established investigator with an active and productive research program. Eligibility is NOT limited to those investigators with past experience in lymphatic research; international applications are welcome.

For more information about the Lymphatic Research Foundation: www.lymphaticresearch.org

The Lymphatic Research Postdoctoral Fellowship Program is administered by The Medical Foundation division. Please direct questions to LLam@hria.org or 617-279-2240 ext. 710.
NIH Accepting Applications for Director’s Early Independence Awards

The National Institutes of Health (NIH) has announced a funding opportunity for the NIH Director’s Early Independence Awards. The awards are for junior investigators wishing to “skip the post-doc” and immediately begin independent research. The deadline for submitting an application is Jan. 30, 2012, and letters of intent are due by Dec. 30.
Gates Foundation Grant Opportunities

The Bill & Melinda Gates Foundation is seeking letters of inquiry in the following areas as part of the Grand Challenges in Global Health program:

 Achieving Healthy Growth Grant Opportunity

Grand Challenges in Global Health is seeking letters of inquiry for the new grant program Discover New Ways to Achieve Healthy Growth.  This program will invest US $15 million in research to discover the causes of growth faltering during the first 1000 days of life and to identify effective and affordable interventions to promote healthy growth.  For more information, please visit  http://www.grandchallenges.org/GrantOpportunities/Pages/healthygrowth.aspx

 This grant opportunity is open until January 25, 2012 at 10:00 a.m. Pacific Standard Time.

 Gut Function Biomarkers Grant Opportunity

Grand Challenges in Global Health is seeking letters of inquiry for the new grant program Biomarkers of Gastrointestinal (Gut) Function and Health.  The program is committing $9 million to develop non-invasive measures of intestinal functioning as a way to assess infant health and development . For more information, please visit http://www.grandchallenges.org/biomarkers/Pages/Gut_Function_Biomarkers.aspx

 This grant opportunity is open until January 11, 2012 at 10:00 a.m. Pacific Standard Time.                                                                                                   

Preventing Preterm Birth Grant Opportunity

Grand Challenges in Global Health, in coordination with the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS), is seeking letters of inquiry for the new grant program Preventing Preterm Birth. The program will invest US $20 million in the discovery and development of interventions to prevent preterm birth and stillbirth by limiting infection and improving nutrition. For more information, please visit http://gappsseattle.org/index.php/research/healthy_birth/

This grant opportunity is open until January 31, 2012.

Related Opportunity From Our Partner:

Rising Stars in Global Health

Grand Challenges Canada is seeking emerging innovators (within 10 years of graduation from a Masters level or Phd) from developing countries. The program is looking for innovative ideas to address complex real world challenges that involve a scientific or technological solution (new or existing) alone or in combination with social and/or business innovations. For more information, please visit http://bit.ly/sFPYsT

This grant opportunity is open until March 23, 2012. 

We look forward to receiving applications from around the world.  

The Grand Challenges Team

Visit our site

http://www.gatesfoundation.org/Pages/home.aspx

Privacy Policy

http://www.gatesfoundation.org/about/Pages/privacy-policy.asp 

Bill & Melinda Gates Foundation

PO Box 23350

Seattle, WA 98102
Mary Kay Ash Charitable Foundation – Limited Competition

The Mary Kay Ash Charitable Foundation http://www.mkacf.org/Pages/Home.aspx funds innovative, translational research with the goal that these efforts will lead to improvement in the diagnosis, prognosis, prevention, or treatment of ovarian, uterine, breast or cervical cancer. The 2012 MKACF awards -- http://www.mkacf.org/Pages/CancerGrantProgram.aspx -- provide up to $100,000 for a two-year period.

 

UConn/UCHC may only submit one grant application. Interested applicants should send a current BioSketch and 2-3 page research abstract (.pdf files) to: orsp@uchc.edu<mailto:orsp@uchc.edu by Tuesday, Jan. 17th. Pre-proposal applications will be reviewed by the ad-hoc scientific advisory committee, which will select the 2012 nominee.
Postdoctoral Fellowship Program in Eating Disorders Research

2012 Grant Cycle

The Hilda and Preston Davis Foundation is pleased to announce the 2012 cycle of its Postdoctoral Fellowship Program in Eating Disorders Research. By attracting young scientists to the field, each fellowship may lead to a lifetime career contribution to understanding the biological causes of eating disorders. The long term goal of the program is to accelerate medical research discoveries that will lead to improved therapies for anorexia nervosa and bulimia nervosa. The awards support postdoctoral fellows working in nonprofit academic or research institutions in the United States.

Proposals must be focused on relevant aspects of the biological causes of anorexia nervosa and bulimia nervosa as defined by clinical criteria. Examples of areas of interest include but are not limited to neural pathways of feeding behavior in animal models; molecular genetic analysis of relevant neural circuit assembly and function; testing of new chemical compounds that might be used in animal models as experimental treatments; and brain imaging technologies that identify neurochemical pathways in patients with these disorders. Clinical psychotherapeutic studies, medication trials, and obesity research are currently outside the scope of this program.

Application Deadline

Thursday, January 12, 2012

(12:00 Noon Eastern Time)

Funding Period and Amount

Up to five three-year awards

July 1, 2012 – June 30, 2015

$43,000 - $63,000 annually

Please direct questions to 617-279-2240, x709 or jbrown@hria.org
Lasker Clinical Research Scholar Program

Applications are due Jan. 24 for the Lasker Clinical Research Scholar Program, an historic partnership between the NIH intramural and extramural communities and the Lasker Foundation. The goals are to bridge the widening gap between cutting-edge research and improved patient care and to nurture the next generation of clinical researchers.

Related links:

New Request for Proposals (RFP) on Centers of Excellence in Pain Education

The NIH Pain Consortium is encouraging medical, dental, nursing, and pharmacy schools to respond to a new funding opportunity to develop Centers of Excellence in Pain Education (CoEPEs). Letters of intent (encouraged but optional) are due Jan. 24, 2012, and applications are due Mar. 5.

Kauffman Foundation Now Accepting Nominations for Junior Faculty Fellowship Grants

Program will award grants of $40,000 each to seven junior faculty members

http://cl.exct.net/ju=fe2b17727660077a701578&ls=fdc015717c670c757214767560&m=fef61175736207&l=fe511577736301787c12&s=fe22107577600279701c77&jb=ffcf14&t

The Ewing Marion Kauffman Foundation is pleased to announce that the nomination period is now open for the Kauffman Junior Faculty Fellowship in Entrepreneurship Research (KJFF). The Kauffman Foundation will award up to seven Junior Faculty Fellowship grants to junior faculty members in the United States whose research has the potential to make significant contributions to the body of literature in entrepreneurship. Each Fellow's university will receive a grant of $40,000 over two years to support the research activities of the Fellow.

Nominations will be accepted online from now until 5:00 p.m. Central Standard Time on Monday, January 23, 2012. Nominees must be tenured or tenure-track junior faculty members at accredited U.S. institutions of higher education who received a Ph.D. or equivalent doctoral degree between January 1, 2007 and December 31, 2010. Nominees will have until 5:00 p.m. Central Standard Time on Monday, March 12, 2012 to complete their online applications for consideration for the fellowship.

To see the complete Call for Nominations, including submission guidelines, please visit

http://www.kauffman.org/kjff <http://cl.exct.net/?ju=fe2a17727660077a701579&ls=fdc015717c670c757214767560&m=fef61175736207&l=fe511577736301787c12&s=fe22107577600279701c77&jb=ffcf14&t=>  

Please direct all questions to kjff@kauffman.org.

DoD Bone Marrow Failure Research Program Funding Opportunities FY2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $3.2 million (M) to the Department of Defense Bone Marrow Failure Research Program (BMFRP) to promote innovative research focused on bone marrow failure (BMF). This program is administered by the U.S. Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

 The BMFRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY12 BMFRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in March 2012. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.

 http://cdmrp.army.mil/pubs/press/2012/12bmfrppreann.shtml

 Idea Award

Investigators at or above the level of Assistant Professor (or equivalent).

Supports innovative ideas and high-impact approaches to bone marrow failure research.

Should include relevant preliminary data.

Clinical trials will not be supported.

Maximum funding of $360,000 in direct costs (plus indirect costs).

Period of performance not to exceed 3 years.

 Postdoctoral Fellowship Training Award

At the time of application submission, Principal Investigators must have:

Successfully completed the requirements for a doctoral degree; and a total of less than 4 years postdoctoral research experience (excluding clinical residency or clinical fellowship training); and at least 75% protected time for research.

Supports exceptionally talented recent doctoral graduates in their pursuit of potentially high-impact BMF research.

Mentor should possess expertise and experience as a BMF researcher.

Training program and mentorship should prepare the postdoctoral fellow for an independent career at the forefront of BMF research.

Should include relevant preliminary data.

Clinical trials will not be supported.

Maximum funding of $120,000 in direct costs (plus indirect costs).

Period of performance not to exceed 2 years.

 All applications must conform to the final program announcements and application instructions that will be available for electronic downloading from the Grants.gov website in March 2012. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline, which will not be known until the Program Announcement is released in March 2012. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines will be available when the program announcements are released.

 Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the BMFRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).   For questions regarding the application and submission requirements the CDMRP helpdesk should be your point of contact.  They can be reached at help@cdmrp.org or 301-682-5507.

 Point of Contact:

CDMRP Public Affairs

301-619-9783

CDMRP.PublicAffairs@amedd.army.mil

 

DoD Prostate Cancer Research Program Funding Opportunities FY 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $80 million (M) to the Department of Defense Prostate Cancer Research Program (PCRP) to support innovative, high-impact prostate cancer research. The mission of the PCRP is to eliminate death and suffering from prostate cancer. This program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

 The PCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY12 PCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in March 2012. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government. Pre-application submission due dates will not be available until the Program Announcements are released in March.

This information can be found at the following link:

 http://cdmrp.army.mil/pubs/press/2012/12pcrppreann.shtml

 Biomarker Validation Award

Independent investigators at or above the level of Assistant Professor (or equivalent) Preproposal is required; application submission is by invitation only.

Supports high-impact research aimed at qualifying and validating prostate cancer biomarkers for rapid transfer to clinical practice Applications that address validation of multiple biomarkers are highly encouraged.

Multi-institutional efforts are highly encouraged Presentation of preliminary data demonstrating biomarker qualification and validation on test samples is required PIs must demonstrate availability and accessibility of samples and /or data, and are encouraged to utilize pre-existing biospecimen banks Studies are expected to be initiated within 6 months of the award date Maximum funding of $2.25M for direct costs (plus indirect costs) Maximum period of performance is 3 years

 Clinical Trial Pilot Award

Independent investigators at or above the level of Assistant Professor (or equivalent) Preproposal is required; application submission is by invitation only Supports rapid execution of hypothesis-based, early phase clinical trials (e.g., Phase 0, Phase I, pilot Phase II) to test interventions that will have a major impact on prostate cancer management. It is anticipated that proposed studies will explore innovative and untested concepts to provide scientific rationale or initial proof-of-principle for larger clinical trials in prostate cancer Also supports patient-based, innovative, hypothesis-driven correlative studies associated with existing/ongoing clinical trials Interventions may include drugs, devices, biologics, surgical procedures, behavior modifications, or other Investigational New Drug or Investigational Device Exemption approvals, if applicable, must be in place before submission of the application Clinical trials are expected to be initiated within 12 months of the award date.

Maximum funding of $450K for direct costs (plus indirect costs) Maximum period of performance is 3 years

 Collaborative Undergraduate Historically Black Colleges and Universities (HBCU) Student Summer Training Program Award Independent investigators at or above the level of Assistant Professor (or equivalent) with a proven record in prostate cancer research and training Supports new or existing summer training programs for undergraduate HBCU students at host institutions with thriving prostate cancer research programs Must enroll a minimum of four undergraduate HBCU trainees per year Host institution must have a record of achievement in prostate cancer research and training.

Maximum funding of $185K for direct costs (plus indirect costs) Maximum period of performance is 3 years

 Exploration - Hypothesis Development Award Investigators at or above postdoctoral fellow (or equivalent) Supports the exploration of highly innovative, untested, potentially groundbreaking concepts in prostate cancer Emphasis is on innovation; potential impact may be difficult to predict Human subject studies are permitted provided the studies are exempt or eligible for expedited review Preliminary data are strongly discouraged. Preliminary data are strongly discouraged Maximum funding of $75K for direct costs (plus indirect costs) Maximum period of performance is 1 year

 Health Disparity Research Award (Modified!)

Established Investigators: Independent investigators at or above the level of Assistant Professor (or equivalent); or

New Investigators: Investigators that meet the following criteria at the application submission deadline date:

Have the freedom to pursue individual aims without formal mentorship

Have not previously received a PCRP Health Disparity Research Award

Have either completed at least 3 years of postdoctoral training or fellowship or are within 5 years of having begun first independent faculty position (or equivalent)

Supports new ideas for prostate cancer disparity research that have the potential to make an important contribution to reducing and ultimately eliminating disparities in prostate cancer incidence, morbidity, and mortality

Preliminary data are encouraged, but not required

New Investigator Option supports applicants early in their faculty appointments or in the process of developing independent research careers

Qualified Collaborator Option supports a higher level of funding for PIs who include a collaborator that significantly contributes to the research project such that it could not otherwise be accomplished and contributes a minimum 10% level of effort to the project

Nested Training Option supports predoctoral and postdoctoral training for individuals committed to pursuing careers as independent investigators in prostate cancer health disparity research

Maximum funding of $450K for direct costs (plus indirect costs)

If applying for the Qualified Collaborator Option, maximum funding of $600K for direct costs (plus indirect costs)

Maximum period of performance is 3 years

Additional funds can be requested if including the Nested Training Option

 Idea Development Award

Established Investigators: Independent investigators at or above the level of Assistant Professor (or equivalent); or

New Investigators: Investigators that meet the following criteria at the application submission deadline date:

Have the freedom to pursue individual aims without formal mentorship

Have not previously received a PCRP Idea Development Award

Have either completed at least 3 years of postdoctoral training or fellowship or are within 5 years of having begun first independent faculty position (or equivalent)

Preproposal is required; application submission is by invitation only

Supports new ideas that represent innovative, high-risk/high-gain approaches to prostate cancer research, and have the potential to make an important contribution to eliminating death and suffering from prostate cancer

Preliminary data are encouraged but not required

Innovation and Impact are the most important review criteria

Clinical trials are not allowed.

 New Investigator Option supports applicants early in their faculty appointments or in the process of developing independent research careers

Established PIs:

Maximum funding of $375K for direct costs (plus indirect costs)

New Investigator Option:

Maximum funding of $225K for direct costs (plus indirect costs)

Maximum period of performance is 3 years

 Laboratory - Clinical Transition Award (Modified!)

Independent investigators at or above the level of Assistant Professor (or equivalent)

Preproposal is required; application submission is by invitation only

Supports product-driven preclinical studies of promising novel lead agents (including devices) that have the potential to revolutionize prostate cancer clinical care

PIs are expected to demonstrate within the application (1) a validated target, (2) access to either one lead agent or a limited number of lead agents for optimization, and (3) the agent's mechanism of action.

The presentation of preliminary data is required to demonstrate validated target availability and distribution in relevant human tissues and substantive information from model systems that supports potential efficacy of the lead agent(s) in humans

Supports research that ranges from preclinical study through cGMP production

Maximum funding of $1.5M for direct costs (plus indirect costs)

Maximum period of performance is 3 years

 Physician Research Training Award

At the time of application submission, the PI must be either:

In the last year of an accredited medical residency or medical fellowship program; or

Within 3 years of having initiated an appointment as Instructor, Assistant Professor, or equivalent

Supports training of physicians with clinical duties for careers in prostate cancer research.

PIs must demonstrate a commitment to a career at the forefront of prostate cancer research and clinical practice

PIs must have a designated mentor with an established research program in prostate cancer

Institutions must provide at least 40% protection of PI's time for research

Projects that focus on providing training in basic research are highly encouraged

Maximum funding of $130K per year for direct costs (plus indirect costs)

Maximum period of performance is 4 years

Postdoctoral Training Award

By December 31, 2012, the PI must:

Have successfully defended a doctoral thesis or posses an M.D. degree

Have 3 years or less of postdoctoral fellowship experience

Supports prostate cancer research training opportunities for postdoctoral trainees who are recent doctoral graduates

PIs must have a designated mentor who is an experienced prostate cancer researcher

Maximum of $115K for direct costs (plus indirect costs up to a maximum rate of 8%)

Maximum period of performance is 2 years

 Synergistic Idea Development Award

Independent investigators at or above the level of Assistant Professor (or equivalent)

Preproposal is required; application submission is by invitation only

Supports new or existing partnerships between two or three independent investigators to address a central innovative question or problem in prostate cancer that may include high risk, provided there is a potential for significant impact

Preliminary data are encouraged but not required

Synergy, Innovation, and Impact are the most important review criteria

Clinical trials are not allowed

Maximum funding of $750K for direct costs (plus indirect costs)

Maximum period of performance is 3 years

 Transformative Impact Award

Independent investigators at or above the level of Assistant Professor (or equivalent)

Preproposal is required; application submission is by invitation only

Supports prostate cancer research efforts with near-term, transformative impact for prostate cancer patients

Research efforts based on team science are expected, with support by a lead PI with demonstrated success in leading large, focused projects

Consistent with the goal of near-term benefit for patients, the scope of the research effort must include translational studies, clinical research, and/or clinical trials

Applicants must demonstrate that they are prepared to initiate the study immediately upon receiving the award (i.e., as of the award date)

Maximum funding of $5.5M for direct costs (plus indirect costs)

Maximum period of performance is 3 years

All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines for the pre-application and full application are not available until the Program Announcements are released in March.

 Requests for email notification of the Program Announcements release may be sent to help@cdmrp.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

 For more information about the PCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 If you would like to request a different recipient to these messages please reply back with the corrected information.

 Point of Contact:

CDMRP Public Affairs

301-619-9783

CDMRP.PublicAffairs@amedd.army.mil

 

Joint Program Committee for Clinical and Rehabilitative Medicine Research Program FY 2012

The Armed Forces Institute of Regenerative Medicine (AFIRM) is dedicated to repairing battlefield injuries through the use of regenerative medicine technologies and associated sciences. 

 The U.S. Army Medical Research and Materiel Command (USAMRMC), with the Office of Naval Research (ONR), the Air Force Medical Service, the Office of Research and Development - Department of Veterans Affairs (VA), the National Institutes of Health (NIH), and the Office of the Assistant Secretary of Defense for Health Affairs (the Sponsors) intend to solicit applications for the AFIRM II. The AFIRM II is anticipated to be funded in fiscal year 2013 (FY13).  The intent of the AFIRM II is to fund basic through translational regenerative medicine research and development.  Activities acceptable under this award may include basic scientific research, development of animal models, preclinical studies required for initiation of FDA-regulated human clinical trials, and Phase I - II human clinical trials.

 The Government anticipates that Offerors will assemble an expert team from multiple academic institutions and/or industry partners to satisfy the objectives of the AFIRM II program announcement. Offerors are expected to seek collaboration with Government laboratories and Medical Centers/Medical Treatment Facilities such as those in the Army, Navy, Air Force, NIH and VA, if mutually beneficial.

 Topic Areas: The Government encourages proposals that specifically address one or more of the following focus areas:

 1)  Extremity Regeneration:  With better body armor in use in contemporary warfare, the heightened prevalence of serious extremity injury on the battlefield has increased requirements to treat, reconstruct, and rehabilitate Wounded Warriors suffering massive tissue loss of the extremities. Patients typically have multiple extremity injuries, which may include damage to skin, muscle, nerve, blood vessels, bone, and connective tissues.  Consideration will be given to both hard and soft tissue regeneration, limb salvage technologies, and regenerative medicine treatment of trauma-induced damage to joints. 

 a.  Soft tissue regeneration should focus on nerve, muscle and vascular injury to the extremities.

 b.  Hard tissue regeneration should focus on bone injury.

 c.  Limb salvage technologies should focus on adequate soft tissue coverage following multiple limb loss and/or extensive soft tissue damage, and alternatives to autologous grafts of nerve, vasculature, bone and/or soft tissues from uninjured tissue.

 d.  Trauma induced damage to joints will focus on the restoration of joint structure and function, and prevention of post-traumatic arthritis.   

 2)  Craniomaxillofacial Regeneration:  Craniomaxillofacial regeneration will focus on both hard and soft tissue solutions to maintain structural integrity (hold its shape) when implanted in the translational phase, integrate with the cell/environment to restore both structure and function, and maintain those attributes over time.

 a.  Soft tissue regeneration should focus on nerve, muscle and vascular injury to the craniomaxillofacial region.

 b.  Hard tissue regeneration should focus on well-shaped bone that maintains form and is of moderate strength (cranial and midface bones), load bearing bone that maintains 3-dimensional shape with the ability to support an articulating process (mandible), and Alveolar bone that supports dentition.

 3)  Skin Regeneration:  Healing of traumatic injuries to the skin and musculoskeletal system in adults often results in the development of hypertrophic scars.  These scars lead to chronic pain, limited range of motion, poor esthetics, and require extensive therapy and rehabilitation.  Primary consideration for the skin regeneration focus area will be given to scarless wound repair and burn injury repair.

 a.  Scarless wound repair efforts should focus on the control of scar formation after injury and/or treatment. Technologies that modulate the inflammatory and fibrotic response and help control scar formation and contracture are the intended focus.

 b.  Full-thickness skin repair efforts should focus on next generation skin substitutes, burn injury inhibitors, and addressing complex or problematic body areas such as hands, face, and feet.

 4)  Composite Tissue Allotransplantation and Immunomodulation:  Composite tissue allotransplantation efforts should focus on immunomodulation and immune tolerance technologies that promote better outcomes for composite tissue allotransplantation.  This focus area may include developing treatments or procedures for major limb amputation or facial disfiguration such as hand or face transplantation.  Additionally, this may include the development of technologies to abrogate the negative outcomes of long-term immunesuppression.

 5)  Genitourinary/Lower Abdomen Reconstruction:  Genitourinary and lower abdominal reconstruction efforts should focus on pelvic and urogenital reconstruction.

 a.  Pelvic reconstruction efforts should focus on promoting technologies that address injury to the anus.

 b.  Urogenital reconstruction efforts should focus on promoting technologies that address injury to external genitalia (penile, scrotal, urethral tissues), perineal tissue, and bladder. 

 Military Relevance: Relevance to the health care needs of the military service members, veterans, and beneficiaries is a key feature of the AFIRM II award.

 The CRMRP is providing information in this pre-announcement to allow investigators time to plan and develop applications. The AFIRM II program announcement and general application instructions for the award mechanism are anticipated to be posted on Grants.gov in March 2012. Application deadlines will be available when the Program Announcement is released. This pre-announcement should not be construed as an obligation by the government.

 All applications must conform to the final program announcement and application instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using Catalog of Federal Domestic Assistance (CFDA) Number 12.420.

 A Pre-Application (Letter of Intent) is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the deadline for submission of Pre-Application (Letter of Intent). Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the program announcements are released.

 Point of Contact:

CDMRP Public Affairs

Email: CDMRP.PublicAffairs@amedd.army.mil

 

DoD Multiple Sclerosis Research Funding Opportunities for FY 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $3.8 million to the Department of Defense Multiple Sclerosis Research Program (MSRP). This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 The MSRP challenges the scientific community to design innovative research relevant to the prevention, etiology, pathogenesis, assessment, and treatment of multiple sclerosis (MS). The vision of the MSRP is to prevent the occurrence, cure, reverse, or slow the progression, and lessen the personal and societal impact of MS. The FY12 MSRP specifically encourages applications that address critical needs of the MS community as listed below:

 Pathophysiological basis of disease progression:

Biological mechanisms of cortical damage in MS Pathological basis of cognitive impairment in MS New and/or improved measures for evaluating cognition in clinical research Treatment strategies for cognitive deficits including, but not limited to new or repurposed agents, and rehabilitation

 Gene-environment interactions in MS:

Environmental influences that modify specific genetic pathways associated with MS disease risk and/or progression Maternal environment influences on MS risk in genetically susceptible offspring Genetic influences on biological processes that are relevant to MS and responsive to environmental factors Epigenetic changes due to environmental exposures and their impact on biological processes that are relevant to MS

 Technological development of hardware and/or software instruments for clinical research data capture and modeling:

Development and validation of measuring tools for real-time assessment of patient outcomes relevant to MS progression or activity Development of in vivo biosensors relevant to MS Novel integrated analysis and modeling of multidisciplinary MS patient data sets (clinical, neuroscience, endocrine, genomic, exomic, transcriptomic, proteomic, microbiomic data, etc.) to better understand MS disease activity, progression, and clinical outcomes.

The MSRP is providing information in this pre-announcement to allow investigators time to plan and develop applications. FY12 MSRP program announcement and general application instructions for the following award mechanism are anticipated to be posted on Grants.gov in March 2012. Application deadlines will be available when the program announcement is released. This pre-announcement should not be construed as an obligation by the Government.

 Idea Award

Eligibility: Investigators at or above the level of Assistant Professor (or equivalent) Supports conceptually innovative, high-risk/potentially high-reward research that could ultimately lead to critical discoveries in understanding the causes and progression of MS and/or improvements in patient care and/or quality of life.

Preliminary data that are relevant to MS and the proposed research project should be included Clinical trials are not allowed Preproposal submission is required; application submission is by invitation only Maximum funding of $400,000 in direct costs (plus indirect costs) Period of performance not to exceed 2 years

 

All applications must conform to the final program announcement and general application instructions that will be available for electronic downloading from the Grants.gov website in March 2012. The application package containing the required forms for the award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application (i.e., preproposal) is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Those due dates will not be available until the Program Announcements are released in March 2012.

 Requests for email notification of the release of CDMRP program announcements may be sent to help@cdmrp.org. For more information about the MSRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 Point of Contact:

CDMRP Public Affairs

301-619-9783

 

FY12 DoD CDMRP Pre-announcements

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides research funding for the peer reviewed programs managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP).

 This e-mail is to notify the research community of the recently released pre-announcements from the following research programs:

§  Peer Reviewed Medical

§  Prostate Cancer

 Brief descriptions of each of the funding opportunities for each of these programs can be found in the respective program’s pre-announcement on the CDMRP website at http://cdmrp.army.mil.  As further funding opportunities become available, additional announcements will be released on the CDMRP website.

 Comprehensive program announcements are expected to be released in March 2012. The program announcements will include detailed descriptions of funding mechanisms, evaluation criteria, submission requirements, and deadlines.

2012 AHA Founders Affiliate Medical Student Fellowship Program

The American Heart Association Founders Affiliate is sponsoring a Medical Student Research Fellowship program.  The application submission deadline is January 31, 2012 at 5:00 pm Eastern Standard Time.

 Medical Student Fellowship Program

The purpose of the grant is to encourage medical students to consider a career in cardiovascular research.  The need for new researchers in the health sciences, from basic science to human behaviors, is critical.  This program is designed to provide students at the crossroads of career choices an opportunity to experience research first hand with an established investigator.

Application deadline:                 Tuesday, January 31, 2012 at 5:00 pm EST.

Award amount:                          Student Stipend: $22,000 (which includes 10% indirect costs)

Award duration:                         Medical Students generally begin their programs between July 1 & September 1 for a period of 12 months.

 Please read the attached program description and if applicable, complete the application and send it back by email no later than January 31, 2012 at 5:00 pm Eastern Standard Time.  Information and forms are also available online at:  Founders Affiliate Local Research Opportunities 

This fellowship is being administered at the AHA’s Founders Affiliate New York City office. For further information please call 212-878-5912. All email inquiries should be sent to my attention at: mary.gonzalez@heart.org.
DoD Ovarian Cancer Research Program Funding Opportunities for FY 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $16 million (M) to the Department of Defense Ovarian Cancer Research Program (OCRP) to support innovative, high-impact ovarian cancer research. The OCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

 

FY12 OCRP program announcements and general application instructions for the following award mechanisms have been posted on Grants.gov website.  Application deadlines begin in April, please refer to the specific Program Announcement for due dates.

 

Full program announcements and application instructions can be found at the following link: http://cdmrp.army.mil/funding/ocrp.shtml

 

Ovarian Cancer Academy Award - pre-application due April 17, 2012 Early-Career investigator must be within the first 3 years of his/her first faculty position (or equivalent) at the time of award. The first faculty position (or equivalent) may be either tenure-track or non-tenure track.

Designated Mentor must be an independent ovarian cancer researcher and at the same institution as the Early-Career Investigator.

Supports the addition of new early-career investigators to the unique, interactive virtual academy that will provide intensive mentoring, national networking, and a peer group for junior faculty.

Designated Mentor who is an experienced ovarian cancer researcher with ovarian cancer funding is required for Early-Career Investigators.

Preliminary data are required.

Institutional match of $50,000 per year is required.

Preproposal is required; application submission is by invitation only.

Maximum funding of $725K for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 

Pilot Award - pre-application due April 9, 2012 Investigators at or above the postdoctoral level (or equivalent).

Supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward.

Innovation and Impact are important review criteria.

Preliminary data are not required, but allowed.

Clinical trials are not allowed.

Preproposal is required; application submission is by invitation only.

Maximum funding of $250K for direct costs with additional $50K for optional nested Teal Scholar (plus indirect costs).

Period of performance not to exceed 2 years.

 

Teal Innovator Award - pre-application due April 17, 2012 Investigators at the level of Professor (or equivalent), and must be recognized in his/her field.

Supports a visionary individual from any field principally outside of, but not exclusive of, ovarian cancer to focus their creativity, innovation, and leadership on ovarian cancer research.

Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the elimination of ovarian cancer.

Preproposal is required; application submission is by invitation only.

Maximum funding of $2.5M for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 

Synergistic Translational Leverage Award pre-application due April 17, 2012 Investigators at or above the level of Assistant Professor (or equivalent).

Supports multidisciplinary partnership between two investigators who will leverage existing human-based resources to address high-impact research ideas or unmet needs in ovarian cancer.

Must clearly define the synergistic components that will facilitate and accelerate progress in a way that could not be accomplished through independent efforts.

Structured to accommodate two Principal Investigators (PIs); the Initiating PI is responsible for the majority of the tasks associated with application submission, and the other PI is the Partnering PI.

Preliminary data are required.

Clinical trials are allowed.

Preproposal is required; application submission is by invitation only.

Maximum funding of $500K for direct costs plus indirect costs).

Period of performance not to exceed 3 years.

 

All applications must conform to the program announcement and application instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

 

Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 

Point of Contact:

CDMRP Public Affairs

301-619-9783

CDMRP.PublicAffairs@amedd.army.mil

 

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $16 million (M) to the Department of Defense Ovarian Cancer Research Program (OCRP) to support innovative, high-impact ovarian cancer research. The OCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

 

FY12 OCRP program announcements and general application instructions for the following award mechanisms have been posted on Grants.gov website.  Application deadlines begin in April, please refer to the specific Program Announcement for due dates.

 

Full program announcements and application instructions can be found at the following link: http://cdmrp.army.mil/funding/ocrp.shtml

 

Ovarian Cancer Academy Award - pre-application due April 17, 2012 Early-Career investigator must be within the first 3 years of his/her first faculty position (or equivalent) at the time of award. The first faculty position (or equivalent) may be either tenure-track or non-tenure track.

Designated Mentor must be an independent ovarian cancer researcher and at the same institution as the Early-Career Investigator.

Supports the addition of new early-career investigators to the unique, interactive virtual academy that will provide intensive mentoring, national networking, and a peer group for junior faculty.

Designated Mentor who is an experienced ovarian cancer researcher with ovarian cancer funding is required for Early-Career Investigators.

Preliminary data are required.

Institutional match of $50,000 per year is required.

Preproposal is required; application submission is by invitation only.

Maximum funding of $725K for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 

Pilot Award - pre-application due April 9, 2012 Investigators at or above the postdoctoral level (or equivalent).

Supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward.

Innovation and Impact are important review criteria.

Preliminary data are not required, but allowed.

Clinical trials are not allowed.

Preproposal is required; application submission is by invitation only.

Maximum funding of $250K for direct costs with additional $50K for optional nested Teal Scholar (plus indirect costs).

Period of performance not to exceed 2 years.

 

Teal Innovator Award - pre-application due April 17, 2012 Investigators at the level of Professor (or equivalent), and must be recognized in his/her field.

Supports a visionary individual from any field principally outside of, but not exclusive of, ovarian cancer to focus their creativity, innovation, and leadership on ovarian cancer research.

Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the elimination of ovarian cancer.

Preproposal is required; application submission is by invitation only.

Maximum funding of $2.5M for direct costs (plus indirect costs).

Period of performance not to exceed 5 years.

 

Synergistic Translational Leverage Award pre-application due April 17, 2012 Investigators at or above the level of Assistant Professor (or equivalent).

Supports multidisciplinary partnership between two investigators who will leverage existing human-based resources to address high-impact research ideas or unmet needs in ovarian cancer.

Must clearly define the synergistic components that will facilitate and accelerate progress in a way that could not be accomplished through independent efforts.

Structured to accommodate two Principal Investigators (PIs); the Initiating PI is responsible for the majority of the tasks associated with application submission, and the other PI is the Partnering PI.

Preliminary data are required.

Clinical trials are allowed.

Preproposal is required; application submission is by invitation only.

Maximum funding of $500K for direct costs plus indirect costs).

Period of performance not to exceed 3 years.

 

All applications must conform to the program announcement and application instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

 

Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 

Point of Contact:

CDMRP Public Affairs

301-619-9783

CDMRP.PublicAffairs@amedd.army.mil

 

 

DoD Peer Reviewed Medical Research Program Funding Opportunities FY 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $50 million (M) to the Department of Defense Peer Reviewed Medical Research Program (PRMRP). The vision of the PRMRP is to improve the health and well-being of all military service members, veterans, and beneficiaries. The PRMRP challenges the scientific and clinical communities to address one of the FY12 congressionally directed topic areas with original ideas that foster new directions in basic science and translational research; novel product development leading to improved therapeutic or diagnostic tools; or clinical trials that address an immediate clinical need. This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 Congressionally Directed Topic Areas: The FY12 PRMRP will solicit research applications for the following 22 topics areas: Arthritis, Composite Tissue Transplantation, Dystonia, Drug Abuse, Epilepsy, Food Allergies, Fragile X Syndrome, Hereditary Angioedema, Inflammatory Bowel Disease, Interstitial Cystitis, Listeria Vaccine for Infectious Disease, Lupus, Malaria, Nanomedicine for Drug Delivery Science, Neuroblastoma, Osteoporosis and Related Bone Disease, Paget's Disease, Polycystic Kidney Disease, Post-Traumatic Osteoarthritis, Scleroderma, Tinnitus, and Tuberculosis.

 Military Relevance: Relevance to the health care needs of the military service members, veterans, and beneficiaries is a key feature of each FY12 PRMRP award mechanism.

 The PRMRP is providing information in this pre-announcement to allow investigators time to plan and develop applications. FY 12 PRMRP program announcements and general application instructions for the following award mechanisms are anticipated to be posted on Grants.gov in February and March 2012. Application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.

 Clinical Trial

Assistant Professor level or above (or equivalent) Supports the rapid implementation of clinical trials of novel interventions with the potential to have a significant impact on patient care in the topic area of interest Clinical trial is expected to be initiated within 12 months of award date Maximum of $2.2 million for direct costs (plus indirect costs) Maximum period of performance is 5 years

 Discovery Award

All Investigators

Supports the exploration of a highly innovative new concept or untested theory Projects involving human subjects or specimens will not be supported unless they are exempt under Title 32, Code of Federal Regulations, Part 219, Section 101(b)(32 CFR 219.101[b]) Maximum of $125,000 for direct costs (plus indirect costs) Maximum period of performance is 18 months

 Investigator-Initiated Research

Assistant Professor level or above (or equivalent) Supports research that will make an original and important contribution to the field of research or patient care in the topic area of interest Partnering Principal Investigator option available Clinical trials will not be funded Preproposal submission is required; application submission is by invitation only Maximum of $750,000 for direct costs (plus indirect costs) Maximum period of performance is 3 years

 Technology/Therapeutic Development

Assistant Professor level or above (or equivalent) Supports the development of new diagnostics or therapies that have the potential to make a strong impact on patient care in the topic area of interest Product-oriented Device Drug Clinical guidance/guidelines Clinical trials will not be funded Maximum of $1.5 million for direct costs (plus indirect costs) Maximum period of performance is 3 years All applications must conform to the final program announcements and application instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov in late February or early March. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline (available when the Program Announcements are released in late February or early March). Applications must be submitted through the federal government's single-entry portal, Grants.gov. Additional submission deadlines are not available until the program announcements are released.

 Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the PRMRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

If you would like to request a different recipient to these messages please reply back with the corrected information.

 Point of Contact:

CDMRP Public Affairs

301-619-9783

 

Department of Defense Neurofibromatosis and the Tuberous Sclerosis Complex Research Programs Funding Opportunities for FY2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $12.8 million to the Department of Defense Neurofibromatosis Research Program (NFRP) and $5.1 million to the Department of Defense Tuberous Sclerosis Complex Research Program (TSCRP). These programs are administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

 The NFRP and TSCRP are providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY12 NFRP and FY12 TSCRP program announcements and general application instructions for the following award mechanisms are anticipated to be posted on Grants.gov in late February or early March 2012. Application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.

 NFRP Clinical Trial Award

Must be an independent investigator at or above the level of Assistant Professor (or equivalent) Fund Phase 0, I, or II clinical trials relevant to NF and/or Schwannomatosis; combinations of phases are permitted Preclinical data required.

Phase I or pilot clinical trial data required for Phase II clinical trial applications Maximum funding of $900,000 in direct costs (plus indirect costs)

Period of performance not to exceed 4 years    

 NFRP Exploration - Hypothesis Development Award All levels of experience Fund the initial exploration of innovative, untested research, and pursue serendipitous observations Projects involving human subjects or human biological substances must be exempt under 32 CFR 219.101(b) (4) or eligible for expedited review under 32 CFR 219.110 or 21 CFR 56.110 Preliminary data is encouraged but not required

 Clinical trials not allowed

Maximum funding of $100,000 in direct costs (plus indirect costs) Period of performance not to exceed 2 years

 NFRP Investigator-Initiated Research Award

PI: Must be an independent investigator at or above the level of Assistant Professor (or equivalent) Fund basic and clinically oriented research relevant to NF and/or Schwannomatosis Optional Feature: Applications that include either a Qualified Collaborator or Postdoctoral Fellow who meet criteria identified in the announcement may apply for a higher level of funding Preliminary data required

Clinical trials not allowed

Maximum funding of $525,000 in direct costs (plus indirect costs) Maximum funding of $675,000 in direct costs (plus indirect costs) for applications including an optional qualified collaborator or nested postdoctoral fellow Period of performance not to exceed 3 years

 NFRP New Investigator Award

Must be an independent investigator at or below the level of Assistant Professor (or equivalent) or an established investigator at or above the level of Assistant Professor seeking to transition into a career in NF research Fund investigators in the early stages of their careers Experience in NF research is allowed, but not required Preliminary data required

Clinical trials not allowed

Maximum funding of $400,000 in direct costs (plus indirect costs) Period of performance not to exceed 3 years

 TSCRP Clinical Trial Award

Must be an independent investigator at or above the level of Assistant Professor (or equivalent) This award may be used to support Phase 0, 1, and 2 clinical trials Pre-application required

Preliminary data or clear scientific rationale required Maximum funding of $1,000,000 in direct costs (plus indirect costs) Period of performance should not exceed 4 years

TSCRP Exploration -Hypothesis Development Award Investigators at all academic levels (or equivalent) Fund the initial exploration of innovative, untested research, and pursue serendipitous observations Projects involving human subjects or human biological substances must be exempt under 32 CFR 219.101(b)(4) Preliminary data is encouraged but not required

Clinical trials not allowed

Maximum funding of $100,000 in direct costs (plus indirect costs) Period of performance should not exceed 2 years

 TSCRP Idea Development Award

Principal Investigator: Independent investigators with a documented faculty appointment (or equivalent) Encourage high-impact, innovative research that will drive the field forward Optional Feature: Applications that include either a Qualified Collaborator or Postdoctoral Fellow who meet criteria identified in the announcement may apply for a higher level of funding Preliminary data required

Clinical trials not allowed

Maximum funding of $425,000 in direct costs (plus indirect costs) Maximum funding of $575,000 in direct costs (plus indirect costs) for applications including an Optional Qualified Collaborator or Nested Postdoctoral Fellow.

Period of performance should not exceed 3 years

 All applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the Grants.gov website in February. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the program announcements are released.

 Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the NFRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 If you are not the correct person or no longer wish to receive these types of announcements please let us know and we will update our distribution list.

 Point of Contact:

CDMRP Public Affairs

301-619-9783

CDMRP.PublicAffairs@amedd.army.mil

Department of Defense Gulf War Illness Research Programs Anticipated Funding for FY12

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $10 million (M) to the Department of Defense Gulf War Illness Research Program (GWIRP) to support innovative, high-impact research into Gulf War Illness.  The Department of Defense Gulf War Illness Research Program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

The GWIRP is providing information in this pre-announcement to allow investigators time to plan and develop applications. FY12 GWIRP program announcements and general application instructions for the following award mechanisms are anticipated to be posted on Grants.gov in February and March 2012. Application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.

 Investigator-Initiated Research Award

Independent investigators at all academic levels are eligible to apply.

*Supports new ideas in basic and clinical developmental research focusing on Gulf War Illness (GWI).

*Preliminary data are not required, and if provided, do not necessarily have to come from the GWI research field.

*Clinical trials are not allowed under this mechanism.

*The maximum allowable funding for the entire period of performance is $600,000 for direct costs.

*The maximum period of performance is 3 years.

More cost-effective studies not requesting the full funding amount are encouraged.

 Innovative Treatment Evaluation Award

Independent investigators at all academic levels are eligible to apply.

*Supports exploratory or small-scale studies evaluating potential treatments not previously studied in GWI.

*Pilot Phase II or Phase I/II trial combinations are permitted.

*Preliminary data are not required, though proposed studies must be supported by logical rationale.

*The maximum allowable funding for the entire period of performance is $450,000 for direct costs.

*The maximum period of performance is 3 years.

More cost-effective studies not requesting the full funding amount are encouraged.

 Consortium Award

Open only to investigators who received an FY10 GWIRP Consortium Development Award *Supports a major multi-institutional research effort conducted by leading Gulf War Illness investigators focused on innovative approaches for:

     Identifying treatments

     Improving GWI definition and diagnostics

     Understanding underlying pathobiology *The consortium will consist of a Coordinating Center and multiple Research Sites.

*May encompass research from basic/mechanistic to preclinical and clinical studies. A minimum of 3 studies must be submitted as part of the Consortium Award application.

*The maximum allowable funding for the entire period of performance is $4,000,000 for direct costs.

*The Consortium Award will be funded incrementally from FY12 and FY14, assuming availability of congressionally appropriated funds in FY14.

*The maximum period of performance is 4 years.

 All applications must conform to the final program announcements and application instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline (which will be available in February or March 2012). Applications must be submitted through the federal government's single-entry portal, Grants.gov.

Requests for email notification of the release of CDMRP program announcements may be sent to help@cdmrp.org. For more information about the GWIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 If you are not the correct person or no longer wish to receive these types of announcements please let us know and we will update our distribution list.

 Point of Contact:

CDMRP Public Affairs

301-619-9783

CDMRP.PublicAffairs@amedd.army.mil
2012 Klarman Program in Eating Disorders Research

We are pleased to announce the 2012 Grant Cycle for the Klarman Family Foundation Grants Program in Eating Disorders Research. The Program’s short-term goal is to support the most outstanding science and expand the pool of scientists whose research explores the basic biology of anorexia nervosa, bulimia nervosa, and/or binge eating disorder. The long-term goal is to improve the lives of patients suffering from these conditions.

Examples of funding areas include but are not limited to molecular genetic analysis of relevant neural circuit assembly and function; epigenetic research; animal models created by genetically altering neural circuits; and testing of new chemical entities that might be used in animal models as exploratory treatments. Please note that imaging studies involving humans are no longer eligible. Investigators conducting research in the neuro-circuitry of fear conditioning or reward behavior may also apply but must justify the relevance of their research projects to the basic biology of eating disorders. Clinical psychotherapeutic studies, medication trials and research in the medical complications of these disorders are outside the scope of this Program.

 Application Deadline:    February 1, 2012

Application Materials:    www.tmfgrants.org/klarman

Funding Begins:            June 1, 2012

 Award Categories:

2-year projects of $400,000 USD

1-year pilot studies of up to

$150,000 USD

 Eligibility: Applicants must hold a faculty appointment at a nonprofit academic, medical or research institution in the United States, Canada or Israel.

 Questions: GLockwood@hria.org or 617-279-2240, x702 

The Klarman Family Foundation Grants Program in Eating Disorders Research is administered by The Medical Foundation, a division of Health Resources in Action, a Boston-based nonprofit.
LRF Additional Support for NIH-funded F32 Postdoctoral Fellows

2012 Grant Cycle

The Lymphatic Research Foundation is a 501(c)(3) not-for profit organization whose mission is to advance research of the lymphatic system and to find the cause of and cure for lymphatic diseases, lymphedema, and related disorders. LRF is pleased to announce that it is offering additional support to outstanding NIH-funded F32 postdoctoral fellows who are currently working in a field relevant to the lymphatic system. The goal of the Additional Support Awards Program is to help foster career interest in the field of lymphatic research by offering additional funds for F32 postdoctoral research projects.

Funding Period and Amount of Award

July 1, 2012 - June 30, 2014

$20,000 over two years  

Application Deadline

February 3, 2012, 1:00 p.m. Eastern Time (GMT-5)

Application Requirements

Online Form, Face Sheet, 500-word essay, and a copy of F32 Application and 

Award Notice. Further instructions: www.tmfgrants.org/LRF32

Eligibility

The Lymphatic Research Foundation is accepting applications from candidates working in the United States who meet the following eligibility requirements:

§  Supported by the NIH F32 Postdoctoral Fellowship Program

§  Have at least one year remaining of F32 support as of July 1, 2012

§  Conduct research that clearly advances the mission of LRF

 

For more information about the Lymphatic Research Foundation, www.lymphaticresearch.org. The Lymphatic Research Foundation Additional Support for NIH-funded F-232 Postdoctoral Fellowship Awards Program is administered by The Medical Foundation division. Please direct questions to LLam@hria.org or 617-279-2240 ext. 710.
Macy Faculty Scholars Program Accepting Applications

The Josiah Macy Jr. Foundation is seeking applicants for the Macy Faculty Scholars Program through March 2012.  Now in its second year, the program is designed to nurture the careers of educational innovators in medicine and nursing and develop the next generation of national leaders in health professions education.  Five early- to mid-career faculty members will be selected for two-year scholarships awarded in the amount of $100,000 per year.
 


ORSP's Partners Quick Links Tools & Training Resources
Office of Research & Sponsored Programs welcomes your feedback and suggestions - contact us at orsp@uchc.edu
263 Farmington Ave., MC-2806, Farmington CT 06032
(860) 679-4040
 
  
A-Z INDEX        UCONN HEALTH CENTER        TEXT-ONLY © University of Connecticut Health Center
Disclaimer   Privacy Notice
Maps & Directions